
<html lang="en"     class="pb-page"  data-request-id="43d753eb-5651-4b11-8148-c30cb67d0fa8"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/acs.jmedchem.9b00282;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2019.62.issue-8"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Carbonic Anhydrase XII Inhibitors Overcome Temozolomide Resistance in Glioblastoma" /></meta><meta name="dc.Creator" content="Prashant  Mujumdar" /></meta><meta name="dc.Creator" content="Joanna  Kopecka" /></meta><meta name="dc.Creator" content="Silvia  Bua" /></meta><meta name="dc.Creator" content="Claudiu T.  Supuran" /></meta><meta name="dc.Creator" content="Chiara  Riganti" /></meta><meta name="dc.Creator" content="Sally-Ann  Poulsen" /></meta><meta name="dc.Description" content="The natural product primary sulfonamide, psammaplin C (1), when used in combination with clinically used chemotherapeutic drugs, including temozolomide, reverses multidrug resistance and increases ..." /></meta><meta name="Description" content="The natural product primary sulfonamide, psammaplin C (1), when used in combination with clinically used chemotherapeutic drugs, including temozolomide, reverses multidrug resistance and increases ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 29, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b00282" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00282" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b00282" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00282" /></link>
        
    
    

<title>Carbonic Anhydrase XII Inhibitors Overcome Temozolomide Resistance in Glioblastoma | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b00282" /></meta><meta property="og:title" content="Carbonic Anhydrase XII Inhibitors Overcome Temozolomide Resistance in Glioblastoma" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.9b00282/20190418/images/large/jm-2019-002823_0011.jpeg" /></meta><meta property="og:description" content="The natural product primary sulfonamide, psammaplin C (1), when used in combination with clinically used chemotherapeutic drugs, including temozolomide, reverses multidrug resistance and increases survival in glioblastoma, a highly aggressive primary brain tumor. We showed previously that the mechanism of action of 1 is novel, acting to indirectly interfere with P-glycoprotein drug efflux activity as a consequence of carbonic anhydrase XII (CA XII) inhibition. To build structure–activity relationships, 45 derivatives of 1 were designed, synthesized, and evaluated against a panel of CA isoforms. Compound 55 was identified as a potent inhibitor of CA XII (Ki = 0.56 nM) and was investigated in vitro and in vivo using samples from glioblastoma patients. The results strengthen the possibility that co-therapy of temozolomide with a CA XII inhibitor may more effectively treat glioblastoma by suppressing an important temozolomide resistance mechanism." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b00282"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b00282">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b00282&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b00282&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b00282&amp;href=/doi/10.1021/acs.jmedchem.9b00282" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 8</span><span class="cit-fg-pageRange">, 4174-4192</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/8" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b00223" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b00378" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Carbonic Anhydrase XII Inhibitors Overcome Temozolomide Resistance in Glioblastoma</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Prashant Mujumdar</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Prashant Mujumdar</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Griffith Institute for Drug Discovery, Griffith University, Don Young Road, Nathan, Brisbane, Queensland 4111, Australia</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Prashant++Mujumdar">Prashant Mujumdar</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Joanna Kopecka</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Joanna Kopecka</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Oncology, University of Torino, Via Santena 5/bis, 10126 Torino, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Joanna++Kopecka">Joanna Kopecka</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Silvia Bua</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Silvia Bua</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">NEUROFARBA Department, Sezione di Scienze Farmaceutiche, Università degli Studi di Firenze, Via Ugo Schiff 6, 50019 Sesto Fiorentino, Florence, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Silvia++Bua">Silvia Bua</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Claudiu T. Supuran</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Claudiu T. Supuran</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">NEUROFARBA Department, Sezione di Scienze Farmaceutiche, Università degli Studi di Firenze, Via Ugo Schiff 6, 50019 Sesto Fiorentino, Florence, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Claudiu+T.++Supuran">Claudiu T. Supuran</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4262-0323" title="Orcid link">http://orcid.org/0000-0003-4262-0323</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Chiara Riganti</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Chiara Riganti</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Oncology, University of Torino, Via Santena 5/bis, 10126 Torino, Italy</div></div><span class="conrtib-corresp"><strong>*</strong>C.R.: e-mail, <a href="/cdn-cgi/l/email-protection#7c1f14151d0e1d520e151b1d1208153c0912150813521508"><span class="__cf_email__" data-cfemail="14777c7d7566753a667d73757a607d54617a7d607b3a7d60">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Chiara++Riganti">Chiara Riganti</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9787-4836" title="Orcid link">http://orcid.org/0000-0001-9787-4836</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Sally-Ann Poulsen</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sally-Ann Poulsen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Griffith Institute for Drug Discovery, Griffith University, Don Young Road, Nathan, Brisbane, Queensland 4111, Australia</div></div><span class="conrtib-corresp"><strong>*</strong>S.-A.P.: e-mail, <a href="/cdn-cgi/l/email-protection#21520f514e544d52444f6146534847474855490f4445540f4054"><span class="__cf_email__" data-cfemail="ea99c49a859f86998f84aa8d98838c8c839e82c48f8e9fc48b9f">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sally-Ann++Poulsen">Sally-Ann Poulsen</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4494-3687" title="Orcid link">http://orcid.org/0000-0003-4494-3687</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00282&amp;href=/doi/10.1021%2Facs.jmedchem.9b00282" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 8</span><span class="cit-pageRange">, 4174–4192</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 29, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>12 February 2019</li><li><span class="item_label"><b>Published</b> online</span>29 March 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 April 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b00282" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00282</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4174%26pageCount%3D19%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DPrashant%2BMujumdar%252C%2BJoanna%2BKopecka%252C%2BSilvia%2BBua%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D8%26contentID%3Dacs.jmedchem.9b00282%26title%3DCarbonic%2BAnhydrase%2BXII%2BInhibitors%2BOvercome%2BTemozolomide%2BResistance%2Bin%2BGlioblastoma%26numPages%3D19%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4192%26publicationDate%3DApril%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b00282"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1142</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">12</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b00282" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Carbonic Anhydrase XII Inhibitors Overcome Temozolomide Resistance in Glioblastoma&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Prashant&quot;,&quot;last_name&quot;:&quot;Mujumdar&quot;},{&quot;first_name&quot;:&quot;Joanna&quot;,&quot;last_name&quot;:&quot;Kopecka&quot;},{&quot;first_name&quot;:&quot;Silvia&quot;,&quot;last_name&quot;:&quot;Bua&quot;},{&quot;first_name&quot;:&quot;Claudiu&quot;,&quot;last_name&quot;:&quot;T. Supuran&quot;},{&quot;first_name&quot;:&quot;Chiara&quot;,&quot;last_name&quot;:&quot;Riganti&quot;},{&quot;first_name&quot;:&quot;Sally-Ann&quot;,&quot;last_name&quot;:&quot;Poulsen&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;29&quot;,&quot;issue&quot;:&quot;8&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;4174-4192&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b00282&quot;},&quot;abstract&quot;:&quot;The natural product primary sulfonamide, psammaplin C (1), when used in combination with clinically used chemotherapeutic drugs, including temozolomide, reverses multidrug resistance and increases survival in glioblastoma, a highly aggressive primary brain tumor. We showed previously that the mechanism of action of 1 is novel, acting to indirectly interfere with P-glycoprotein drug efflux activity as a consequence of carbonic anhydrase XII (CA XII) inhibition. To build structure–activity relationships, 45 derivatives of 1 were designed, synthesized, and evaluated against a panel of CA isoforms. Compound 55 was identified as a potent inhibitor of CA XII (Ki = 0.56 nM) and was investigated in vitro and in vivo using samples from glioblastoma patients. The results strengthen the possibility that co-therapy of temozolomide with a CA XII inhibitor may more effectively treat glioblastoma by suppressing an important temozolomide resistance mechanism.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00282&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00282" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00282&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00282" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00282&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00282" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00282&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00282&amp;href=/doi/10.1021/acs.jmedchem.9b00282" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b00282" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b00282" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00282&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b00282%26sid%3Dliteratum%253Aachs%26pmid%3D30925064%26genre%3Darticle%26aulast%3DMujumdar%26date%3D2019%26atitle%3DCarbonic%2BAnhydrase%2BXII%2BInhibitors%2BOvercome%2BTemozolomide%2BResistance%2Bin%2BGlioblastoma%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D8%26spage%3D4174%26epage%3D4192%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292234" title="Chromatography">Chromatography</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=290716" title="Sulfones">Sulfones</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/8" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/jmcmar.2019.62.issue-8/20190425/jmcmar.2019.62.issue-8.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.9b00282/20190418/images/medium/jm-2019-002823_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.9b00282/20190418/images/large/jm-2019-002823_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00282&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The natural product primary sulfonamide, psammaplin C (<b>1</b>), when used in combination with clinically used chemotherapeutic drugs, including temozolomide, reverses multidrug resistance and increases survival in glioblastoma, a highly aggressive primary brain tumor. We showed previously that the mechanism of action of <b>1</b> is novel, acting to indirectly interfere with P-glycoprotein drug efflux activity as a consequence of carbonic anhydrase XII (CA XII) inhibition. To build structure–activity relationships, 45 derivatives of <b>1</b> were designed, synthesized, and evaluated against a panel of CA isoforms. Compound <b>55</b> was identified as a potent inhibitor of CA XII (<i>K</i><sub>i</sub> = 0.56 nM) and was investigated in vitro and in vivo using samples from glioblastoma patients. The results strengthen the possibility that co-therapy of temozolomide with a CA XII inhibitor may more effectively treat glioblastoma by suppressing an important temozolomide resistance mechanism.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43054" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43054" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">CA enzymes (CA, EC 4.2.1.1) are involved in maintaining pH homeostasis. This maintenance is achieved via catalysis of the reversible hydration of carbon dioxide to bicarbonate and a proton.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> There are two extracellular facing membrane bound CAs, CA IX and CA XII, that are highly expressed in the hypoxic core of solid tumors where they contribute to pH homeostasis of the tumor microenvironment, specifically to benefit tumor growth.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> We recently demonstrated that CA XII colocalizes with another membrane protein, the drug efflux protein, P-glycoprotein (Pgp), in a range of drug resistant cancer cells including glioblastoma.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Furthermore, we showed that CA XII maintains the optimal pH to support the drug efflux activity of Pgp, leading to drug resistant cells.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3,4)</a> Psammaplin C (<b>1</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), is one of only two described natural products comprising a primary sulfonamide functional group in its structure.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> We recently reported an improved and facile synthesis of compound <b>1</b> and subsequently showed that it inhibited CA enzymes.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Compound <b>1</b> was a particularly potent CA XII inhibitor (<i>K</i><sub>i</sub> = 0.79 nM). Using high resolution X-ray crystallography, we observed the sulfonamide of <b>1</b> directly coordinated to the active site zinc cation in both CA IX and CA XII related proteins, consistent with the binding pose observed for other primary sulfonamide–CA complexes reported in the Protein Data Bank.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Compound <b>1</b> was then selected for in vivo studies in an orthotopic mouse model using primary cells obtained from three glioblastoma patients. The combination of <b>1</b>, with both front-line and second-line chemotherapeutics, resensitized drug resistant glioblastoma to chemotherapy while significantly extending overall survival of the treated animals compared to chemotherapy treatment alone.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Notably, compound <b>1</b> shows no toxicity and is only effective if used in combination with a chemotherapy. Given that compound <b>1</b> acts with an unprecedented mechanism of action to reverse multidrug resistance in aggressive glioblastoma xenografts, the aim of the current study was to build structure–activity relationships (SARs) around the core scaffold of <b>1</b>. To enable this, a series of novel target compounds have been designed, synthesized, and evaluated for inhibition properties against the two cancer relevant human CA isoforms, CA IX and XII. We identified a suitable compound (compound <b>55</b>) for validation of the in vitro and in vivo action of <b>1</b> observed when coadministered with temozolomide in glioblastoma.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.9b00282/20190418/images/medium/jm-2019-002823_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.9b00282/20190418/images/large/jm-2019-002823_0001.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Psammaplin C <b>1</b>, a natural product primary sulfonamide, is a subnanomolar inhibitor of the cancer related carbonic anhydrase isozyme, CA XII (<i>K</i><sub>i</sub> = 0.79 nM).<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> There are three distinct structural components, (a) a 3-bromo-4-hydroxybenzyl group, red, (b) an aminoethyl primary sulfonamide functional group, blue, and (c) a free oxime moiety, green.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.9b00282/20190418/images/large/jm-2019-002823_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00282&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>1</b> comprises three distinct structural components, (a) a 3-bromo-4-hydroxybenzyl group, (b) an aminoethyl primary sulfonamide functional group, and (c) a free oxime moiety (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). An unhindered primary sulfonamide is a minimum requirement for CA inhibition, and this feature was maintained in the structure of all target compounds (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). The SAR around the aminoethyl sulfonamide in <b>1</b> was explored by replacement of this component with variable aliphatic and/or aromatic sulfonamides. The benzyl moiety SAR was explored by introducing different substitution patterns on the benzyl group. In total, a library of 18 novel derivatives of <b>1</b> were synthesized and evaluated for CA inhibition. Additionally, as the requirement for the free oxime moiety of <b>1</b> on enzyme inhibition was unknown, the 27 intermediate sulfonamide compounds with protected oxime groups were also evaluated for CA enzyme inhibition in this study (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). The selection of precursor compounds from which to generate the target SAR library compounds <b>27</b>–<b>68</b>, sulfonamides (<b>2</b>–<b>6</b>), and protected oximes (<b>7</b>–<b>14</b>) was informed by disconnection of the amide bond of <b>1</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.9b00282/20190418/images/medium/jm-2019-002823_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.9b00282/20190418/images/large/jm-2019-002823_0002.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Library precursor compounds sulfonamides <b>2</b>–<b>6</b> and protected oximes <b>7</b>–<b>14</b> were used toward the preparation of psammaplin C derivatives: protected oximes <b>27</b>–<b>42</b>, <b>59</b>–<b>68</b>, <b>72</b>–<b>76</b> and free oximes <b>43</b>–<b>58</b> and <b>69</b>–<b>71</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.9b00282/20190418/images/large/jm-2019-002823_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00282&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71670" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71670" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemical Synthesis</h3><div class="NLM_p">On the basis of our findings when developing a synthetic route to <b>1</b>, we were aware that orthogonal oxime protecting groups may be required to accommodate the variable substituents on the benzyl moiety in the target compounds.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> The synthesis of precursor compounds in which the oxime hydroxyl group is protected as either a benzyl ether (<i>O</i>-Bn set; <b>7</b>–<b>10</b>) or a tetrahydropyran-2-yl ether (<i>O</i>-THP set; <b>11</b>–<b>14</b>) was carried out. To prepare <b>7</b>–<b>14</b>, commercially available aldehydes <b>15</b>–<b>18</b> were first treated with <i>N</i>-acetylglycine under Erlenmeyer conditions to generate benzylidene oxazolone intermediates <b>19</b>–<b>22</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). The oxazolones were then hydrolyzed by refluxing in aqueous 10% HCl to generate the corresponding phenylpyruvic acids <b>23</b>–<b>26</b>. Lastly, oximation of crude <b>23</b>–<b>26</b> with NH<sub>2</sub>OBn·HCl or NH<sub>2</sub>OTHP afforded the eight precursor protected oximes <b>7</b>–<b>10</b> and <b>11</b>–<b>14</b>, respectively, <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7,8)</a></div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.9b00282/20190418/images/medium/jm-2019-002823_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.9b00282/20190418/images/large/jm-2019-002823_0006.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of <i>O</i>-Bn and <i>O</i>-THP Protected Oximes <b>7</b>–<b>10</b> and <b>11</b>–<b>14</b>, Respectively, from Commercially Available Aldehydes <b>15</b>–<b>18</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.9b00282/20190418/images/large/jm-2019-002823_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00282&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) <i>N</i>-acetylglycine, NaOAc, Ac<sub>2</sub>O, 120 °C, 3 h; (ii) aq HCl (10%), reflux, 15 h; (iii) pyridine, H<sub>2</sub>NOBn·HCl, rt, 15 h; (iv) pyridine, H<sub>2</sub>NOTHP, rt, 15 h. R<sup>1</sup> and R<sup>2</sup> = H if not specified otherwise. Yields of <b>7</b>–<b>14</b> are over two steps from <b>19</b>–<b>22</b>.</p></p></figure><div class="NLM_p">The <i>O</i>-Bn oxime psammaplin C derivatives were accessible by the reaction of the amino group of sulfonamides <b>2</b>–<b>5</b> with the carboxylic acid group of the <i>O</i>-Bn protected oximes <b>7</b>–<b>10</b> in the presence of EDC·HCl and HOBt·H<sub>2</sub>O (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). Amino sulfonamides <b>2</b>–<b>4</b> are commercially available, while thiadiazole sulfonamide <b>5</b> was synthesized as reported previously.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> In principle, 16 <i>O</i>-Bn oxime psammaplin C derivatives (<b>27</b>–<b>42</b>) are possible; however the subsequent removal of the <i>O</i>-Bn group using transfer hydrogenation proceeded cleanly only for nonbrominated precursors, while debenzylation occurred with simultaneous debromination for brominated precursor compounds <b>28</b>, <b>32</b>, <b>36</b>, and <b>40</b>.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Our efforts to address the latter side reaction (described below, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) were not successful, and thus we elected not to synthesize the then two remaining bromine containing <i>O</i>-Bn compounds (compounds <b>34</b> and <b>38</b>). Although <i>O</i>-Bn compounds <b>39</b>–<b>41</b> were successfully prepared from thiadiazole sulfonamide <b>5</b>, they were unreactive to O-debenzylation using transfer hydrogenation. It was hypothesized that the soft sulfur in the heterocycle of these compounds may poison the Pd catalyst. Furthermore, the attempted synthesis of compound <b>42</b> from thiadiazole sulfonamide <b>5</b> and <i>O</i>-Bn protected oxime <b>10</b> gave no desired product (evidenced by TLC). In summary, 13 of 16 possible <i>O</i>-Bn protected oxime derivatives of <b>1</b> were prepared (<b>27</b>–<b>33</b>, <b>35</b>–<b>37</b>, and <b>39</b>–<b>41</b>) of which six reacted cleanly toward O-debenzylation in subsequent transfer hydrogenation to provide synthetic access to the target corresponding free oxime compounds <b>43</b>, <b>45</b>, <b>47</b>, <b>49</b>, <b>51</b>, and <b>53</b>.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.9b00282/20190418/images/medium/jm-2019-002823_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.9b00282/20190418/images/large/jm-2019-002823_0007.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis toward Psammaplin C Derivatives <b>27</b>–<b>58</b> from <i>O</i>-Bn Precursors <b>7</b>–<b>10</b> and Sulfonamides <b>2</b>–<b>5</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.9b00282/20190418/images/large/jm-2019-002823_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00282&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) EDC·HCl, HOBt·H<sub>2</sub>O, <b>2</b>–<b>5</b>, dry DMF, rt, 24 h; (ii) cyclohexene, Pd(OH)<sub>2</sub>, absolute EtOH, reflux, 2–6 h. R<sup>1</sup>, R<sup>2</sup> = H unless otherwise specified. Compounds <b>55</b>–<b>58</b> were not obtained.</p></p></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Reaction Conditions Assessed for O-Debenzylation of the Brominated Derivatized <i>O</i>-Bn Oxime <b>28</b> as a Model Compound</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">entry</th><th class="colsep0 rowsep0" align="center">reaction conditions</th><th class="colsep0 rowsep0" align="center">observation</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">Pd/C, HCOOH, NEt<sub>3</sub> (cat.), EtOH, 60 °C, 3–5 h</td><td class="colsep0 rowsep0" align="left">debenzylation/debromination</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">H<sub>2</sub> (60 mbar), Pd/C, dioxane–AcOH (1:1), rt, 12 h</td><td class="colsep0 rowsep0" align="left">debenzylation/debromination</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">H<sub>2</sub> (atm), Pd/C, MeOH–AcOH (1:1), rt, 12 h</td><td class="colsep0 rowsep0" align="left">debromination</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">Pd(OH)<sub>2</sub>, cyclohexene, EtOH, reflux, 12 h</td><td class="colsep0 rowsep0" align="left">no reaction</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">TMSI, dry DCM, rt, 3 days</td><td class="colsep0 rowsep0" align="left">no reaction</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">TMSCl, NaI, ACN, 0 °C to rt, 12 h</td><td class="colsep0 rowsep0" align="left">no reaction</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">7</td><td class="colsep0 rowsep0" align="left">AlCl<sub>3</sub>, <i>N</i>,<i>N</i>-dimethylaniline, DCM, rt, 12 h</td><td class="colsep0 rowsep0" align="left">no reaction</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">TFA/toluene (1:1), rt, overnight</td><td class="colsep0 rowsep0" align="left">no reaction</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">9</td><td class="colsep0 rowsep0" align="left">BF<sub>3</sub>·Et<sub>2</sub>O, NaI, ACN, 0 °C to rt, 12 h</td><td class="colsep0 rowsep0" align="left">decomposition (TLC)</td></tr></tbody></table></div></div><div class="NLM_p">With the bromo derivatized <i>O</i>-Bn oxime <b>28</b> as a model compound we attempted various alternative conditions to remove the <i>O</i>-Bn moiety to prepare the corresponding free oxime <b>44</b>, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>. Formic acid–triethylamine mediated transfer hydrogenation<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, entry 1) and Pd-catalyzed hydrogenation<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12,13)</a> with H<sub>2</sub> (60 mbar) (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, entry 2) afforded debenzylation and debromination. Pd-catalyzed hydrogenation with H<sub>2</sub> (atm) afforded debromination only (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, entry 3). No reaction was observed with either transfer hydrogenation<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, entry 4), trimethylsilyl iodide<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> (TMSI) (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, entry 5), in situ generation of TMSI<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, entry 6), use of a Lewis acid<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> AlCl<sub>3</sub> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, entry 7) or TFA–toluene (1:1)<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, entry 8). In the case of BF<sub>3</sub>·Et<sub>2</sub>O <a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, entry 9) decomposition of <b>28</b> was observed (evidenced by TLC).</div><div class="NLM_p">As the brominated and/or thiadiazole containing target free oximes were not accessible using <i>O</i>-Bn as a protecting group, we next investigated the <i>O</i>-THP protected oxime precursors <b>11</b>–<b>14</b> as an alternative source for these compounds. Compounds <b>11</b>–<b>14</b> were combined with 1 equiv of the corresponding sulfonamide <b>2</b>–<b>5</b> in the presence of the amide coupling reagents EDC·HCl and HOBt·H<sub>2</sub>O (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). Of the 10 target <i>O</i>-THP protected psammaplin C derivatives (<b>59</b>–<b>68</b>) nine formed successfully (<b>59</b>–<b>67</b>). The THP group of <b>59</b>–<b>67</b> was then cleanly removed under acidic conditions (4.0 M HCl in 1,4-dioxane) to afford the corresponding target psammaplin C free oxime derivatives (<b>44</b>, <b>46</b>, <b>48</b>, <b>50</b>, <b>52</b>, <b>54</b>–<b>57</b>) (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>).<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> As neither <i>O</i>-Bn <b>42</b> nor <i>O</i>-THP <b>68</b> (prepared from <b>5</b> and <b>10</b> or <b>14</b>, respectively) was successfully synthesized, this necessarily meant that the free oxime <b>58</b> was not accessible.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.9b00282/20190418/images/medium/jm-2019-002823_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.9b00282/20190418/images/large/jm-2019-002823_0008.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis toward Psammaplin C Derivatives <b>44</b>, <b>46</b>, <b>48</b>, <b>50</b>, <b>52</b>, <b>54</b>, and <b>55</b>–<b>68</b> from the Corresponding <i>O</i>-THP Precursors <b>11</b>–<b>14</b> and Sulfonamides <b>2</b>–<b>5</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.9b00282/20190418/images/large/jm-2019-002823_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00282&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) EDC·HCl, HOBt·H<sub>2</sub>O, <b>2</b>–<b>5</b>, dry DMF, rt, 24 h; (ii) 4 M HCl in 1,4-dioxane, 0 °C, 4–10 h. R<sup>1</sup>, R<sup>2</sup> = H unless otherwise specified.</p></p></figure><div class="NLM_p">The remaining three target derivatives comprise the aminoethyl linked primary sulfonamide group as found in the natural product <b>1</b> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). The compounds (<b>69</b>–<b>71</b>) were prepared from <b>6</b> and protected oximes oximes <b>72</b>–<b>75</b> as reported by ourselves earlier.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3,4)</a> Compound <b>1</b> was prepared from <b>76</b> as reported earlier.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a></div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.9b00282/20190418/images/medium/jm-2019-002823_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.9b00282/20190418/images/large/jm-2019-002823_0003.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Aminoethyl primary sulfonamides: natural product <b>1</b>, protected oxime derivatives <b>72</b>–<b>76</b>, and free oxime derivatives <b>69</b>, <b>70</b>, and <b>71</b>.<a onclick="showRef(event, 'ref3 ref6'); return false;" href="javascript:void(0);" class="ref ref3 ref6">(3,6)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.9b00282/20190418/images/large/jm-2019-002823_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00282&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Carbonic Anhydrase Inhibition</h3><div class="NLM_p">The CA I, II, IX, and XII inhibition and selectivity data for psammaplin C (<b>1</b>) and the free oxime target compounds (<b>43</b>–<b>58</b>, <b>69</b>–<b>71</b>) are provided in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>. For comparison, data are also provided for the clinically used CA inhibitor, the related thiadiazole sulfonamide acetazolamide (AZA). The CA I, II, IX, and XII inhibition and selectivity data for <i>O</i>-Bn or <i>O</i>-THP protected derivatives (<b>27</b>–<b>33</b>, <b>35</b>–<b>37</b>, <b>39</b>–<b>41</b>, and <b>59</b>–<b>67</b>) are provided in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Human CA Inhibition Profile for Psammaplin C (<b>1</b>), Its Derivatives (<b>43</b>–<b>58</b>, <b>69</b>–<b>71</b>), and Acetazolamide (AZA)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.9b00282/20190418/images/medium/jm-2019-002823_0009.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center"><i>K</i><sub>i</sub> (nM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="rowsep1 colsep0" colspan="4" align="center"><i>K</i><sub>i</sub> ratio<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">CA I</th><th class="colsep0 rowsep0" align="center">CA II</th><th class="colsep0 rowsep0" align="center">CA IX</th><th class="colsep0 rowsep0" align="center">CA XII</th><th class="colsep0 rowsep0" align="center">I/IX</th><th class="colsep0 rowsep0" align="center">I/XII</th><th class="colsep0 rowsep0" align="center">II/IX</th><th class="colsep0 rowsep0" align="center">II/XII</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">6.5</td><td class="colsep0 rowsep0" align="left">3.5</td><td class="colsep0 rowsep0" align="left">34.1</td><td class="colsep0 rowsep0" align="left">>50000</td><td class="colsep0 rowsep0" align="left">0.191</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.103</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44</b></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">587</td><td class="colsep0 rowsep0" align="left">5.6</td><td class="colsep0 rowsep0" align="left">>50000</td><td class="colsep0 rowsep0" align="left">775</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.757</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.007</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">59.3</td><td class="colsep0 rowsep0" align="left">0.05</td><td class="colsep0 rowsep0" align="left">12600</td><td class="colsep0 rowsep0" align="left">680</td><td class="colsep0 rowsep0" align="left">0.005</td><td class="colsep0 rowsep0" align="left">0.087</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">8.3</td><td class="colsep0 rowsep0" align="left">0.04</td><td class="colsep0 rowsep0" align="left">132</td><td class="colsep0 rowsep0" align="left">209</td><td class="colsep0 rowsep0" align="left">0.063</td><td class="colsep0 rowsep0" align="left">0.040</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">619</td><td class="colsep0 rowsep0" align="left">140</td><td class="colsep0 rowsep0" align="left">3400</td><td class="colsep0 rowsep0" align="left">471</td><td class="colsep0 rowsep0" align="left">0.182</td><td class="colsep0 rowsep0" align="left">1.31</td><td class="colsep0 rowsep0" align="left">0.041</td><td class="colsep0 rowsep0" align="left">0.297</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">809</td><td class="colsep0 rowsep0" align="left">254</td><td class="colsep0 rowsep0" align="left">2800</td><td class="colsep0 rowsep0" align="left">>50000</td><td class="colsep0 rowsep0" align="left">0.289</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.091</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">81.6</td><td class="colsep0 rowsep0" align="left">36.8</td><td class="colsep0 rowsep0" align="left">353</td><td class="colsep0 rowsep0" align="left">174</td><td class="colsep0 rowsep0" align="left">0.231</td><td class="colsep0 rowsep0" align="left">0.469</td><td class="colsep0 rowsep0" align="left">0.104</td><td class="colsep0 rowsep0" align="left">0.211</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">72.6</td><td class="colsep0 rowsep0" align="left">25.0</td><td class="colsep0 rowsep0" align="left">343</td><td class="colsep0 rowsep0" align="left">312</td><td class="colsep0 rowsep0" align="left">0.212</td><td class="colsep0 rowsep0" align="left">0.233</td><td class="colsep0 rowsep0" align="left">0.073</td><td class="colsep0 rowsep0" align="left">0.080</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">30.7</td><td class="colsep0 rowsep0" align="left">7.2</td><td class="colsep0 rowsep0" align="left">3.5</td><td class="colsep0 rowsep0" align="left">7.9</td><td class="colsep0 rowsep0" align="left">8.77</td><td class="colsep0 rowsep0" align="left">3.89</td><td class="colsep0 rowsep0" align="left">2.06</td><td class="colsep0 rowsep0" align="left">0.911</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>52</b></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">192</td><td class="colsep0 rowsep0" align="left">20.5</td><td class="colsep0 rowsep0" align="left">27.9</td><td class="colsep0 rowsep0" align="left">36.7</td><td class="colsep0 rowsep0" align="left">6.88</td><td class="colsep0 rowsep0" align="left">5.23</td><td class="colsep0 rowsep0" align="left">0.735</td><td class="colsep0 rowsep0" align="left">0.559</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>53</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">15.3</td><td class="colsep0 rowsep0" align="left">0.45</td><td class="colsep0 rowsep0" align="left">3.5</td><td class="colsep0 rowsep0" align="left">20.6</td><td class="colsep0 rowsep0" align="left">4.37</td><td class="colsep0 rowsep0" align="left">0.743</td><td class="colsep0 rowsep0" align="left">0.129</td><td class="colsep0 rowsep0" align="left">0.022</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>54</b></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">2.8</td><td class="colsep0 rowsep0" align="left">0.35</td><td class="colsep0 rowsep0" align="left">10.5</td><td class="colsep0 rowsep0" align="left">21.6</td><td class="colsep0 rowsep0" align="left">0.267</td><td class="colsep0 rowsep0" align="left">0.130</td><td class="colsep0 rowsep0" align="left">0.033</td><td class="colsep0 rowsep0" align="left">0.016</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>55</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">2.2</td><td class="colsep0 rowsep0" align="left">1.1</td><td class="colsep0 rowsep0" align="left">1.3</td><td class="colsep0 rowsep0" align="left">0.56</td><td class="colsep0 rowsep0" align="left">1.69</td><td class="colsep0 rowsep0" align="left">3.93</td><td class="colsep0 rowsep0" align="left">0.846</td><td class="colsep0 rowsep0" align="left">1.96</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>56</b></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">54.5</td><td class="colsep0 rowsep0" align="left">7.4</td><td class="colsep0 rowsep0" align="left">94.0</td><td class="colsep0 rowsep0" align="left">45.2</td><td class="colsep0 rowsep0" align="left">0.580</td><td class="colsep0 rowsep0" align="left">1.21</td><td class="colsep0 rowsep0" align="left">0.079</td><td class="colsep0 rowsep0" align="left">0.164</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>57</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">46.9</td><td class="colsep0 rowsep0" align="left">9.6</td><td class="colsep0 rowsep0" align="left">19.2</td><td class="colsep0 rowsep0" align="left">7.3</td><td class="colsep0 rowsep0" align="left">2.44</td><td class="colsep0 rowsep0" align="left">6.43</td><td class="colsep0 rowsep0" align="left">0.500</td><td class="colsep0 rowsep0" align="left">1.32</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>58</b><a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>69</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">3930</td><td class="colsep0 rowsep0" align="left">242</td><td class="colsep0 rowsep0" align="left">>50000</td><td class="colsep0 rowsep0" align="left">>50000</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>70</b></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">9.1</td><td class="colsep0 rowsep0" align="left">4.5</td><td class="colsep0 rowsep0" align="left">3300</td><td class="colsep0 rowsep0" align="left">43.2</td><td class="colsep0 rowsep0" align="left">0.003</td><td class="colsep0 rowsep0" align="left">0.211</td><td class="colsep0 rowsep0" align="left">0.001</td><td class="colsep0 rowsep0" align="left">0.104</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>71</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">1570</td><td class="colsep0 rowsep0" align="left">151</td><td class="colsep0 rowsep0" align="left">3120</td><td class="colsep0 rowsep0" align="left">219</td><td class="colsep0 rowsep0" align="left">0.503</td><td class="colsep0 rowsep0" align="left">7.17</td><td class="colsep0 rowsep0" align="left">0.048</td><td class="colsep0 rowsep0" align="left">0.689</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">48.1</td><td class="colsep0 rowsep0" align="left">88.0</td><td class="colsep0 rowsep0" align="left">12.3</td><td class="colsep0 rowsep0" align="left">0.79</td><td class="colsep0 rowsep0" align="left">3.91</td><td class="colsep0 rowsep0" align="left">60.9</td><td class="colsep0 rowsep0" align="left">7.15</td><td class="colsep0 rowsep0" align="left">111</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AZA</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">250</td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">5.7</td><td class="colsep0 rowsep0" align="left">10.0</td><td class="colsep0 rowsep0" align="left">43.9</td><td class="colsep0 rowsep0" align="left">0.480</td><td class="colsep0 rowsep0" align="left">2.11</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Errors ± 5% of the reported values from three separate assays.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">The <i>K</i><sub>i</sub> ratios are indicative of isozyme selectivity for transmembrane CA IX and CA XII. Where values are <0.0001, no value is shown.</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">Compound <b>58</b> not synthesized.</p></div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. CA I, II, IX, and XII Inhibition and Isozyme Selectivity Data for Intermediate Compounds, <i>O</i>-Bn, or <i>O</i>-THP Protected Derivatives <b>27</b>–<b>33</b>, <b>35</b>–<b>37</b>, <b>39</b>–<b>41</b>, <b>59</b>–<b>67</b>, and <b>72</b>–<b>76</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.9b00282/20190418/images/medium/jm-2019-002823_0010.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center"><i>K</i><sub>i</sub> (nM)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="rowsep1 colsep0" colspan="4" align="center"><i>K</i><sub>i</sub> ratio<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">CA I</th><th class="colsep0 rowsep0" align="center">CA II</th><th class="colsep0 rowsep0" align="center">CA IX</th><th class="colsep0 rowsep0" align="center">CA XII</th><th class="colsep0 rowsep0" align="center">I/IX</th><th class="colsep0 rowsep0" align="center">I/XII</th><th class="colsep0 rowsep0" align="center">II/IX</th><th class="colsep0 rowsep0" align="center">II/XII</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">>50000</td><td class="colsep0 rowsep0" align="left">3780</td><td class="colsep0 rowsep0" align="left">>50000</td><td class="colsep0 rowsep0" align="left">>50000</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">>50000</td><td class="colsep0 rowsep0" align="left">>50000</td><td class="colsep0 rowsep0" align="left">>50000</td><td class="colsep0 rowsep0" align="left">>50000</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">669</td><td class="colsep0 rowsep0" align="left">37.6</td><td class="colsep0 rowsep0" align="left">>50000</td><td class="colsep0 rowsep0" align="left">>50000</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">>50000</td><td class="colsep0 rowsep0" align="left">6470</td><td class="colsep0 rowsep0" align="left">>50000</td><td class="colsep0 rowsep0" align="left">>50000</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">>50000</td><td class="colsep0 rowsep0" align="left">479</td><td class="colsep0 rowsep0" align="left">395</td><td class="colsep0 rowsep0" align="left">>50000</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1.21</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">>50000</td><td class="colsep0 rowsep0" align="left">1750</td><td class="colsep0 rowsep0" align="left">>50000</td><td class="colsep0 rowsep0" align="left">>50000</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">37.3</td><td class="colsep0 rowsep0" align="left">2.2</td><td class="colsep0 rowsep0" align="left">5680</td><td class="colsep0 rowsep0" align="left">>50000</td><td class="colsep0 rowsep0" align="left">0.007</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">>50000</td><td class="colsep0 rowsep0" align="left">>50000</td><td class="colsep0 rowsep0" align="left">>50000</td><td class="colsep0 rowsep0" align="left">>50000</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">>50000</td><td class="colsep0 rowsep0" align="left">>50000</td><td class="colsep0 rowsep0" align="left">>50000</td><td class="colsep0 rowsep0" align="left">>50000</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">276</td><td class="colsep0 rowsep0" align="left">207</td><td class="colsep0 rowsep0" align="left">179</td><td class="colsep0 rowsep0" align="left">825</td><td class="colsep0 rowsep0" align="left">1.54</td><td class="colsep0 rowsep0" align="left">0.335</td><td class="colsep0 rowsep0" align="left">1.16</td><td class="colsep0 rowsep0" align="left">0.251</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">46.5</td><td class="colsep0 rowsep0" align="left">3.2</td><td class="colsep0 rowsep0" align="left">5.1</td><td class="colsep0 rowsep0" align="left">39.1</td><td class="colsep0 rowsep0" align="left">9.12</td><td class="colsep0 rowsep0" align="left">1.19</td><td class="colsep0 rowsep0" align="left">0.627</td><td class="colsep0 rowsep0" align="left">0.082</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">800</td><td class="colsep0 rowsep0" align="left">160</td><td class="colsep0 rowsep0" align="left">2510</td><td class="colsep0 rowsep0" align="left">862</td><td class="colsep0 rowsep0" align="left">0.320</td><td class="colsep0 rowsep0" align="left">0.928</td><td class="colsep0 rowsep0" align="left">0.064</td><td class="colsep0 rowsep0" align="left">0.186</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">5.8</td><td class="colsep0 rowsep0" align="left">0.72</td><td class="colsep0 rowsep0" align="left">2.4</td><td class="colsep0 rowsep0" align="left">5.5</td><td class="colsep0 rowsep0" align="left">2.42</td><td class="colsep0 rowsep0" align="left">1.06</td><td class="colsep0 rowsep0" align="left">0.300</td><td class="colsep0 rowsep0" align="left">0.130</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>59</b></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">>50000</td><td class="colsep0 rowsep0" align="left">4050</td><td class="colsep0 rowsep0" align="left">>50000</td><td class="colsep0 rowsep0" align="left">>50000</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>60</b></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">3750</td><td class="colsep0 rowsep0" align="left">265</td><td class="colsep0 rowsep0" align="left">18430</td><td class="colsep0 rowsep0" align="left">16400</td><td class="colsep0 rowsep0" align="left">0.203</td><td class="colsep0 rowsep0" align="left">0.229</td><td class="colsep0 rowsep0" align="left">0.014</td><td class="colsep0 rowsep0" align="left">0.016</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>61</b></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">8450</td><td class="colsep0 rowsep0" align="left">1460</td><td class="colsep0 rowsep0" align="left">>50000</td><td class="colsep0 rowsep0" align="left">>50000</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>62</b></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">121</td><td class="colsep0 rowsep0" align="left">6.9</td><td class="colsep0 rowsep0" align="left">2450</td><td class="colsep0 rowsep0" align="left">397</td><td class="colsep0 rowsep0" align="left">0.049</td><td class="colsep0 rowsep0" align="left">0.305</td><td class="colsep0 rowsep0" align="left">0.003</td><td class="colsep0 rowsep0" align="left">0.017</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>63</b></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">173</td><td class="colsep0 rowsep0" align="left">1950</td><td class="colsep0 rowsep0" align="left">>50000</td><td class="colsep0 rowsep0" align="left">>50000</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>64</b></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">28.7</td><td class="colsep0 rowsep0" align="left">12.6</td><td class="colsep0 rowsep0" align="left">35.9</td><td class="colsep0 rowsep0" align="left">35.4</td><td class="colsep0 rowsep0" align="left">0.799</td><td class="colsep0 rowsep0" align="left">0.811</td><td class="colsep0 rowsep0" align="left">0.351</td><td class="colsep0 rowsep0" align="left">0.356</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>65</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">34.6</td><td class="colsep0 rowsep0" align="left">0.08</td><td class="colsep0 rowsep0" align="left">4.6</td><td class="colsep0 rowsep0" align="left">0.90</td><td class="colsep0 rowsep0" align="left">7.52</td><td class="colsep0 rowsep0" align="left">38.4</td><td class="colsep0 rowsep0" align="left">0.017</td><td class="colsep0 rowsep0" align="left">0.089</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>66</b></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">741</td><td class="colsep0 rowsep0" align="left">122</td><td class="colsep0 rowsep0" align="left">942</td><td class="colsep0 rowsep0" align="left">733</td><td class="colsep0 rowsep0" align="left">0.787</td><td class="colsep0 rowsep0" align="left">1.01</td><td class="colsep0 rowsep0" align="left">0.130</td><td class="colsep0 rowsep0" align="left">0.166</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>67</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">50.1</td><td class="colsep0 rowsep0" align="left">0.78</td><td class="colsep0 rowsep0" align="left">27.3</td><td class="colsep0 rowsep0" align="left">35.8</td><td class="colsep0 rowsep0" align="left">1.84</td><td class="colsep0 rowsep0" align="left">1.40</td><td class="colsep0 rowsep0" align="left">0.029</td><td class="colsep0 rowsep0" align="left">0.022</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>72</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">60.1</td><td class="colsep0 rowsep0" align="left">2.1</td><td class="colsep0 rowsep0" align="left">>50000</td><td class="colsep0 rowsep0" align="left">>50000</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>73</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">4130</td><td class="colsep0 rowsep0" align="left">339</td><td class="colsep0 rowsep0" align="left">4150</td><td class="colsep0 rowsep0" align="left">6200</td><td class="colsep0 rowsep0" align="left">0.995</td><td class="colsep0 rowsep0" align="left">0.666</td><td class="colsep0 rowsep0" align="left">0.082</td><td class="colsep0 rowsep0" align="left">0.055</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>74</b></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">8060</td><td class="colsep0 rowsep0" align="left">4350</td><td class="colsep0 rowsep0" align="left">>50000</td><td class="colsep0 rowsep0" align="left">>50000</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>75</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">896</td><td class="colsep0 rowsep0" align="left">647</td><td class="colsep0 rowsep0" align="left">5400</td><td class="colsep0 rowsep0" align="left">466</td><td class="colsep0 rowsep0" align="left">0.166</td><td class="colsep0 rowsep0" align="left">1.92</td><td class="colsep0 rowsep0" align="left">0.120</td><td class="colsep0 rowsep0" align="left">1.39</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>76</b><a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">566</td><td class="colsep0 rowsep0" align="left">592</td><td class="colsep0 rowsep0" align="left">4600</td><td class="colsep0 rowsep0" align="left">570</td><td class="colsep0 rowsep0" align="left">0.123</td><td class="colsep0 rowsep0" align="left">0.993</td><td class="colsep0 rowsep0" align="left">0.129</td><td class="colsep0 rowsep0" align="left">1.04</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Errors ± 5% of the reported values from three separate assays.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">The <i>K</i><sub>i</sub> ratios are indicative of isozyme selectivity for transmembrane CA IX and CA XII. Where values are <0.0001, no value is shown.</p></div><div class="footnote" id="t3fn3"><sup><sup>c</sup></sup><p class="last">Compound <b>76</b> was synthesized as reported by us previously.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a></p></div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Structure–Activity Relationships</h3><div class="NLM_p last">The three distinct components of the core structure natural product <b>1</b> were systematically varied, including the (a) the nature of the oxime moiety, (b) the benzyl group substituents, and (c) spacer to the primary sulfonamide functional group. Comparing the inhibition data of <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> (free oximes) and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a> (<i>O</i>-Bn and <i>O</i>-THP protected oximes), it is apparent that compounds comprising a free oxime group are generally stronger CA inhibitors than the corresponding compound where the oxime protected. Furthermore, the less hydrophobic THP protecting group appears generally better tolerated than the benzyl protecting group of the oximes. The protected oximes of the sulfonamide partners <b>2</b>, <b>3</b>, <b>4</b>, and <b>6</b> mostly exhibited weak inhibition (<i>K</i><sub>i</sub> > 1 μM), with many showing no inhibition at the highest test concentration of 50 μM. The exceptions to this trend indicate however that there is a complex interplay between the oxime and the spacer to the essential primary sulfonamide that impacts the enzyme inhibition characteristics. For example, in the subset of thiadiazole sulfonamides <b>39</b> (<i>O</i>-Bn), <b>65</b> (<i>O</i>-THP), and <b>55</b> (free oxime) the presence of an oxime protecting group has almost no impact on activity at CA IX (<i>K</i><sub>i</sub> of 5.1, 4.6, and 1.3 nM, respectively) and minimal impact at CA XII (<i>K</i><sub>i</sub> = 39.1, 0.90, and 0.56 nM, respectively). The thiadiazole group is found in the par excellence clinically used sulfonamide, acetazolamide (AZA) (CA IX <i>K</i><sub>i</sub> = 25 nM, CA XII <i>K</i><sub>i</sub> = 5.7 nM). Notably, the thiadiazole compounds of our study offer stronger cancer associated CA inhibition than AZA. When comparing the compounds with the natural product lead compound <b>1</b> (CA XII <i>K</i><sub>i</sub> = 0.79 nM, CA IX <i>K</i><sub>i</sub> = 12.3 nM), it is noted that while compound <b>1</b> has around 10-fold selectivity for CA XII over CA IX, compounds <b>65</b> and <b>55</b> also have selectivity for CA XII over CA IX (albeit lessened), while for compound <b>39</b> the selectivity is reversed with <b>39</b> being ∼8-fold selective for CA IX over CA XII. The profile of these compounds, as strong CA IX and XII inhibitors with varying degrees of isozyme selectivity, represents a significant finding for the provision of novel lead compounds with potential for future biological applications to validate the anticancer potential of CA IX and CA XII. Lastly, when considering the SAR of the benzyl substitution pattern (3-bromo-4-hydroxy, 4-hydroxy, 3-bromo, and unsubstituted), there is no clear SAR; again the linker to the sulfonamide partner appears to be the dominant factor in driving the SAR profile within the various subsets of compounds. This finding does however indicate that the benzyl group may provide a useful handle to fine-tune for drug-like properties without adverse impacts on bioactivity. This is a reassuring attribute for further developing this novel chemotype if applied within a drug lead optimization campaign.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> In Vitro Efficacy</h3><div class="NLM_p">Glioblastoma stem cells (SC) are a tumor cell subset responsible for tumor recurrence and relapse owing to their high chemorefractoriness.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> One mechanism by which SCs induce chemoresistance is their high level of P-glycoprotein (Pgp),<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> a surface-associated efflux pump that recognizes a broad spectrum of chemotherapeutic drugs,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> including temozolomide (TMZ), the first-line treatment option in glioblastoma.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> The coadministration of direct Pgp inhibitors (e.g., tariquidar) with chemotherapy has repeatedly failed in clinical trials because of high toxicity. This toxicity is attributed to inhibition of Pgp present in healthy tissues and to unexpected drug–drug interactions.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> We have recently reported an alternative approach, selective reduction of Pgp activity in glioblastoma SC without the off target toxicity associated with using direct Pgp inhibitors. Our approach is to instead target CA XII, an enzyme central to supporting Pgp activity in the hypoxic microenvironment of glioblastoma SC but is not required for Pgp activity elsewhere.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> The action of CA XII generates the mild alkaline pH under which Pgp operates with the highest efficiency, and therefore inhibition of CA XII renders Pgp significantly less effective.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><div class="NLM_p">Compound <b>55</b>, a free oxime derived from the thiadiazoyl sulfonamide scaffold, showed very strong inhibition of all the CA isozymes, in particular CA XII (<i>K</i><sub>i</sub> = 0.56 nM). Compound <b>55</b> was stable in Balb/c mice plasma and to mouse microsomes (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00282/suppl_file/jm9b00282_si_001.pdf" class="ext-link">Supporting Information, Table 1</a>). This compound was selected to validate the restorative effect on TMZ efficacy found when combining <b>1</b> with TMZ in drug resistant glioblastoma. From primary glioblastoma cells derived from three patients with a poor clinical response to TMZ (unknown patient numbers, UPN1–3) we separated and propagated the more differentiated component, termed adherent cells (AC), and the SC-enriched component, termed neurospheres (NS). Cells in both culture conditions were profiled for CA XII and Pgp expression and interaction as reported by ourselves previously.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Data are summarized in <a href="/doi/suppl/10.1021/acs.jmedchem.9b00282/suppl_file/jm9b00282_si_001.pdf" class="ext-link">Supporting Information, Table 2</a>.</div><div class="NLM_p">Preliminary in vitro assays were carried out to establish that compound <b>55</b> reduces Pgp activity in NS similarly to compound <b>1</b>. Cells from UPN1–3 were treated with doxorubicin (dox, 5 μM) in the presence or absence of compound <b>1</b> (10 nM) or <b>55</b> (10 nM). Compound <b>55</b> lowered Pgp ATPase activity (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00282/suppl_file/jm9b00282_si_001.pdf" class="ext-link">Supporting Information, Figure 1A</a>) and increased the intracellular dox concentration (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00282/suppl_file/jm9b00282_si_001.pdf" class="ext-link">Supporting Information, Figure 1B</a>) to a level comparable to the concentration found in AC. This in turn partially restored dox-induced damage, measured as the extracellular release of lactate dehydrogenase (LDH; <a href="/doi/suppl/10.1021/acs.jmedchem.9b00282/suppl_file/jm9b00282_si_001.pdf" class="ext-link">Supporting Information, Figure 1C</a>) while reducing cell viability (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00282/suppl_file/jm9b00282_si_001.pdf" class="ext-link">Supporting Information, Figure 1D</a>). Next, studies were extended to the glioblastoma front-line drug TMZ. In NS, TMZ reduces both Pgp expression and activity (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A,B) in line with previous findings indicating that TMZ is both a substrate and a down regulator of Pgp expression.<a onclick="showRef(event, 'ref23 ref26'); return false;" href="javascript:void(0);" class="ref ref23 ref26">(23,26)</a> Compound <b>55</b> had no effect on Pgp expression (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A) but reduced Pgp activity (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B); this reduction was more pronounced when <b>55</b> was used in combination with TMZ (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B). Compound <b>55</b> enhanced TMZ accumulation (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>C) and TMZ efficacy to a level comparable with that found in TMZ-treated AC (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>D–F), where Pgp and CA XII are undetectable, or TMZ-treated NS Pgp knock-out clones (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>C–F), where Pgp is undetectable while CA XII levels are unaltered.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> The efficacy parameters measured included cell damage (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>D), apoptosis, as indicated by the cleavage of caspase 3 (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>E), and cell viability (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>F). All findings were consistent with earlier studies performed using <b>1</b> and provide confirmation that CA XII inhibition is likely responsible for the chemosensitizing effect observed.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a></div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.9b00282/20190418/images/medium/jm-2019-002823_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.9b00282/20190418/images/large/jm-2019-002823_0004.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Compound <b>55</b> restores temozolomide efficacy in glioblastoma stem cells. NSs were grown for 48 h (A–E) or 72 h (F) in fresh medium (−) or in medium containing 50 μM temozolomide (T) or 10 nM compound <b>55</b>, alone or in combination. (B–D, F) Pooled data of patients UPN1–3 are presented as the mean ± SD (<i>n</i> = 4 independent experiments for each patient). ACs were included as control cells with undetectable CA XII or Pgp levels. (A) UPN2 NSs were lysed and immunoblotted for Pgp and CA XII. The figure is representative of one out of three experiments. (B) Spectrophotometric measure of Pgp ATPase activity, measured in triplicate in NS. (∗) <i>p</i> < 0.01: T/<b>55</b>/T + <b>55</b>-treated vs untreated (−) cells. (°) <i>p</i> < 0.005: (T + <b>55</b>)-treated vs T-treated cells. (C) Intracellular concentration of temozolomide (TMZ), measured in duplicate after cell radiolabeling. NS clones knocked out for Pgp (KOPgp) and AC were included as control cells where expression of Pgp is undetectable. (∗) <i>p</i> < 0.001: <b>55</b>-treated or KOPgp vs untreated (−) NS. (D) LDH release, measured spectrophotometrically in duplicate. (∗) <i>p</i> < 0.001: treated vs untreated (−) NS or AC. (°) <i>p</i> < 0.001: (T + <b>55</b>)/(T + KOPgp) vs T-treated NS. (E) UPN2 NSs, incubated as reported in (A) and/or knocked out for Pgp, were lysed and immunoblotted for procaspase 3 and cleaved caspase 3. The figure is representative of one out of three experiments. (F) Cell viability measured by a chemiluminescence-based assay in quadruplicates. (∗) <i>p</i> < 0.001: treated vs untreated (−)-NS or AC. (°) <i>p</i> < 0.001: (T + <b>55</b>)/(T + KOPgp) vs T-treated NS.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.9b00282/20190418/images/large/jm-2019-002823_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00282&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> In Vivo Efficacy</h3><div class="NLM_p">Orthotopically implanted glioblastoma NS-derived tumors (with coexpression of Pgp and CAXII) from UPN1–3 (GB-NS-PDX, or patient-derived xenografts) were prepared to assess the in vivo effect of TMZ (50 mg/kg), compound <b>55</b> (3.8 μg/kg), and the combination of TMZ (50 mg/kg) plus <b>55</b> (3.8 μg/kg). The dose selected for <b>55</b> was matched to the dosage used previously for <b>1</b>,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> to allow a direct comparison between the two compounds. Consistent with the cell culture studies above, GB-NS-PDX from UPN1 and UPN2 were resistant to TMZ (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A,B). Indeed, the mean tumor volumes at the end of the treatment were 146.50 ± 36.45 mm<sup>3</sup> for untreated animals and 117.67 ± 50.55 mm<sup>3</sup> for TMZ-treated animals (UPN1), 237.00 ± 92.37 mm<sup>3</sup> for untreated animals and 231.83 ± 68.32 mm<sup>3</sup> for TMZ-treated animals (UPN2). The GB-NS-PDX from UPN3 showed partial sensitivity to TMZ (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A,B), with a mean tumor volume at the end of the treatment of 249.67 ± 48.19 mm<sup>3</sup> for untreated animals and 116.33 ± 40.25 mm<sup>3</sup> for TMZ-treated animals. The response of UPN3 correlates with the more favorable genetic profile toward TMZ sensitivity, time to recurrence after TMZ treatment, and longest overall survival of the three patients, as reported earlier.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> When GB-NS-PDX were treated with compound <b>55</b> alone, there was no reduction of tumor growth. When compound <b>55</b> and TMZ were combined, tumor growth in all GB-NS-PDX was significantly decreased with the mean tumor volumes of 91.50 ± 13.54 mm<sup>3</sup>, 115.17 ± 25.62 mm<sup>3</sup>, and 62.00 ± 11.67 mm<sup>3</sup> for UPN1, UPN2, and UPN3, respectively, at the end of the combined treatment (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A,B). These volumes are significantly smaller than those of untreated mice for all the UPNs and of TMZ-treated mice for UPN1 and UPN2.</div><figure id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.9b00282/20190418/images/medium/jm-2019-002823_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.9b00282/20190418/images/large/jm-2019-002823_0005.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Compound <b>55</b> restores temozolomide efficacy in resistant orthtotopic patient-derived glioblastoma xenografts. (A) Representative in vivo bioluminescence imaging of orthotopically implanted UPN2 NS, in animals treated with vehicle (ctrl), compound <b>55</b>, and temozolomide (T), as follows: (1) control group, treated with 0.2 mL of saline solution intravenously (iv); (2) <b>55</b> group, treated with 3.8 μg/kg compound <b>55</b> iv; (3) T group, treated with 50 mg/kg T per os (po); (4) T + <b>55</b> group, treated with 50 mg/kg T po + 3.8 μg/kg compound <b>55</b> iv (6 animals/group). (B) Tumor volume at the time of sacrifice. Pooled data of patients UPN1–3-derived tumors are presented as the mean ± SD. UPN1, (∗) <i>p</i> < 0.005: T + <b>55</b> vs ctrl. Not significant: T + <b>55</b> vs T. UPN2, (∗) <i>p</i> < 0.001: T + <b>55</b> vs ctrl. (°) <i>p</i> < 0.001: T + <b>55</b> vs TMZ. UPN3, (∗) <i>p</i> < 0.005: T/(T + <b>55</b>) vs ctrl. (°) <i>p</i> < 0.05: T + <b>55</b> vs T. (C) Overall survival probability was calculated using the Kaplan–Meier method. UPN1, <i>p</i> < 0.05: T + <b>55</b> vs ctrl. <i>p</i> < 0.05: T + <b>55</b> vs T. UPN2, <i>p</i> < 0.001: T + <b>55</b> vs ctrl. <i>p</i> < 0.001: T + <b>55</b> vs T. UPN3, <i>p</i> < 0.01: T + <b>55</b> vs ctrl. Not significant: T + <b>55</b> vs T (log rank test; not reported in the figure). (D) Representative intratumor staining with hematoxylin and eosin (HE) or the indicated antibodies, from UPN2-derived tumors. The photographs are representative of sections from 5 tumors/group of treatment. Bar = 10 μm (10× ocular lens, 20× objective). (E) Quantification of immunohistochemical images, performed on sections with 111–94 nuclei/field. The percentage of proliferating cells was determined by the ratio Ki67-positive nuclei/total number (hematoxylin-positive) of nuclei using ImageJ software. The ctrl group percentage was considered 100%. The percentage of caspase 3 positive cells was determined by Photoshop program. Data are presented as the mean ± SD. (∗) <i>p</i> < 0.001: T + <b>55</b> vs ctrl. (°) <i>p</i> < 0.02: T + <b>55</b> vs T.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.9b00282/20190418/images/large/jm-2019-002823_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00282&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As expected, the overall survival showed an opposite trend to tumor growth. The median survival of untreated and TMZ-treated mice was 49 and 42.5 months, respectively, for UPN1, 47, and 46.5 months, respectively, for UPN2, and 47.5 and 67.5 months, respectively, for UPN3 (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>C). While treatment with <b>55</b> alone had no effect on the overall survival, when <b>55</b> is in combination with TMZ, there is a marked increase in the animal survival, with the median survival 58.5 months for UPN1, 65.5 months for UPN2, and 75.5 months for UPN3. This corresponds to an increase of 9.5, 18.5, and 28 months over untreated mice and an increase of 16, 19, and 8 months over TMZ treated mice, respectively, for UPN1–3. These data suggest that the use of <b>55</b> is particularly effective against the GB more resistant to TMZ. The combination of TMZ with <b>55</b> rescued the antiproliferative and proapoptotic effects of TMZ, as verified by reduced intratumor-positive staining for Ki67 and increased activation of caspase 3 (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>D,E).</div><div class="NLM_p last">Overall, these data suggest that the cytotoxic effects observed with the combination of compound <b>55</b> and TMZ in vitro were recapitulated in vivo. Furthermore, although TMZ alone reduced Pgp expression and activity in NS, this reduction was not sufficient to yield antitumor efficacy in vivo. The greater inhibition of Pgp, as achieved by combining the potent CA XII inhibitor <b>55</b> with TMZ, was however able to restore the intracellular cytotoxic levels of TMZ and facilitate enhanced drug efficacy in GB-NS-PDX. We are aware that Pgp is not the only resistance mechanism of TMZ, with genetic background (O<sup>6</sup>-methylguanine DNA methyltransferase (MGMT) status, isocitrate dehydrogenase 2 (IDH2) and p53 mutations, epithelial growth factor receptor (EGFR) amplification) also a predictor of patient response to TMZ.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> As reported previously,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> the patient samples of this study have different genetic backgrounds; however, all patient-derived NS coexpress Pgp and CA XII. We have observed significantly increased TMZ resistance in the corresponding patients NS over AC independent of MGMT status or other genetic differences.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Collectively, our data imply that targeting this Pgp/CA XII interaction may be exploited to improve TMZ efficacy in vivo. Our results confirm this combination therapy strategy was indeed effective in restoring TMZ efficacy in vivo and importantly in increasing overall survival in GB-NS-PDX bearing TMZ-resistant tumors.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36656" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36656" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">The inspiration for this study was the unprecedented in vivo activity of the lead compound, the unusual natural product <b>1</b>, toward reversal of drug resistance in glioblastoma. The combination of <b>1</b>, with chemotherapy, resensitized drug resistant glioblastoma to TMZ while significantly extending overall survival of treated animals compared to chemotherapy treatment alone. We have established substantial SAR around <b>1</b> in this study, in particular demonstrating that the ethyl sulfonamide moiety, when replaced with a thiadiazoyl sulfonamide, gives two novel compounds (<b>55</b> and <b>65</b>) with subnanomolar CA XII inhibition activity as well as very good inhibition of the other cancer-associated CA isozyme, CA IX. Compound <b>55</b> was selected for in vitro and in vivo evaluation in patient derived cell and xenograft models of glioblastoma. The bioactivity of <b>55</b> paralleled that of compound <b>1</b> in glioblastoma. This provides more evidence that specific inhibition of CA XII can resensitize glioblastoma to chemotherapy and increase overall survival. Our results suggest exploration of a new combination therapy, based on a CA XII inhibitor with TMZ, as a potentially viable clinical tool to overcome Pgp-mediated TMZ-resistance in glioblastoma SC. We propose this combination therapy may be more effective than current treatment options.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82374" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82374" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> General Chemistry</h3><div class="NLM_p last">Amino sulfonamide compounds <b>2</b>–<b>4</b> are commercially available, while amino sulfonamide compounds <b>5</b> and <b>6</b> were synthesized as reported.<a onclick="showRef(event, 'ref6 ref9'); return false;" href="javascript:void(0);" class="ref ref6 ref9">(6,9)</a> Compounds <b>14</b>, <b>22</b>, <b>26</b>, and <b>76</b> were synthesized as reported.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Compounds <b>69</b>–<b>75</b> were synthesized as reported.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3,4)</a> All reactions were carried out in dry solvents under anhydrous conditions, unless otherwise mentioned. All chemicals were purchased commercially and used without further purification. All reactions were monitored by TLC using silica plates with visualization of product bands by UV fluorescence (λ = 254 nm) and charring with vanillin (6 g of vanillin in 100 mL of EtOH containing 1% (v/v) concentrated sulfuric acid) stain. Silica gel flash chromatography was performed using silica gel 60 Å (230–400 mesh). NMR (<sup>1</sup>H, <sup>13</sup>C, COSY, and HSQC) spectra were recorded on Bruker AVANCE III HD 500 MHz NMR spectrometer equipped with a BBO probe at 25 °C. Chemical shifts for <sup>1</sup>H and <sup>13</sup>C NMR obtained in DMSO-<i>d</i><sub>6</sub> are reported in ppm relative to residual solvent proton (δ = 2.50 ppm) and carbon (δ = 39.5 ppm) signals, respectively. Multiplicity is indicated as follows: s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), dd (doublet of doublet), bs (broad signal). Coupling constants are reported in hertz (Hz). LRMS (ESI) data were recorded on a Waters ZQ ESI mass spectrometer using electrospray as the ionization technique in positive-ion and/or negative-ion modes as stated. HRMS (ESI) data were acquired on a 12 T SolariX XR FT-ICR-MS using electrospray as the ionization technique in positive-ion and/or negative-ion modes as stated. All MS analysis samples were prepared as solutions in methanol. Purity of all compounds was >95% as determined by Agilent HPLC 1100 series with UV detection. The melting points are uncorrected. Proton and carbon atoms for NMR assignments are designated as shown below.<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.9b00282/20190418/images/medium/jm-2019-002823_0012.gif" alt="" id="fx3" /></img></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> General Procedure 1. Synthesis of Benzylidene Oxazolones</h3><div class="NLM_p last">To a mixture of anhydrous NaOAc (1.0 equiv) and <i>N</i>-acetylglycine (1.0 equiv) suspended in Ac<sub>2</sub>O (10.0 equiv) at rt under inert atmosphere was added the relevant benzaldehyde <b>15</b>–<b>18</b> (1.0 equiv). The resulting mixture was stirred at 120 °C for 4 h and then cooled to rt. After complete precipitation, the solid was filtered, poured into ice cold water (25–30 mL), and vigorously stirred for 15–20 min. The mixture was then filtered and the residual solid dried under reduced pressure. The crude product was used in the next step without further purification. The title compounds were however purified for characterization purposes as described for each compound of the series <b>19</b>–<b>22</b>.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> General Procedure 2. Synthesis of Arylpyruvic Acids Followed by Oxime Group Protection</h3><div class="NLM_p">A mixture of the required oxazolone <b>19</b>–<b>22</b> (1 equiv) in 10% aqueous HCl (10 mL/mmol) was stirred at reflux in water (100–102 °C) for 12–14 h. The reaction mixture was then allowed to cool to rt over 2–3 h and the product precipitated. After complete precipitation, the solid was collected by suction filtration, washed with ice cold water (10–15 mL), and dried under reduced pressure. The filtrate was washed with EtOAc (3 × 20 mL), and the organic fractions were combined, washed with water (1 × 20 mL) and saturated aqueous NaCl (1 × 20 mL), dried over MgSO<sub>4</sub>, and concentrated under reduced pressure. The oily residue was triturated with a minimum amount of <i>n</i>-hexane. The <i>n</i>-hexane portion was carefully decanted, and the remaining crude solid was dried under reduced pressure. The crude solids of the arylpyruvic acids <b>23</b>–<b>26</b> collected by filtration and extraction–trituration were combined and used for the next step without any purification.</div><div class="NLM_p last">To a mixture of the required arylpyruvic acid derivative <b>23</b>–<b>26</b> (1 equiv) and benzyloxyamine hydrochloride (NH<sub>2</sub>OBn·HCl, 1.5 equiv) or <i>O</i>-(tetrahydro-2<i>H</i>-pyran-2-yl)hydroxylamine (NH<sub>2</sub>OTHP, 1.5 equiv) was added anhydrous pyridine (2 mL/mmol) under an argon atmosphere. The reaction mixture was stirred overnight (12–14 h) at rt. Pyridine was removed under reduced pressure, to the residue was added 1.0 N HCl (5.5 mL/mmol) and extracted in EtOAc (3 × 25 mL). The combined organic fractions were washed with saturated aqueous NaCl (1 × 20 mL/mmol), dried over MgSO<sub>4</sub>, and concentrated under reduced pressure. The desired protected oximes were purified as described for each compound in the series of <b>7</b>–<b>14</b>.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> General Procedure 3. Amide Coupling</h3><div class="NLM_p last">To a mixture of <i>O</i>-Bn or <i>O</i>-THP protected oximino acid <b>7</b>–<b>14</b> (1.0 equiv), EDC·HCl (1.5 equiv), and HOBt·H<sub>2</sub>O (1.5 equiv) under an argon atmosphere was added anhydrous DMF (10 mL/mmol), and the resulting solution was stirred at rt for 45 min. Next, the corresponding aromatic amine sulfonamide <b>2</b>–<b>5</b> (1.0 equiv) was added and the mixture stirred at rt for 24 h. The solvent was evaporated under high vacuum and water (15 mL), added to the remaining residue, followed by extraction with EtOAc (3 × 25 mL). The combined organic fractions were washed with saturated aqueous NaHCO<sub>3</sub> (2 × 15 mL/mmol), saturated aqueous NaCl (1 × 20 mL/mmol), dried over MgSO<sub>4</sub>, and concentrated under reduced pressure. The desired compounds were purified as described in the series of <b>27</b>–<b>33</b>, <b>35</b>–<b>37</b>, <b>39</b>–<b>41</b>, and <b>59</b>–<b>67</b>.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> General Procedure 4. Deprotection of Oxime Benzyl Ether Using Transfer Hydrogenation</h3><div class="NLM_p last">To a solution of the required oxime benzyl ether (<b>27</b>, <b>29</b>, <b>31</b>, <b>33</b>, <b>35</b>, and <b>37</b>) (1.0 mmol) in absolute EtOH (8 mL/mmol) and cyclohexene (4 mL/mmol) was added 20% Pd(OH)<sub>2</sub> and the resulting reaction mixture stirred at reflux in EtOH (78–82 °C). After the reaction was complete (as evidenced by TLC monitoring), the mixture was filtered through a Celite bed and washed with MeOH or acetone (2 × 20 mL). The filtrate was evaporated under reduced pressure and the residue purified as described for the compound series <b>43</b>, <b>45</b>, <b>47</b>, <b>49</b>, <b>51</b>, and <b>53</b>.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> General Procedure 5. Deprotection of Oxime Tetrahydropyran-2-yl Ether</h3><div class="NLM_p last">To the required oxime tetrahydropyran-2-yl ether <b>59</b>–<b>67</b> (1.0 mmol) was added 4.0 M HCl in 1,4-dioxane (15 mL/mmol) at 0 °C. The reaction mixture was stirred at 0 °C until complete (as evidenced by TLC monitoring). The solvent was evaporated under reduced pressure and the residue purified as described for the compound series of <b>44</b>, <b>46</b>, <b>48</b>, <b>50</b>, <b>52</b> and <b>54</b>–<b>57</b>.</div></div><div id="sec4_6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> (2<i>E</i>)-2-[(Benzyloxy)imino]-3-phenylpropanoic Acid (<b>7</b>)</h3><div class="NLM_p last">Compound <b>7</b> was synthesized from crude arylpyruvic acid <b>23</b> (0.5 g, 3.05 mmol) according to general procedure 2. The crude residue was purified by flash chromatography (0.5–1% MeOH in DCM) to afford the title compound as a white solid (0.65 g, 79%). <i>R</i><sub><i>f</i></sub> = 0.37 (10% MeOH in DCM). Mp = 75–77 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>H</sub> = 13.16 (bs, 1H, COOH), 7.36–7.16 (m, 10H, H<sub>Ar</sub>), 5.27 (s, 2H, Ph-CH<sub>2</sub>-O), 3.85 (s, 2H, Ph-CH<sub>2</sub>-C). General assignments were confirmed by <sup>1</sup>H–<sup>1</sup>H gCOSY. <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>C</sub> = 164.3 (C<sub>quat</sub>), 151.2 (C<sub>quat</sub>), 136.9 (C<sub>quat</sub>), 135.9 (C<sub>quat</sub>), 128.5 (2 × CH<sub>Ar</sub>), 128.4 (2 × CH<sub>Ar</sub>), 128.3 (2 × CH<sub>Ar</sub>), 128.0 (CH<sub>Ar</sub>), 127.9 (2 × CH<sub>Ar</sub>), 126.4 (CH<sub>Ar</sub>), 76.5 (Ph-<u class="uu">C</u>H<sub>2</sub>-O), 30.8 (Ph-<u class="uu">C</u>H<sub>2</sub>-C). General assignments were confirmed by <sup>1</sup>H–<sup>13</sup>C HSQC. LRMS (ESI): <i>m</i>/<i>z</i> = 270 [M + H]<sup>+</sup>, 292 [M + Na]<sup>+</sup>. HRMS (ESI): calcd for [C<sub>16</sub>H<sub>15</sub>NO<sub>3</sub> – H]<sup>+</sup> 268.0979, found 268.0978.</div></div><div id="sec4_6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> (2<i>E</i>)-2-[(Benzyloxy)imino]-3-(3-bromophenyl)propanoic Acid (<b>8</b>)</h3><div class="NLM_p last">Compound <b>8</b> was synthesized from crude arylpyruvic acid <b>24</b> (0.7 g, 2.88 mmol) according to general procedure 2. The crude residue was purified by flash chromatography (1% MeOH in DCM) to afford the title compound as a white solid (0.64 g, 64%). <i>R</i><sub><i>f</i></sub> = 0.32 (10% MeOH in DCM). Mp = 130–132 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>H</sub> = 13.2 (bs, 1H, COOH), 7.42 (d, <i>J</i> = 7.8 Hz, 1H, H<sub>Ar</sub>), 7.38–7.30 (m, 6H, H<sub>Ar</sub>), 7.24 (t, <i>J</i> = 7.8 Hz, 1H, H<sub>Ar</sub>), 7.17 (d, <i>J</i> = 7.6 Hz, 1H, H<sub>Ar</sub>), 5.27 (s, 2H, Ph-CH<sub>2</sub>-O), 3.84 (s, 2H, Ph-CH<sub>2</sub>-C). General assignments were confirmed by <sup>1</sup>H–<sup>1</sup>H gCOSY. <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>C</sub> = 164.1 (C<sub>quat</sub>), 150.5 (C<sub>quat</sub>), 138.7 (C<sub>quat</sub>), 136.8 (C<sub>quat</sub>), 131.2 (CH<sub>Ar</sub>), 130.5 (CH<sub>Ar</sub>), 129.3 (CH<sub>Ar</sub>), 128.4 (2 × CH<sub>Ar</sub>), 128.0 (CH<sub>Ar</sub>), 127.9 (2 × CH<sub>Ar</sub>), 127.6 (CH<sub>Ar</sub>), 121.6 (C<sub>quat</sub>), 76.7 (Ph-<u class="uu">C</u>H<sub>2</sub>-O), 30.4 (Ph-<u class="uu">C</u>H<sub>2</sub>-C). General assignments were confirmed by <sup>1</sup>H–<sup>13</sup>C HSQC. LRMS (ESI): <i>m</i>/<i>z</i> = 370, 372 [M + Na, <sup>79</sup>Br, <sup>81</sup>Br]<sup>+</sup>. HRMS (ESI): calcd for [C<sub>16</sub>H<sub>14</sub>BrNO<sub>3</sub> – H, <sup>79</sup>Br]<sup>+</sup> 346.0084, found 346.0082, calcd for [C<sub>16</sub>H<sub>14</sub>BrNO<sub>3</sub> – H, <sup>81</sup>Br]<sup>+</sup> 348.0064, found 348.0062.</div></div><div id="sec4_6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> (2<i>E</i>)-2-[(Benzyloxy)imino]-3-(4-hydroxyphenyl)propanoic Acid (<b>9</b>)</h3><div class="NLM_p last">Compound <b>9</b> was synthesized from crude arylpyruvic acid <b>25</b> (2.5 g, 13.88 mmol) according to general procedure 2. The crude residue was purified by flash chromatography (2–3% MeOH in DCM) to afford the title compound as a pale yellow solid (2.432 g, 61%). <i>R</i><sub><i>f</i></sub> = 0.25 (10% MeOH in DCM). Mp = 120–122 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>H</sub> = 13.07 (bs, 1H, COOH), 9.22 (s, 1H, Ph-OH), 7.38–7.32 (m, 5H, H<sub>Ar</sub>), 6.96 (d, <i>J</i> = 8.35 Hz, 2H, H<sub>Ar</sub>), 6.65 (d, <i>J</i> = 8.45 Hz, 2H, H<sub>Ar</sub>), 5.26 (s, 2H, Ph-CH<sub>2</sub>-O), 3.72 (s, 2H, Ph-CH<sub>2</sub>-C). General assignments were confirmed by <sup>1</sup>H–<sup>1</sup>H gCOSY. <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>C</sub> = 164.3 (C<sub>quat</sub>), 155.9 (C<sub>quat</sub>), 151.7 (C<sub>quat</sub>), 137.0 (C<sub>quat</sub>), 129.6 (2 × CH<sub>Ar</sub>), 128.3 (2 × CH<sub>Ar</sub>), 127.9 (3 × CH<sub>Ar</sub>), 125.8 (C<sub>quat</sub>), 115.2 (2 × CH<sub>Ar</sub>), 76.4 (Ph-<u class="uu">C</u>H<sub>2</sub>-O), 29.8 (Ph-<u class="uu">C</u>H<sub>2</sub>-C). General assignments were confirmed by <sup>1</sup>H–<sup>13</sup>C HSQC. LRMS (ESI): <i>m</i>/<i>z</i> = 286 [M + H]<sup>+</sup>. HRMS (ESI): calcd for [C<sub>16</sub>H<sub>15</sub>NO<sub>4</sub> – H]<sup>+</sup> 284.0928, found 284.0927.</div></div><div id="sec4_6_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> (2<i>E</i>)-2-[(Benzyloxy)imino]-3-(3-bromo-4-hydroxyphenyl)propanoic Acid (<b>10</b>)</h3><div class="NLM_p last">Compound <b>10</b> was synthesized from crude arylpyruvic acid <b>26</b> (0.4 g, 1.55 mmol) according to general procedure 2. The crude residue was purified by flash chromatography (1.5% MeOH in DCM) to afford the title compound as a white solid (0.352 g, 62%). <i>R</i><sub><i>f</i></sub> = 0.10 (10% MeOH in DCM). Mp = 150–152 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>H</sub> = 13.16 (s, 1H, COOH), 10.07 (s, 1H, Ph-OH), 7.38–7.31 (m, 5H, H<sub>Ar</sub>), 7.27 (d, <i>J</i> = 1.8 Hz, 1H, H<sub>Ar</sub>), 6.97 (dd, <i>J</i> = 8.3, 1.85 Hz, 1H, H<sub>Ar</sub>), 6.85 (d, <i>J</i> = 8.25 Hz, 1H, H<sub>Ar</sub>), 5.26 (s, 2H, Ph-CH<sub>2</sub>-O), 3.72 (s, 2H, Ph-CH<sub>2</sub>-C). General assignments were confirmed by <sup>1</sup>H–<sup>1</sup>H gCOSY. <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>C</sub> = 164.2 (C<sub>quat</sub>), 152.6 (C<sub>quat</sub>), 151.1 (C<sub>quat</sub>), 136.9 (C<sub>quat</sub>), 132.7 (CH<sub>Ar</sub>), 128.9 (CH<sub>Ar</sub>), 128.4 (3 × CH<sub>Ar</sub>), 128.0 (2 × CH<sub>Ar</sub>), 127.8 (C<sub>quat</sub>), 116.2 (CH<sub>Ar</sub>), 109.0 (C<sub>quat</sub>), 76.6 (Ph-<u class="uu">C</u>H<sub>2</sub>-O), 29.4 (Ph-<u class="uu">C</u>H<sub>2</sub>-C). General assignments were confirmed by <sup>1</sup>H–<sup>13</sup>C HSQC. LRMS (ESI): <i>m</i>/<i>z</i> = 364 [M + H]<sup>+</sup>, 386 [M + Na]<sup>+</sup>. HRMS (ESI): calcd for [C<sub>16</sub>H<sub>14</sub>BrNO<sub>4</sub> – H, <sup>79</sup>Br]<sup>+</sup> 362.0033, found 362.0031, calcd for [C<sub>16</sub>H<sub>14</sub>BrNO<sub>4</sub> – H, <sup>81</sup>Br]<sup>+</sup> 364.0013, found 364.0011.</div></div><div id="sec4_6_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> (2<i>E</i>)-2-[(Oxan-2-yloxy)imino]-3-phenylpropanoic Acid (<b>11</b>)</h3><div class="NLM_p last">Compound <b>11</b> was synthesized from crude arylpyruvic acid <b>23</b> (1.6 g, 9.76 mmol) according to general procedure 2. The crude residue was purified by flash chromatography (0.5–1% MeOH in DCM) to afford the title compound as a white solid (1.065 g, 42%). <i>R</i><sub><i>f</i></sub> = 0.17 (10% MeOH in DCM). Mp = 57–59 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>H</sub> = 7.31–7.28 (m, 2H, H<sub>Ar</sub>), 7.23–7.19 (m, 3H, H<sub>Ar</sub>), 5.35 (s, 1H, CH<sub>THP</sub>), 3.90 (d, <i>J</i> = 13.6 Hz, 1H, Ph-C<u class="uu">H</u>H-C), 3.84 (d, <i>J</i> = 13.6 Hz, 1H, Ph-CH<u class="uu">H</u>-C), 3.49–3.45 (m, 2H, H<sub>THP</sub>), 1.75–1.69 (m, 3H, H<sub>THP</sub>), 1.59–1.52 (m, 2H, H<sub>THP</sub>), 1.45–1.43 (m, 1H, H<sub>THP</sub>), COOH proton in exchange. General assignments were confirmed by <sup>1</sup>H–<sup>1</sup>H gCOSY. <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>C</sub> = 164.5 (C<sub>quat</sub>), 151.9 (C<sub>quat</sub>), 136.1 (C<sub>quat</sub>), 128.6 (2 × CH<sub>Ar</sub>), 128.4 (2 × CH<sub>Ar</sub>), 126.4 (CH<sub>Ar</sub>), 100.8 (CH<sub>THP</sub>), 61.3 (CH<sub>2</sub>-THP), 31.0 (Ph-CH<sub>2</sub>-C), 28.1 (CH<sub>2</sub>-THP), 24.6 (CH<sub>2THP</sub>), 18.5 (CH<sub>2</sub>-THP). General assignments were confirmed by <sup>1</sup>H–<sup>13</sup>C HSQC. LRMS (ESI): <i>m</i>/<i>z</i> = 286 [M + Na]<sup>+</sup>. HRMS (ESI): calcd for [C<sub>14</sub>H<sub>17</sub>NO<sub>4</sub> – H]<sup>+</sup> 262.1085, found 262.1083.</div></div><div id="sec4_6_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> (2<i>E</i>)-3-(3-Bromophenyl)-2-[(oxan-2-yloxy)imino]propanoic Acid (<b>12</b>)</h3><div class="NLM_p last">Compound <b>12</b> was synthesized from crude arylpyruvic acid <b>24</b> (1.0 g, 4.11 mmol) according to general procedure 2. The crude residue was purified by flash chromatography (1–2% MeOH in DCM) to afford the title compound as a white solid (0.82 g, 58%). <i>R</i><sub><i>f</i></sub> = 0.28 (10% MeOH in DCM). Mp = 64–66 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>H</sub> = 13.32 (bs, 1H, COOH), 7.45 (s, 1H, H<sub>Ar</sub>), 7.42 (d, <i>J</i> = 7.65 Hz, 1H, H<sub>Ar</sub>), 7.27 (t, <i>J</i> = 7.65 Hz, 1H, H<sub>Ar</sub>), 7.24–7.22 (m, 1H, H<sub>Ar</sub>), 5.37 (s, 1H, CH<sub>THP</sub>), 3.89 (d, <i>J</i> = 13.7 Hz, 1H, Ph-C<u class="uu">H</u>H-C), 3.84 (d, <i>J</i> = 13.75 Hz, 1H, Ph-CH<u class="uu">H</u>-C), 3.48–3.41 (m, 2H, H<sub>THP</sub>), 1.75–1.67 (m, 3H, H<sub>THP</sub>), 1.60–1.52 (m, 2H, H<sub>THP</sub>), 1.46–1.44 (m, 1H, H<sub>THP</sub>). General assignments were confirmed by <sup>1</sup>H–<sup>1</sup>H gCOSY. <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>C</sub> = 164.4 (C<sub>quat</sub>), 151.2 (C<sub>quat</sub>), 138.9 (C<sub>quat</sub>), 131.6 (CH<sub>Ar</sub>), 130.6 (CH<sub>Ar</sub>), 129.3 (CH<sub>Ar</sub>), 127.6 (CH<sub>Ar</sub>), 121.5 (C<sub>quat</sub>), 100.8 (CH<sub>THP</sub>), 61.2 (CH<sub>2</sub>-THP), 30.7 (Ph-<u class="uu">C</u>H<sub>2</sub>-C), 28.0 (CH<sub>2</sub>-THP), 24.5 (CH<sub>2</sub>-THP), 18.3 (CH<sub>2</sub>-THP). General assignments were confirmed by <sup>1</sup>H–<sup>13</sup>C HSQC. LRMS (ESI): <i>m</i>/<i>z</i> = 364, 366 [M + Na, <sup>79</sup>Br, <sup>81</sup>Br]<sup>+</sup>. HRMS (ESI): calcd for [C<sub>14</sub>H<sub>16</sub>BrNO<sub>4</sub> – H, <sup>79</sup>Br]<sup>+</sup> 340.0189, found 340.0186, calcd for [C<sub>14</sub>H<sub>16</sub>BrNO<sub>4</sub> – H, <sup>81</sup>Br]<sup>+</sup> 342.0169, found 342.0166.</div></div><div id="sec4_6_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> (2<i>E</i>)-3-(4-Hydroxyphenyl)-2-[(oxan-2-yloxy)imino]propanoic Acid (<b>13</b>)</h3><div class="NLM_p last">Compound <b>13</b> was synthesized from crude arylpyruvic acid <b>25</b> (1.9 g, 10.56 mmol) according to general procedure 2. The crude residue was purified by flash chromatography (3–4% MeOH in DCM) to afford the title compound as a pale yellow oil (1.30 g, 44%). <i>R</i><sub><i>f</i></sub> = 0.17 (10% MeOH in DCM). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>H</sub> = 9.25 (s, 1H, Ph-OH), 7.04 (d, <i>J</i> = 8.6 Hz, 2H, H<sub>Ar</sub>), 6.67 (d, <i>J</i> = Hz, 2H, H<sub>Ar</sub>), 5.34–5.33 (m, 1H, CH<sub>THP</sub>), 3.76 (d, <i>J</i> = 13.4 Hz, 1H, Ph-C<u class="uu">H</u>H-C), 3.70 (d, <i>J</i> = 13.4 Hz, 1H, Ph-CH<u class="uu">H</u>-C), 3.56–3.47 (m, 2H, H<sub>THP</sub>), 1.76–1.69 (m, 3H, H<sub>THP</sub>), 1.60–1.53 (m, 2H, H<sub>THP</sub>), 1.48–1.44 (m, 1H, H<sub>THP</sub>), COOH proton in exchange. General assignments were confirmed by <sup>1</sup>H–<sup>1</sup>H gCOSY. <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>C</sub> = 164.6 (C<sub>quat</sub>), 155.9 (C<sub>quat</sub>), 152.4 (C<sub>quat</sub>), 129.7 (2 × CH<sub>Ar</sub>), 126.0 (C<sub>quat</sub>), 115.2 (2 × CH<sub>Ar</sub>), 100.7 (CH<sub>THP</sub>), 61.4 (CH<sub>2</sub>-THP), 30.0 (Ph-<u class="uu">C</u>H<sub>2</sub>-C), 28.2 (CH<sub>2</sub>-THP), 24.6 (CH<sub>2</sub>-THP), 18.6 (CH<sub>2</sub>-THP). General assignments were confirmed by <sup>1</sup>H–<sup>13</sup>C HSQC. LRMS (ESI): <i>m</i>/<i>z</i> = 302 [M + Na]<sup>+</sup>. HRMS (ESI): calcd for [C<sub>14</sub>H<sub>17</sub>NO<sub>5</sub> – H]<sup>+</sup> 278.1034, found 278.1032.</div></div><div id="sec4_6_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> (<i>E</i>)-4-Benzylidene-2-methyloxazol-5(4<i>H</i>)-one (<b>19</b>)</h3><div class="NLM_p last">Compound <b>19</b> was synthesized from compound <b>15</b> (4.0 g, 37.69 mmol) according to general procedure 1 as a yellow solid (4.5 g, 64%, crude). A portion of the crude solid was purified by flash chromatography (5–8% acetone in <i>n</i>-hexane) to afford the title compound as a yellow solid. <i>R</i><sub><i>f</i></sub> = 0.46 (20% acetone in <i>n</i>-hexane). Mp = 148–150 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>H</sub> = 8.18–8.17 (m, 2H, H<sub>Ar</sub>), 7.51–7.47 (m, 3H, H<sub>Ar</sub>), 7.22 (s, 1H, Ph-CH═C), 2.39 (s, 3H, CH<sub>3</sub>). General assignments were confirmed by <sup>1</sup>H–<sup>1</sup>H gCOSY. <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>C</sub> = 167.3 (C<sub>quat</sub>), 166.7 (C<sub>quat</sub>), 133.0 (C<sub>quat</sub>), 132.6 (C<sub>quat</sub>), 131.9 (2 × CH<sub>Ar</sub>), 131.0 (1 × CH<sub>Ar</sub>), 129.7 (Ph-<u class="uu">C</u>H═C), 128.8 (2 × CH<sub>Ar</sub>), 15.3 (CH<sub>3</sub>). General assignments were confirmed by <sup>1</sup>H–<sup>13</sup>C HSQC. LRMS (ESI): <i>m</i>/<i>z</i> = 188 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> (<i>E</i>)-4-(3-Bromobenzylidene)-2-methyloxazol-5(4<i>H</i>)-one (<b>20</b>)</h3><div class="NLM_p last">Compound <b>20</b> was synthesized from compound <b>16</b> (5.0 g, 27.02 mmol) according to general procedure 1 as a yellow solid (5.25 g, 73%, crude). A portion of the crude solid was purified by flash chromatography (5–8% acetone in <i>n</i>-hexane) to afford the title compound as a yellow solid. <i>R</i><sub><i>f</i></sub> = 0.45 (20% acetone in <i>n</i>-hexane). Mp = 120–122 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>H</sub> = 8.42 (s, 1H, H<sub>Ar</sub>), 8.14 (d, <i>J</i> = 8.1 Hz, 1H, H<sub>Ar</sub>), 7.67 (d, <i>J</i> = 7.05 Hz, 1H, H<sub>Ar</sub>), 7.45 (t, <i>J</i> = 7.9 Hz, 1H, H<sub>Ar</sub>), 7.20 (s, 1H, Ph-CH═C), 2.41 (s, 3H, CH<sub>3</sub>). General assignments were confirmed by <sup>1</sup>H–<sup>1</sup>H gCOSY. <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>C</sub> = 167.3 (C<sub>quat</sub>), 166.6 (C<sub>quat</sub>), 135.0 (C<sub>quat</sub>), 133.4 (C<sub>quat</sub>), 133.3 (CH<sub>Ar</sub>), 133.0 (CH<sub>Ar</sub>), 130.5 (CH<sub>Ar</sub>), 130.4 (CH<sub>Ar</sub>), 127.3 (Ph-<u class="uu">C</u>H═C), 121.7 (C<sub>quat</sub>), 15.1 (CH<sub>3</sub>). General assignments were confirmed by <sup>1</sup>H–<sup>13</sup>C HSQC. LRMS (ESI): <i>m</i>/<i>z</i> = 305 [M + K]<sup>+</sup>.</div></div><div id="sec4_6_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> (<i>E</i>)-4-((2-Methyl-5-oxooxazol-4(5<i>H</i>)-ylidene)methyl)phenyl Acetate (<b>21</b>)</h3><div class="NLM_p last">Compound <b>21</b> was synthesized from compound <b>17</b> (5.0 g, 40.94 mmol) according to general procedure 1 as yellow solid (6.5 g, 65%, crude). A portion of the crude solid was purified by flash chromatography (8–10% acetone in <i>n</i>-hexane) to afford the title compound as a yellow solid. <i>R</i><sub><i>f</i></sub> = 0.29 (20% acetone in <i>n</i>-hexane). Mp = 130–132 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>H</sub> = 8.22 (d, <i>J</i> = 8.7 Hz, 2H, H<sub>Ar</sub>), 7.27 (d, <i>J</i> = 8.65 Hz, 2H, H<sub>Ar</sub>), 7.23 (s, 1H, Ph-CH═C), 2.39 (s, 3H, CH<sub>3</sub>), 2.29 (s, 3H, CH<sub>3</sub>). General assignments were confirmed by <sup>1</sup>H–<sup>1</sup>H gCOSY. <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>C</sub> = 168.8 (C<sub>quat</sub>), 167.3 (C<sub>quat</sub>), 166.8 (C<sub>quat</sub>), 152.3 (C<sub>quat</sub>), 133.2 (2 × CH<sub>Ar</sub>), 132.4 (C<sub>quat</sub>), 130.7 (C<sub>quat</sub>), 128.8 (Ph-<u class="uu">C</u>H═C), 122.4 (2 × CH<sub>Ar</sub>), 20.8 (CH<sub>3</sub>), 15.3 (CH<sub>3</sub>). General assignments were confirmed by <sup>1</sup>H–<sup>13</sup>C HSQC. LRMS (ESI): <i>m</i>/<i>z</i> = 246 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> (2<i>E</i>)-2-[(Benzyloxy)imino]-3-phenyl-<i>N</i>-[2-(4-sulfamoylphenyl)ethyl]propanamide (<b>27</b>)</h3><div class="NLM_p last">Compound <b>27</b> was synthesized from compound <b>7</b> (0.1 g, 0.37 mmol) according to general procedure 3. The crude solid was purified by flash chromatography (gradient: 1.5–2% MeOH in DCM) to afford the title compound as a white solid (0.081 g, 49%). <i>R</i><sub><i>f</i></sub> = 0.37 (5% MeOH in DCM). Mp = 115–117 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>H</sub> = 8.17 (t, <i>J</i> = 5.6 Hz, 1H, N-H), 7.72 (d, <i>J</i> = 7.95 Hz, 2H, H<sub>Ar</sub>), 7.37–7.17 (m, 12H, H<sub>Ar</sub> and SO<sub>2</sub>NH<sub>2</sub>), 7.14 (d, <i>J</i> = 7.45 Hz, 2H, H<sub>Ar</sub>), 5.23 (s, 2H, Ph-CH<sub>2</sub>-O), 3.83 (s, 2H, Ph-CH<sub>2</sub>-C), 3.38 (q, <i>J</i> = 6.55 Hz, 2H, HN-C<u class="uu">H</u><sub>2</sub>-CH<sub>2</sub>), 2.83 (t, <i>J</i> = 7.05 Hz, 2H, HN-CH<sub>2</sub>-C<u class="uu">H</u><sub>2</sub>). General assignments were confirmed by <sup>1</sup>H–<sup>1</sup>H gCOSY. <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>C</sub> = 162.3 (C<sub>quat</sub>), 152.7 (C<sub>quat</sub>), 143.4 (C<sub>quat</sub>), 142.0 (C<sub>quat</sub>), 137.0 (C<sub>quat</sub>), 136.0 (C<sub>quat</sub>), 129.0 (2 × CH<sub>Ar</sub>), 128.6 (2 × CH<sub>Ar</sub>), 128.3 (2 × CH<sub>Ar</sub>), 128.2 (2 × CH<sub>Ar</sub>), 127.9 (3 × CH<sub>Ar</sub>), 126.2 (CH<sub>Ar</sub>), 125.6 (2 × CH<sub>Ar</sub>), 76.3 (Ph-<u class="uu">C</u>H<sub>2</sub>-O), 40.0 (HN-<u class="uu">C</u>H<sub>2</sub>-CH<sub>2</sub>), 34.5 (HN-CH<sub>2</sub>-<u class="uu">C</u>H<sub>2</sub>), 29.8 (Ph-<u class="uu">C</u>H<sub>2</sub>-C). General assignments were confirmed by <sup>1</sup>H–<sup>13</sup>C HSQC. LRMS (ESI): <i>m</i>/<i>z</i> = 452 [M + H]<sup>+</sup>, 474 [M + Na]<sup>+</sup>. HRMS (ESI): calcd for [C<sub>24</sub>H<sub>25</sub>N<sub>3</sub>O<sub>4</sub>S + H]<sup>+</sup> 452.1638, found 452.1641.</div></div><div id="sec4_6_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> (2<i>E</i>)-2-[(Benzyloxy)imino]-3-(3-bromophenyl)-<i>N</i>-[2-(4-sulfamoylphenyl)ethyl]propanamide (<b>28</b>)</h3><div class="NLM_p last">Compound <b>28</b> was synthesized from compound <b>8</b> (0.25 g, 0.72 mmol) according to general procedure 3. The crude solid was purified by flash chromatography (gradient: 1.5–2% MeOH in DCM) to afford the title compound as a white solid (0.242 g, 64%). <i>R</i><sub><i>f</i></sub> = 0.35 (5% MeOH in DCM). Mp = 141–143 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>H</sub> = 8.23 (t, <i>J</i> = 5.75 Hz, 1H, N-H), 7.73 (d, <i>J</i> = 6.25 Hz, 2H, H<sub>Ar</sub>), 7.40–7.31 (m, 9H, H<sub>Ar</sub>), 7.27 (s, 2H, SO<sub>2</sub>NH<sub>2</sub>), 7.22 (t, <i>J</i> = 7.75 Hz, 1H, H<sub>Ar</sub>), 7.14 (d, <i>J</i> = 8.1 Hz, 1H, H<sub>Ar</sub>), 5.23 (s, 2H, Ph-CH<sub>2</sub>-O), 3.82 (s, 2H, Ph-CH<sub>2</sub>-C), 3.39 (q, <i>J</i> = 6.2 Hz, 2H, HN-C<u class="uu">H</u><sub>2</sub>-CH<sub>2</sub>), 2.84 (t, <i>J</i> = 7.1 Hz, 2H, HN-CH<sub>2</sub>-C<u class="uu">H</u><sub>2</sub>). General assignments were confirmed by <sup>1</sup>H–<sup>1</sup>H gCOSY. <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>C</sub> = 162.1 (C<sub>quat</sub>), 152.0 (C<sub>quat</sub>), 143.4 (C<sub>quat</sub>), 142.0 (C<sub>quat</sub>), 138.8 (C<sub>quat</sub>), 136.8 (C<sub>quat</sub>), 131.4 (CH<sub>Ar</sub>), 130.5 (CH<sub>Ar</sub>), 129.2 (CH<sub>Ar</sub>), 129.0 (2 × CH<sub>Ar</sub>), 128.4 (2 × CH<sub>Ar</sub>), 128.0 (CH<sub>Ar</sub>), 127.9 (2 × CH<sub>Ar</sub>), 127.7 (CH<sub>Ar</sub>), 125.6 (2 × CH<sub>Ar</sub>), 121.5 (C<sub>quat</sub>), 76.44 (Ph-<u class="uu">C</u>H<sub>2</sub>-O), 40.1 (HN-<u class="uu">C</u>H<sub>2</sub>-CH<sub>2</sub>), 34.5 (HN-CH<sub>2</sub>-<u class="uu">C</u>H<sub>2</sub>), 29.5 (Ph-<u class="uu">C</u>H<sub>2</sub>-C). General assignments were confirmed by <sup>1</sup>H–<sup>13</sup>C HSQC. LRMS (ESI): <i>m</i>/<i>z</i> = 530 [M + H, <sup>79</sup>Br]<sup>+</sup>. HRMS (ESI): calcd for [C<sub>24</sub>H<sub>24</sub>BrN<sub>3</sub>O<sub>4</sub>S + H, <sup>79</sup>Br]<sup>+</sup> 530.0743, found 530.0740, calcd for [C<sub>24</sub>H<sub>24</sub>BrN<sub>3</sub>O<sub>4</sub>S + H, <sup>81</sup>Br]<sup>+</sup> 532.0723, found 532.0723.</div></div><div id="sec4_6_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> (2<i>E</i>)-2-[(Benzyloxy)imino]-3-(4-hydroxyphenyl)-<i>N</i>-[2-(4-sulfamoylphenyl)ethyl]propanamide (<b>29</b>)</h3><div class="NLM_p last">Compound <b>29</b> was synthesized from compound <b>9</b> (0.5 g, 1.75 mmol) according to general procedure 3. The crude solid was purified by flash chromatography (gradient: 1.5–2% MeOH in DCM) to afford the title compound as a light yellow solid (0.66 g, 81%). <i>R</i><sub><i>f</i></sub> = 0.18 (5% MeOH in DCM). Mp = 122–124 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>H</sub> = 9.19 (s, 1H, Ph-OH), 8.12 (t, <i>J</i> = 5.85 Hz, 1H, N-H), 7.72 (d, <i>J</i> = 8.2 Hz, 2H, H<sub>Ar</sub>), 7.39–7.33 (m, 7H, H<sub>Ar</sub>), 7.27 (s, 2H, SO<sub>2</sub>NH<sub>2</sub>), 6.95 (d, <i>J</i> = 8.4 Hz, 2H, H<sub>Ar</sub>), 6.63 (d, <i>J</i> = 8.45 Hz, 2H, H<sub>Ar</sub>), 5.22 (s, 2H, Ph-CH<sub>2</sub>-O), 3.70 (s, 2H, Ph-CH<sub>2</sub>-C), 3.36 (q, <i>J</i> = 6.9 Hz, 2H, HN-C<u class="uu">H</u><sub>2</sub>-CH<sub>2</sub>), 2.82 (t, <i>J</i> = 7.15 Hz, 2H, HN-CH<sub>2</sub>-C<u class="uu">H</u><sub>2</sub>). General assignments were confirmed by <sup>1</sup>H–<sup>1</sup>H gCOSY. <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>C</sub> = 162.4 (C<sub>quat</sub>), 155.8 (C<sub>quat</sub>), 153.2 (C<sub>quat</sub>), 143.5 (C<sub>quat</sub>), 142.0 (C<sub>quat</sub>), 137.0 (C<sub>quat</sub>), 129.7 (2 × CH<sub>Ar</sub>), 129.0 (2 × CH<sub>Ar</sub>), 128.3 (2 × CH<sub>Ar</sub>), 128.0 (2 × CH<sub>Ar</sub>), 127.9 (CH<sub>Ar</sub>), 125.9 (C<sub>quat</sub>), 125.6 (2 × CH<sub>Ar</sub>), 115.1 (2 × CH<sub>Ar</sub>), 76.2 (Ph-<u class="uu">C</u>H<sub>2</sub>-O), 40.1 (HN-<u class="uu">C</u>H<sub>2</sub>-CH<sub>2</sub>), 34.6 (HN-CH<sub>2</sub>-C<u class="uu">H</u><sub>2</sub>), 28.9 (Ph-<u class="uu">C</u>H<sub>2</sub>-C). General assignments were confirmed by <sup>1</sup>H–<sup>13</sup>C HSQC. LRMS (ESI): <i>m</i>/<i>z</i> = 468 [M + H]<sup>+</sup>, 490 [M + Na]<sup>+</sup>. HRMS (ESI): calcd for [C<sub>24</sub>H<sub>25</sub>N<sub>3</sub>O<sub>5</sub>S + K]<sup>+</sup> 506.1146, found 506.1147.</div></div><div id="sec4_6_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> (2<i>E</i>)-2-[(Benzyloxy)imino]-3-(3-bromo-4-hydroxyphenyl)-<i>N</i>-[2-(4-sulfamoylphenyl)ethyl]propanamide (<b>30</b>)</h3><div class="NLM_p last">Compound <b>30</b> was synthesized from compound <b>10</b> (0.1 g, 0.27 mmol) according to general procedure 3. The crude solid was purified by flash chromatography (gradient: 1.5–2% MeOH in DCM) to afford the title compound as a white solid (0.068 g, 46%). <i>R</i><sub><i>f</i></sub> = 0.32 (5% MeOH in DCM). Mp = 108–110 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>H</sub> = 10.04 (s, 1H, Ph-OH), 8.17 (t, <i>J</i> = 5.85 Hz, 1H, N-H), 7.73 (d, <i>J</i> = 8.25 Hz, 2H, H<sub>Ar</sub>), 7.39–7.32 (m, 7H, H<sub>Ar</sub>), 7.28 (d, <i>J</i> = 2.0 Hz, 1H, H<sub>Ar</sub>), 7.27 (s, 2H, SO<sub>2</sub>NH<sub>2</sub>), 6.96 (dd, <i>J</i> = 8.35, 2.0 Hz, 1H, H<sub>Ar</sub>), 6.82 (d, <i>J</i> = 8.3 Hz, 1H, H<sub>Ar</sub>), 5.22 (s, 2H, Ph-CH<sub>2</sub>-O), 3.70 (s, 2H, Ph-CH<sub>2</sub>-C), 3.37 (q, <i>J</i> = 7.25 Hz, 2H, HN-C<u class="uu">H</u><sub>2</sub>-CH<sub>2</sub>), 2.83 (t, <i>J</i> = 7.15 Hz, 2H, HN-CH<sub>2</sub>-C<u class="uu">H</u><sub>2</sub>). General assignments were confirmed by <sup>1</sup>H–<sup>1</sup>H gCOSY. <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>C</sub> = 162.2 (C<sub>quat</sub>), 152.6 (C<sub>quat</sub>), 152.5 (C<sub>quat</sub>), 143.4 (C<sub>quat</sub>), 142.0 (C<sub>quat</sub>), 136.9 (C<sub>quat</sub>), 132.9 (CH<sub>Ar</sub>), 129.1 (CH<sub>Ar</sub>), 129.0 (2 × CH<sub>Ar</sub>), 128.4 (2 × CH<sub>Ar</sub>), 128.0 (2 × CH<sub>Ar</sub>), 127.97 (CH<sub>Ar</sub>), 127.9 (C<sub>quat</sub>), 125.7 (2 × CH<sub>Ar</sub>), 116.2 (CH<sub>Ar</sub>), 108.9 (C<sub>quat</sub>), 76.3 (Ph-<u class="uu">C</u>H<sub>2</sub>-O), 40.1 (HN-<u class="uu">C</u>H<sub>2</sub>-CH<sub>2</sub>), 34.6 (HN-CH<sub>2</sub>-<u class="uu">C</u>H<sub>2</sub>), 28.6 (Ph-<u class="uu">C</u>H<sub>2</sub>-C). General assignments were confirmed by <sup>1</sup>H–<sup>13</sup>C HSQC. LRMS (ESI): <i>m</i>/<i>z</i> = 546 [M + H, <sup>79</sup>Br]<sup>+</sup>, 568 [M + Na, <sup>79</sup>Br]<sup>+</sup>. HRMS (ESI): calcd for [C<sub>24</sub>H<sub>24</sub>BrN<sub>3</sub>O<sub>5</sub>S + Na, <sup>79</sup>Br]<sup>+</sup> 568.0512, found 568.0510, calcd for [C<sub>24</sub>H<sub>24</sub>BrN<sub>3</sub>O<sub>5</sub>S + Na, <sup>81</sup>Br]<sup>+</sup> 570.0491, found 570.0490.</div></div><div id="sec4_6_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> (2<i>E</i>)-2-[(Benzyloxy)imino]-3-phenyl-<i>N</i>-[(4-sulfamoylphenyl)methyl]propanamide (<b>31</b>)</h3><div class="NLM_p last">Compound <b>31</b> was synthesized from compound <b>7</b> (0.25 g, 0.93 mmol) according to general procedure 3. The crude solid was purified by flash chromatography (gradient: 1.5–2% MeOH in DCM) to afford the title compound as a white solid (0.168 g, 41%). <i>R</i><sub><i>f</i></sub> = 0.39 (5% MeOH in DCM). Mp = 183–185 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>H</sub> = 8.76 (t, <i>J</i> = 6.2 Hz, 1H, N-H), 7.74 (d, <i>J</i> = 7.9 Hz, 2H, H<sub>Ar</sub>), 7.37–7.34 (m, 7H, H<sub>Ar</sub>), 7.28 (s, 2H, SO<sub>2</sub>NH<sub>2</sub>), 7.25 (d, <i>J</i> = 7.6 Hz, 2H, H<sub>Ar</sub>), 7.21 (d, <i>J</i> = 6.85 Hz, 1H, H<sub>Ar</sub>), 7.17 (d, <i>J</i> = 8.0 Hz, 2H, H<sub>Ar</sub>), 5.26 (s, 2H, Ph-CH<sub>2</sub>-O), 4.39 (d, <i>J</i> = 6.0 Hz, 2H, HN-C<u class="uu">H</u><sub>2</sub>-Ph), 3.86 (s, 2H, Ph-CH<sub>2</sub>-C). General assignments were confirmed by <sup>1</sup>H–<sup>1</sup>H gCOSY. <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>C</sub> = 162.6 (C<sub>quat</sub>), 152.7 (C<sub>quat</sub>), 143.2 (C<sub>quat</sub>), 142.6 (C<sub>quat</sub>), 136.9 (C<sub>quat</sub>), 135.9 (C<sub>quat</sub>), 128.7 (2 × CH<sub>Ar</sub>), 128.3 (4 × CH<sub>Ar</sub>), 128.0 (2 × CH<sub>Ar</sub>), 127.9 (CH<sub>Ar</sub>), 127.3 (2 × CH<sub>Ar</sub>), 126.3 (CH<sub>Ar</sub>), 125.6 (2 × CH<sub>Ar</sub>), 76.4 (Ph-<u class="uu">C</u>H<sub>2</sub>-O), 42.0 (HN-<u class="uu">C</u>H<sub>2</sub>-Ph), 30.0 (Ph-<u class="uu">C</u>H<sub>2</sub>-C). General assignments were confirmed by <sup>1</sup>H–<sup>13</sup>C HSQC. LRMS (ESI): <i>m</i>/<i>z</i> = 438 [M + H]<sup>+</sup>, 460 [M + Na]<sup>+</sup>. HRMS (ESI): calcd for [C<sub>23</sub>H<sub>23</sub>N<sub>3</sub>O<sub>4</sub>S + H, <sup>79</sup>Br]<sup>+</sup> 438.1482, found 438.1483.</div></div><div id="sec4_6_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> (2<i>E</i>)-2-[(Benzyloxy)imino]-3-(3-bromophenyl)-<i>N</i>-[(4-sulfamoylphenyl)methyl]propanamide (<b>32</b>)</h3><div class="NLM_p last">Compound <b>32</b> was synthesized from compound <b>8</b> (0.2 g, 0.58 mmol) according to general procedure 3. The crude solid was purified by flash chromatography (gradient: 1.5–2% MeOH in DCM) to afford the title compound as a white solid (0.220 g, 74%). <i>R</i><sub><i>f</i></sub> = 0.28 (5% MeOH in DCM). Mp = 161–163 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>H</sub> = 8.83 (t, <i>J</i> = 6.15 Hz, 1H, N-H), 7.76 (d, <i>J</i> = 8.1 Hz, 2H, H<sub>Ar</sub>), 7.41–7.32 (m, 9H, H<sub>Ar</sub>), 7.28 (s, 2H, SO<sub>2</sub>NH<sub>2</sub>), 7.22 (t, <i>J</i> = 7.75 Hz, 1H, H<sub>Ar</sub>), 7.18 (d, <i>J</i> = 7.7 Hz, 1H, H<sub>Ar</sub>), 5.26 (s, 2H, Ph-CH<sub>2</sub>-O), 4.41 (d, <i>J</i> = 6.15 Hz, 2H, HN-C<u class="uu">H</u><sub>2</sub>-Ph), 3.85 (s, 2H, Ph-CH<sub>2</sub>-C). General assignments were confirmed by <sup>1</sup>H–<sup>1</sup>H gCOSY. <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>C</sub> = 162.5 (C<sub>quat</sub>), 152.0 (C<sub>quat</sub>), 143.2 (C<sub>quat</sub>), 142.6 (C<sub>quat</sub>), 138.7 (C<sub>quat</sub>), 136.8 (C<sub>quat</sub>), 131.4 (CH<sub>Ar</sub>), 130.5 (CH<sub>Ar</sub>), 129.2 (CH<sub>Ar</sub>), 128.4 (2 × CH<sub>Ar</sub>), 128.0 (3 × CH<sub>Ar</sub>), 127.8 (CH<sub>Ar</sub>), 127.3 (2 × CH<sub>Ar</sub>), 125.6 (2 × CH<sub>Ar</sub>), 121.6 (C<sub>quat</sub>), 76.5 (Ph-<u class="uu">C</u>H<sub>2</sub>-O), 42.0 (HN-<u class="uu">C</u>H<sub>2</sub>-Ph), 29.6 (Ph-<u class="uu">C</u>H<sub>2</sub>-C). General assignments were confirmed by <sup>1</sup>H–<sup>13</sup>C HSQC. LRMS (ESI): <i>m</i>/<i>z</i> = 516 [M + H]<sup>+</sup>, 538 [M + Na]<sup>+</sup>. HRMS (ESI): calcd for [C<sub>23</sub>H<sub>22</sub>BrN<sub>3</sub>O<sub>4</sub>S + H, <sup>79</sup>Br]<sup>+</sup> 516.0587, found 516.0587, calcd for [C<sub>23</sub>H<sub>22</sub>BrN<sub>3</sub>O<sub>4</sub>S + H, <sup>81</sup>Br]<sup>+</sup> 518.0566, found 518.0567.</div></div><div id="sec4_6_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> (2<i>E</i>)-2-[(Benzyloxy)imino]-3-(4-hydroxyphenyl)-<i>N</i>-[(4-sulfamoylphenyl)methyl]propanamide (<b>33</b>)</h3><div class="NLM_p last">Compound <b>33</b> was synthesized from compound <b>9</b> (0.3 g, 1.05 mmol) according to general procedure 3. The crude solid was purified by flash chromatography (gradient: 1.5–2% MeOH in DCM) to afford the title compound as a white solid (0.384 g, 81%). <i>R</i><sub><i>f</i></sub> = 0.20 (5% MeOH in DCM). Mp = 183–185 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>H</sub> = 9.21 (s, 1H, Ph-OH), 8.71 (t, <i>J</i> = 6.15 Hz, 1H, N-H), 7.74 (d, <i>J</i> = 8.15 Hz, 2H, H<sub>Ar</sub>), 7.38–7.34 (m, 7H, H<sub>Ar</sub>), 7.27 (s, 2H, SO<sub>2</sub>NH<sub>2</sub>), 6.96 (d, <i>J</i> = 8.25 Hz, 2H, H<sub>Ar</sub>), 6.63 (d, <i>J</i> = 8.3 Hz, 2H, H<sub>Ar</sub>), 5.25 (s, 2H, Ph-CH<sub>2</sub>-O), 4.38 (d, <i>J</i> = 6.15 Hz, 2H, HN-C<u class="uu">H</u><sub>2</sub>-Ph), 3.73 (s, 2H, Ph-CH<sub>2</sub>-C). General assignments were confirmed by <sup>1</sup>H–<sup>1</sup>H gCOSY. <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>C</sub> = 162.7 (C<sub>quat</sub>), 155.8 (C<sub>quat</sub>), 153.3 (C<sub>quat</sub>), 143.3 (C<sub>quat</sub>), 142.6 (C<sub>quat</sub>), 137.0 (C<sub>quat</sub>), 129.7 (2 × CH<sub>Ar</sub>), 128.3 (2 × CH<sub>Ar</sub>), 128.0 (2 × CH<sub>Ar</sub>), 127.9 (CH<sub>Ar</sub>), 127.3 (2 × CH<sub>Ar</sub>), 125.8 (C<sub>quat</sub>), 125.6 (2 × CH<sub>Ar</sub>), 115.1 (2 × CH<sub>Ar</sub>), 76.3 (Ph-<u class="uu">C</u>H<sub>2</sub>-O), 42.0 (HN-<u class="uu">C</u>H<sub>2</sub>-Ph), 29.0 (Ph-<u class="uu">C</u>H<sub>2</sub>-C). General assignments were confirmed by <sup>1</sup>H–<sup>13</sup>C HSQC. LRMS (ESI): <i>m</i>/<i>z</i> = 454 [M + H]<sup>+</sup>, 474 [M + Na]<sup>+</sup>. HRMS (ESI): calcd for [C<sub>23</sub>H<sub>23</sub>N<sub>3</sub>O<sub>5</sub>S + H]<sup>+</sup> 454.1431, found 454.1432.</div></div><div id="sec4_6_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> (2<i>E</i>)-2-[(Benzyloxy)imino]-3-phenyl-<i>N</i>-(4-sulfamoylphenyl)propanamide (<b>35</b>)</h3><div class="NLM_p last">Compound <b>35</b> was synthesized from compound <b>7</b> (0.3 g, 1.11 mmol) according to general procedure 3. The crude product was purified by flash chromatography (gradient: 1.5–2% MeOH in DCM) to afford the title compound as a white solid (0.295 g, 63%). <i>R</i><sub><i>f</i></sub> = 0.39 (5% MeOH in DCM). Mp = 187–189 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>H</sub> = 10.13 (s, 1H, N-H), 7.89 (d, <i>J</i> = 7.4 Hz, 2H, H<sub>Ar</sub>), 7.78 (d, <i>J</i> = 8.75 Hz, 2H, H<sub>Ar</sub>), 7.40–7.33 (m, 5H, H<sub>Ar</sub>), 7.28–7.25 (m, 4H, H<sub>Ar</sub> and SO<sub>2</sub>NH<sub>2</sub>), 7.23–7.18 (m, 3H, H<sub>Ar</sub>), 5.36 (s, 2H, Ph-CH<sub>2</sub>-O), 3.94 (s, 2H, Ph-CH<sub>2</sub>-C). General assignments were confirmed by <sup>1</sup>H–<sup>1</sup>H gCOSY. <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>C</sub> = 161.5 (C<sub>quat</sub>), 152.8 (C<sub>quat</sub>), 141.0 (C<sub>quat</sub>), 139.0 (C<sub>quat</sub>), 136.7 (C<sub>quat</sub>), 135.7 (C<sub>quat</sub>), 128.7 (2 × CH<sub>Ar</sub>), 128.41 (2 × CH<sub>Ar</sub>), 128.37 (2 × CH<sub>Ar</sub>), 128.05 (CH<sub>Ar</sub>), 128.00 (2 × CH<sub>Ar</sub>), 126.45 (2 × CH<sub>Ar</sub>), 126.40 (CH<sub>Ar</sub>), 119.8 (2 × CH<sub>Ar</sub>), 76.7 (Ph-<u class="uu">C</u>H<sub>2</sub>-O), 29.9 (Ph-<u class="uu">C</u>H<sub>2</sub>-C). General assignments were confirmed by <sup>1</sup>H–<sup>13</sup>C HSQC. LRMS (ESI): <i>m</i>/<i>z</i> = 424 [M + H]<sup>+</sup>, 446 [M + Na]<sup>+</sup>. HRMS (ESI): calcd for [C<sub>22</sub>H<sub>21</sub>N<sub>3</sub>O<sub>4</sub>S + H]<sup>+</sup> 424.1325, found 424.1327.</div></div><div id="sec4_6_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> (2<i>E</i>)-2-[(Benzyloxy)imino]-3-(3-bromophenyl)-<i>N</i>-(4-sulfamoylphenyl)propanamide (<b>36</b>)</h3><div class="NLM_p last">Compound <b>36</b> was synthesized from compound <b>8</b> (0.25 g, 0.72 mmol) according to general procedure 3. The crude product was purified by flash chromatography (gradient: 1–1.5% MeOH in DCM) to afford the title compound as a white solid (0.13 g, 36%). <i>R</i><sub><i>f</i></sub> = 0.33 (5% MeOH in DCM). Mp = 212–214 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>H</sub> = 10.35 (s, 1H, N-H), 7.89 (d, <i>J</i> = 8.75 Hz, 2H, H<sub>Ar</sub>), 7.79 (d, <i>J</i> = 8.75 Hz, 2H, H<sub>Ar</sub>), 7.42–7.33 (m, 7H, H<sub>Ar</sub>), 7.26 (s, 2H, SO<sub>2</sub>NH<sub>2</sub>), 7.24–7.22 (m, 2H, H<sub>Ar</sub>), 5.37 (s, 2H, Ph-CH<sub>2</sub>-O), 3.92 (s, 2H, Ph-CH<sub>2</sub>-C). General assignments were confirmed by <sup>1</sup>H–<sup>1</sup>H gCOSY. <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>C</sub> = 161.3 (C<sub>quat</sub>), 152.1 (C<sub>quat</sub>), 140.9 (C<sub>quat</sub>), 139.1 (C<sub>quat</sub>), 138.5 (C<sub>quat</sub>), 136.6 (C<sub>quat</sub>), 131.4 (CH<sub>Ar</sub>), 130.5 (CH<sub>Ar</sub>), 129.3 (CH<sub>Ar</sub>), 128.4 (2 × CH<sub>Ar</sub>), 128.1 (CH<sub>Ar</sub>), 128.0 (2 × CH<sub>Ar</sub>), 127.8 (CH<sub>Ar</sub>), 126.5 (2 × CH<sub>Ar</sub>), 121.6 (C<sub>quat</sub>), 119.9 (2 × CH<sub>Ar</sub>), 76.9 (Ph-<u class="uu">C</u>H<sub>2</sub>-O), 29.7 (Ph-<u class="uu">C</u>H<sub>2</sub>-C). General assignments were confirmed by <sup>1</sup>H–<sup>13</sup>C HSQC. LRMS (ESI): <i>m</i>/<i>z</i> = 502 [M + H]<sup>+</sup>, 524 [M + Na]<sup>+</sup>. HRMS (ESI): calcd for [C<sub>22</sub>H<sub>20</sub>BrN<sub>3</sub>O<sub>4</sub>S + H, <sup>79</sup>Br]<sup>+</sup> 502.0430, found 502.0431, calcd for [C<sub>22</sub>H<sub>20</sub>BrN<sub>3</sub>O<sub>4</sub>S + H, <sup>81</sup>Br]<sup>+</sup> 504.0410, found 504.0411.</div></div><div id="sec4_6_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> (2<i>E</i>)-2-[(Benzyloxy)imino]-3-(4-hydroxyphenyl)-<i>N</i>-(4-sulfamoylphenyl)propanamide (<b>37</b>)</h3><div class="NLM_p last">Compound <b>37</b> was synthesized from compound <b>9</b> (0.3 g, 1.05 mmol) according to general procedure 3. The crude product was purified by flash chromatography (gradient: 1.5–2% MeOH in DCM) to afford the title compound as a white solid (0.375 g, 81%). <i>R</i><sub><i>f</i></sub> = 0.2 (5% MeOH in DCM). Mp = 176–178 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>H</sub> = 10.29 (s, 1H, N-H), 9.25 (s, 1H, Ph-OH), 7.88 (d, <i>J</i> = 8.9 Hz, 2H, H<sub>Ar</sub>), 7.77 (d, <i>J</i> = 8.85 Hz, 2H, H<sub>Ar</sub>), 7.40–7.33 (m, 5H, H<sub>Ar</sub>), 7.27 (s, 2H, SO<sub>2</sub>NH<sub>2</sub>), 7.02 (d, <i>J</i> = 8.5 Hz, 2H, H<sub>Ar</sub>), 6.65 (d, <i>J</i> = 8.55 Hz, 2H, H<sub>Ar</sub>), 5.36 (s, 2H, Ph-CH<sub>2</sub>-O), 3.81 (s, 2H, Ph-CH<sub>2</sub>-C). General assignments were confirmed by <sup>1</sup>H–<sup>1</sup>H gCOSY. <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>C</sub> = 161.6 (C<sub>quat</sub>), 155.9 (C<sub>quat</sub>), 153.3 (C<sub>quat</sub>), 141.1 (C<sub>quat</sub>), 139.0 (C<sub>quat</sub>), 136.8 (C<sub>quat</sub>), 129.8 (2 × CH<sub>Ar</sub>), 128.4 (2 × CH<sub>Ar</sub>), 128.1 (3 × CH<sub>Ar</sub>), 126.5 (2 × CH<sub>Ar</sub>), 125.6 (C<sub>quat</sub>), 119.8 (2 × CH<sub>Ar</sub>), 115.2 (2 × CH<sub>Ar</sub>), 76.6 (Ph-<u class="uu">C</u>H<sub>2</sub>-O), 29.0 (Ph-<u class="uu">C</u>H<sub>2</sub>-C). General assignments were confirmed by <sup>1</sup>H–<sup>13</sup>C HSQC. LRMS (ESI): 462 [M + Na]<sup>+</sup>. HRMS (ESI): calcd for [C<sub>22</sub>H<sub>21</sub>N<sub>3</sub>O<sub>5</sub>S + K]<sup>+</sup> 478.0833, found 478.0834.</div></div><div id="sec4_6_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> (2<i>E</i>)-2-[(Benzyloxy)imino]-3-phenyl-<i>N</i>-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)propanamide (<b>39</b>)</h3><div class="NLM_p last">Compound <b>39</b> was synthesized from compound <b>7</b> (0.15 g, 0.56 mmol) according to general procedure 3. The crude solid was purified by flash chromatography (gradient: 1–1.5% MeOH in DCM) to afford the title compound as a white foam (0.175 g, 49%). <i>R</i><sub><i>f</i></sub> = 0.4 (5% MeOH in DCM). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>H</sub> = 13.17 (s, 1H, N-H), 8.35 (s, 2H, SO<sub>2</sub>NH<sub>2</sub>), 7.42–7.33 (m, 5H, H<sub>Ar</sub>), 7.28–7.25 (m, 2H, H<sub>Ar</sub>), 7.22–7.19 (m, 3H, H<sub>Ar</sub>), 5.42 (s, 2H, Ph-CH<sub>2</sub>-O), 3.95 (s, 2H, Ph-CH<sub>2</sub>-C). General assignments were confirmed by <sup>1</sup>H–<sup>1</sup>H gCOSY. <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>C</sub> = 164.8 (C<sub>quat</sub>), 162.2 (C<sub>quat</sub>), 161.1 (C<sub>quat</sub>), 150.5 (C<sub>quat</sub>), 136.6 (C<sub>quat</sub>), 135.3 (C<sub>quat</sub>), 128.6 (2 × CH<sub>Ar</sub>), 128.5 (2 × CH<sub>Ar</sub>), 128.4 (2 × CH<sub>Ar</sub>), 128.2 (2 × CH<sub>Ar</sub>), 128.15 (CH<sub>Ar</sub>), 126.5 (CH<sub>Ar</sub>), 77.4 (Ph-<u class="uu">C</u>H<sub>2</sub>-O), 30.0 (Ph-<u class="uu">C</u>H<sub>2</sub>-C). General assignments were confirmed by <sup>1</sup>H–<sup>13</sup>C HSQC. LRMS (ESI): <i>m</i>/<i>z</i> = 432 [M + H]<sup>+</sup>, 454 [M + Na]<sup>+</sup>. HRMS (ESI): calcd for [C<sub>18</sub>H<sub>17</sub>N<sub>5</sub>O<sub>4</sub>S<sub>2</sub> + Na]<sup>+</sup> 454.0614, found 454.0615.</div></div><div id="sec4_6_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> (2<i>E</i>)-2-[(Benzyloxy)imino]-3-(3-bromophenyl)-<i>N</i>-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)propanamide (<b>40</b>)</h3><div class="NLM_p last">Compound <b>40</b> was synthesized from compound <b>8</b> (0.25 g, 0.72 mmol) according to general procedure 3. The crude solid was purified by flash chromatography (1.5–2% MeOH in DCM) to afford the title compound as a white solid (0.201 g, 55%). <i>R</i><sub><i>f</i></sub> = 0.25 (5% MeOH in DCM). Mp = 76–78 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>H</sub> = 13.19 (s, 1H, N-H), 8.34 (s, 2H, SO<sub>2</sub>NH<sub>2</sub>), 7.42–7.34 (m, 7H, H<sub>Ar</sub>), 7.24–7.19 (m, 2H, H<sub>Ar</sub>), 5.41 (s, 2H, Ph-CH<sub>2</sub>-O), 3.94 (s, 2H, Ph-CH<sub>2</sub>-C). General assignments were confirmed by <sup>1</sup>H–<sup>1</sup>H gCOSY. <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>C</sub> = 164.7 (C<sub>quat</sub>), 162.1 (C<sub>quat</sub>), 161.2 (C<sub>quat</sub>), 149.9 (C<sub>quat</sub>), 138.1 (C<sub>quat</sub>), 136.5 (C<sub>quat</sub>), 131.3 (CH<sub>Ar</sub>), 130.6 (CH<sub>Ar</sub>), 129.5 (CH<sub>Ar</sub>), 128.4 (2 × CH<sub>Ar</sub>), 128.2 (3 × CH<sub>Ar</sub>), 127.7 (CH<sub>Ar</sub>), 121.6 (C<sub>quat</sub>), 77.5 (Ph-<u class="uu">C</u>H<sub>2</sub>-O), 29.7 (Ph-<u class="uu">C</u>H<sub>2</sub>-C). General assignments were confirmed by <sup>1</sup>H–<sup>13</sup>C HSQC. LCMS (ESI): <i>m</i>/<i>z</i> = 510, 512 [M + H, <sup>79</sup>Br, <sup>81</sup>Br]<sup>+</sup>. HRMS (ESI): calcd for [C<sub>18</sub>H<sub>16</sub>BrN<sub>5</sub>O<sub>4</sub>S<sub>2</sub> + Na, <sup>79</sup>Br]<sup>+</sup> 531.9719, found 531.9719, calcd for [C<sub>18</sub>H<sub>16</sub>BrN<sub>5</sub>O<sub>4</sub>S<sub>2</sub> + Na, <sup>81</sup>Br]<sup>+</sup> 533.9697, found 533.9700.</div></div><div id="sec4_6_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> (2<i>E</i>)-2-[(Benzyloxy)imino]-3-(4-hydroxyphenyl)-<i>N</i>-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)propanamide (<b>41</b>)</h3><div class="NLM_p last">Compound <b>41</b> was synthesized from compound <b>9</b> (0.3 g, 1.50 mmol) according to general procedure 3. The crude solid was purified by flash chromatography (gradient: 1.5–2% MeOH in DCM) to afford the title compound as a white solid (0.192 g, 41%). <i>R</i><sub><i>f</i></sub> = 0.14 (5% MeOH in DCM). Mp = 213-215 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>H</sub> = 13.11 (s, 1H, N-H), 9.24 (s, 1H, Ph-OH), 8.34 (s, 2H, SO<sub>2</sub>NH<sub>2</sub>), 7.43–7.33 (m, 5H, H<sub>Ar</sub>), 6.99 (d, <i>J</i> = 8.1 Hz, 2H, H<sub>Ar</sub>), 6.63 (d, <i>J</i> = 7.85 Hz, 2H, H<sub>Ar</sub>), 5.40 (s, 2H, Ph-CH<sub>2</sub>-O), 3.81 (s, 2H, Ph-CH<sub>2</sub>-C). General assignments were confirmed by <sup>1</sup>H–<sup>1</sup>H gCOSY. <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>C</sub> = 164.7 (C<sub>quat</sub>), 162.2 (C<sub>quat</sub>), 161.1 (C<sub>quat</sub>), 156.0 (C<sub>quat</sub>), 151.0 (C<sub>quat</sub>), 136.7 (C<sub>quat</sub>), 129.7 (2 × CH<sub>Ar</sub>), 128.4 (2 × CH<sub>Ar</sub>), 128.2 (2 × CH<sub>Ar</sub>), 128.1 (CH<sub>Ar</sub>), 125.2 (C<sub>quat</sub>), 115.2 (2 × CH<sub>Ar</sub>), 77.3 (Ph-<u class="uu">C</u>H<sub>2</sub>-O), 29.1 (Ph-<u class="uu">C</u>H<sub>2</sub>-C). General assignments were confirmed by <sup>1</sup>H–<sup>13</sup>C HSQC. LRMS (ESI): 448 [M + H]<sup>+</sup>, 470 [M + Na]<sup>+</sup>. HRMS (ESI): calcd for [C<sub>18</sub>H<sub>17</sub>N<sub>5</sub>O<sub>5</sub>S<sub>2</sub> + Na]<sup>+</sup> 470.0563, found 470.0565.</div></div><div id="sec4_6_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> (2<i>E</i>)-2-(<i>N</i>-Hydroxyimino)-3-phenyl-<i>N</i>-[2-(4-sulfamoylphenyl)ethyl]propanamide (<b>43</b>)</h3><div class="NLM_p last">Compound <b>43</b> was synthesized from compound <b>27</b> (0.05 g, 0.11 mmol) according to general procedure 4. The crude solid was purified by flash chromatography (gradient: 3–5% MeOH in DCM) to afford the title compound as a white solid (0.025 g, 63%). <i>R</i><sub><i>f</i></sub> = 0.24 (10% MeOH in DCM). Mp = 212–214 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>H</sub> = 11.76 (s, 1H, N-OH), 7.97 (t, <i>J</i> = 5.8 Hz, 1H, N-H), 7.72 (d, <i>J</i> = 8.15 Hz, 2H, H<sub>Ar</sub>), 7.35 (d, <i>J</i> = 8.15 Hz, 2H, H<sub>Ar</sub>), 7.27–7.24 (m, 4H, H<sub>Ar</sub> and SO<sub>2</sub>NH<sub>2</sub>), 7.18–7.15 (m, 3H, H<sub>Ar</sub>), 3.81 (s, 2H, Ph-CH<sub>2</sub>-C), 3.39 (q, <i>J</i> = 6.75 Hz, 2H, HN-C<u class="uu">H</u><sub>2</sub>-CH<sub>2</sub>), 2.83 (t, <i>J</i> = 7.05 Hz, 2H, HN-CH<sub>2</sub>-C<u class="uu">H</u><sub>2</sub>). General assignments were confirmed by <sup>1</sup>H–<sup>1</sup>H gCOSY. <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>C</sub> = 163.2 (C<sub>quat</sub>), 151.9 (C<sub>quat</sub>), 143.5 (C<sub>quat</sub>), 142.0 (C<sub>quat</sub>), 136.7 (C<sub>quat</sub>), 129.0 (2 × CH<sub>Ar</sub>), 128.6 (2 × CH<sub>Ar</sub>), 128.2 (2 × CH<sub>Ar</sub>), 126.0 (CH<sub>Ar</sub>), 125.6 (2 × CH<sub>Ar</sub>), 39.8 (HN-<u class="uu">C</u>H<sub>2</sub>-CH<sub>2</sub>), 34.5 (HN-CH<sub>2</sub>-<u class="uu">C</u>H<sub>2</sub>), 28.9 (Ph-<u class="uu">C</u>H<sub>2</sub>-C). General assignments were confirmed by <sup>1</sup>H–<sup>13</sup>C HSQC. LRMS (ESI): <i>m</i>/<i>z</i> = 362 [M + H]<sup>+</sup>, 384 [M + Na]<sup>+</sup>. HRMS (ESI): calcd for [C<sub>17</sub>H<sub>19</sub>N<sub>3</sub>O<sub>4</sub>S + Na]<sup>+</sup> 384.0988, found 384.0994.</div></div><div id="sec4_6_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> (2<i>E</i>)-3-(3-Bromophenyl)-2-(<i>N</i>-hydroxyimino)-<i>N</i>-[2-(4-sulfamoylphenyl)ethyl]propanamide (<b>44</b>)</h3><div class="NLM_p last">Compound <b>44</b> was synthesized from compound <b>59</b> (0.05 g, 0.0954 mmol) according to general procedure 5. The crude solid was purified by flash chromatography (gradient: 4–5% MeOH in DCM) to afford the title compound as a white solid (0.015 g, 37%). <i>R</i><sub><i>f</i></sub> = 0.35 (10% MeOH in DCM). Mp = 110–112 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>H</sub> = 11.89 (s, 1H, N-OH), 8.03 (t, <i>J</i> = 5.9 Hz, 1H, N-H), 7.72 (d, <i>J</i> = 8.2 Hz, 2H, H<sub>Ar</sub>), 7.39–7.38 (m, 2H, H<sub>Ar</sub>), 7.35 (d, <i>J</i> = 8.25 Hz, 2H, H<sub>Ar</sub>), 7.27 (s, 2H, SO<sub>2</sub>NH<sub>2</sub>), 7.24 (t, <i>J</i> = 7.85 Hz, 1H, H<sub>Ar</sub>), 7.19–7.17 (m, 1H, H<sub>Ar</sub>), 3.81 (s, 2H, Ph-CH<sub>2</sub>-C), 3.40 (q, <i>J</i> = 6.75 Hz, 2H, HN-C<u class="uu">H</u><sub>2</sub>-CH<sub>2</sub>), 2.84 (t, <i>J</i> = 7.1 Hz, 2H, HN-CH<sub>2</sub>-C<u class="uu">H</u><sub>2</sub>). General assignments were confirmed by <sup>1</sup>H–<sup>1</sup>H gCOSY. <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>C</sub> = 163.1 (C<sub>quat</sub>), 151.4 (C<sub>quat</sub>), 143.6 (C<sub>quat</sub>), 142.0 (C<sub>quat</sub>), 139.6 (C<sub>quat</sub>), 131.3 (CH<sub>Ar</sub>), 130.5 (CH<sub>Ar</sub>), 129.1 (2 × CH<sub>Ar</sub>), 129.0 (CH<sub>Ar</sub>), 127.8 (CH<sub>Ar</sub>), 125.7 (2 × CH<sub>Ar</sub>), 121.5 (C<sub>quat</sub>), 39.9 (HN-<u class="uu">C</u>H<sub>2</sub>-CH<sub>2</sub>), 34.6 (HN-CH<sub>2</sub>-<u class="uu">C</u>H<sub>2</sub>), 28.7 (Ph-<u class="uu">C</u>H<sub>2</sub>-C). General assignments were confirmed by <sup>1</sup>H–<sup>13</sup>C HSQC. LRMS (ESI): <i>m</i>/<i>z</i> = 440, 442 [M + H, <sup>79</sup>Br, <sup>81</sup>Br]<sup>+</sup>, 462, 464 [M + Na, <sup>79</sup>Br, <sup>81</sup>Br]<sup>+</sup>. HRMS (ESI): calcd for [C<sub>17</sub>H<sub>18</sub>BrN<sub>3</sub>O<sub>4</sub>S – H, <sup>79</sup>Br]<sup>+</sup> 438.0128, found 438.0128, calcd for [C<sub>17</sub>H<sub>18</sub>BrN<sub>3</sub>O<sub>4</sub>S – H, <sup>81</sup>Br]<sup>+</sup> 440.0107, found 440.0109.</div></div><div id="sec4_6_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> (2<i>E</i>)-2-(<i>N</i>-Hydroxyimino)-3-(4-hydroxyphenyl)-<i>N</i>-[2-(4-sulfamoylphenyl)ethyl]propanamide (<b>45</b>)</h3><div class="NLM_p last">Compound <b>45</b> was synthesized from compound <b>29</b> (0.3 g, 0.64 mmol) according to general procedure 4. The crude solid was purified by flash chromatography (gradient: 4–5% MeOH in DCM) to afford the title compound as a white solid (0.16 g, 66%). <i>R</i><sub><i>f</i></sub> = 0.16 (10% MeOH in DCM). Mp = 189–191 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>H</sub> = 11.66 (s, 1H, N-OH), 9.14 (s, 1H, Ph-OH), 7.92 (t, <i>J</i> = 5.85 Hz, 1H, N-H), 7.72 (d, <i>J</i> = 8.15 Hz, 2H, H<sub>Ar</sub>), 7.35 (d, <i>J</i> = 8.2 Hz, 2H, H<sub>Ar</sub>), 7.26 (s, 2H, SO<sub>2</sub>NH<sub>2</sub>), 6.98 (d, <i>J</i> = 8.35 Hz, 2H, H<sub>Ar</sub>), 6.64 (d, <i>J</i> = 8.4 Hz, 2H, H<sub>Ar</sub>), 3.68 (s, 2H, Ph-CH<sub>2</sub>-C), 3.38 (q, <i>J</i> = 6.65 Hz, 2H, HN-C<u class="uu">H</u><sub>2</sub>-CH<sub>2</sub>), 2.82 (t, <i>J</i> = 7.1 Hz, 2H, HN-CH<sub>2</sub>-C<u class="uu">H</u><sub>2</sub>). General assignments were confirmed by <sup>1</sup>H–<sup>1</sup>H gCOSY. <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>C</sub> = 163.3 (C<sub>quat</sub>), 155.5 (C<sub>quat</sub>), 152.4 (C<sub>quat</sub>), 143.6 (C<sub>quat</sub>), 142.0 (C<sub>quat</sub>), 129.7 (2 × CH<sub>Ar</sub>), 129.0 (2 × CH<sub>Ar</sub>), 126.7 (C<sub>quat</sub>), 125.6 (2 × CH<sub>Ar</sub>), 115.0 (2 × CH<sub>Ar</sub>), 39.9 (HN-<u class="uu">C</u>H<sub>2</sub>-CH<sub>2</sub>), 34.6 (HN-CH<sub>2</sub>-<u class="uu">C</u>H<sub>2</sub>), 28.0 (Ph-<u class="uu">C</u>H<sub>2</sub>-C). General assignments were confirmed by <sup>1</sup>H–<sup>13</sup>C HSQC. LRMS (ESI): <i>m</i>/<i>z</i> = 378 [M + H]<sup>+</sup>, 400 [M + Na]<sup>+</sup>. HRMS (ESI): calcd for [C<sub>17</sub>H<sub>19</sub>N<sub>3</sub>O<sub>5</sub>S + Na]<sup>+</sup> 400.09376, found 400.09420.</div></div><div id="sec4_6_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> (2<i>E</i>)-3-(3-Bromo-4-hydroxyphenyl)-2-(<i>N</i>-hydroxyimino)-<i>N</i>-[2-(4-sulfamoylphenyl)ethyl]propanamide (<b>46</b>)</h3><div class="NLM_p last">Compound <b>46</b> was synthesized from compound <b>60</b> (0.115 g, 0.21 mmol) according to general procedure 5. The crude solid was purified by flash chromatography (gradient: 4–5% MeOH in DCM) to afford the title compound as a white solid (0.075 g, 77%). <i>R</i><sub><i>f</i></sub> = 0.28 (10% MeOH in DCM). Mp = 81–83 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>H</sub> = 11.8 (s, 1H, N-OH), 10.03 (s, 1H, Ph-OH), 8.01 (t, <i>J</i> = 5.85 Hz, 1H, N-H), 7.72 (d, <i>J</i> = 8.35 Hz, 2H, H<sub>Ar</sub>), 7.36 (d, <i>J</i> = 8.35 Hz, 2H, H<sub>Ar</sub>), 7.29 (d, <i>J</i> = 2.15 Hz, 1H, H<sub>Ar</sub>), 7.28 (s, 2H, SO<sub>2</sub>NH<sub>2</sub>), 7.01 (dd, <i>J</i> = 7.65, 2.1 Hz, 1H, H<sub>Ar</sub>), 6.84 (d, <i>J</i> = 8.3 Hz, 1H, H<sub>Ar</sub>), 3.69 (s, 2H, Ph-CH<sub>2</sub>-C), 3.38 (q, <i>J</i> = 7.05 Hz, 2H, HN-C<u class="uu">H</u><sub>2</sub>-CH<sub>2</sub>), 2.83 (t, <i>J</i> = 7.15 Hz, 2H, HN-CH<sub>2</sub>-C<u class="uu">H</u><sub>2</sub>). General assignments were confirmed by <sup>1</sup>H–<sup>1</sup>H gCOSY. <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>C</sub> = 163.2 (C<sub>quat</sub>), 152.4 (C<sub>quat</sub>), 152.0 (C<sub>quat</sub>), 143.6 (C<sub>quat</sub>), 142.0 (C<sub>quat</sub>), 132.8 (CH<sub>Ar</sub>), 129.14 (CH<sub>Ar</sub>), 129.1 (2 × CH<sub>Ar</sub>), 128.8 (C<sub>quat</sub>), 125.7 (2 × CH<sub>Ar</sub>), 116.2 (CH<sub>Ar</sub>), 108.9 (C<sub>quat</sub>), 40.0 (HN-<u class="uu">C</u>H<sub>2</sub>-CH<sub>2</sub>), 34.6 (HN-CH<sub>2</sub>-<u class="uu">C</u>H<sub>2</sub>), 27.7 (Ph-<u class="uu">C</u>H<sub>2</sub>-C). General assignments were confirmed by <sup>1</sup>H–<sup>13</sup>C HSQC. LRMS (ESI): <i>m</i>/<i>z</i> = 456, 458 [M + H, <sup>79</sup>Br, <sup>81</sup>Br]<sup>+</sup>, 478, 480 [M + Na, <sup>79</sup>Br, <sup>81</sup>Br]<sup>+</sup>. HRMS (ESI): calcd for [C<sub>17</sub>H<sub>18</sub>BrN<sub>3</sub>O<sub>5</sub>S – H, <sup>79</sup>Br]<sup>+</sup> 454.0077, found 454.0080, calcd for [C<sub>17</sub>H<sub>18</sub>BrN<sub>3</sub>O<sub>5</sub>S – H, <sup>81</sup>Br]<sup>+</sup> 456.0056, found 456.0060.</div></div><div id="sec4_6_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> (2<i>E</i>)-2-(<i>N</i>-Hydroxyimino)-3-phenyl-<i>N</i>-[(4-sulfamoylphenyl)methyl]propanamide (<b>47</b>)</h3><div class="NLM_p last">Compound <b>47</b> was synthesized from compound <b>31</b> (0.1 g, 0.23 mmol) according to general procedure 4. The crude solid was purified by flash chromatography (gradient: 3–5% MeOH in DCM) to afford the title compound as a white solid (0.025 g, 63%). <i>R</i><sub><i>f</i></sub> = 0.24 (10% MeOH in DCM). Mp = 212–214 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>H</sub> = 11.86 (s, 1H, N-OH), 8.61 (t, <i>J</i> = 6.15 Hz, 1H, N-H), 7.74 (d, <i>J</i> = 6.9 Hz, 2H, H<sub>Ar</sub>), 7.36 (d, <i>J</i> = 7.75 Hz, 2H, H<sub>Ar</sub>), 7.27–7.17 (m, 7H, H<sub>Ar</sub> and SO<sub>2</sub>NH<sub>2</sub>), 4.39 (d, <i>J</i> = 6.2 Hz, 2H, HN-C<u class="uu">H</u><sub>2</sub>-Ph), 3.85 (s, 2H, Ph-CH<sub>2</sub>-C). General assignments were confirmed by <sup>1</sup>H–<sup>1</sup>H gCOSY. <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>C</sub> = 163.6 (C<sub>quat</sub>), 152.0 (C<sub>quat</sub>), 143.5 (C<sub>quat</sub>), 142.5 (C<sub>quat</sub>), 136.7 (C<sub>quat</sub>), 128.7 (2 × CH<sub>Ar</sub>), 128.2 (2 × CH<sub>Ar</sub>), 127.2 (2 × CH<sub>Ar</sub>), 126.0 (CH<sub>Ar</sub>), 125.6 (2 × CH<sub>Ar</sub>), 41.9 (HN-<u class="uu">C</u>H<sub>2</sub>-Ph), 29.1 (Ph-<u class="uu">C</u>H<sub>2</sub>-C). General assignments were confirmed by <sup>1</sup>H–<sup>13</sup>C HSQC. LRMS (ESI): <i>m</i>/<i>z</i> = 348 [M + H]<sup>+</sup>, 370 [M + Na]<sup>+</sup>. HRMS (ESI): calcd for [C<sub>16</sub>H<sub>17</sub>N<sub>3</sub>O<sub>4</sub>S + Na]<sup>+</sup> 370.0832, found 370.0841.</div></div><div id="sec4_6_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> (2<i>E</i>)-3-(3-Bromophenyl)-2-(<i>N</i>-hydroxyimino)-<i>N</i>-[(4-sulfamoylphenyl)methyl]propanamide (<b>48</b>)</h3><div class="NLM_p last">Compound <b>48</b> was synthesized from compound <b>61</b> (0.08 g, 0.16 mmol) according to general procedure 5. The crude solid was purified by flash chromatography (gradient: 4–5% MeOH in DCM) to afford the title compound as a white solid (0.032 g, 48%). <i>R</i><sub><i>f</i></sub> = 0.14 (10% MeOH in DCM). Mp = 75–77 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>H</sub> = 11.98 (s, 1H, N-OH), 8.67 (t, <i>J</i> = 6.25 Hz, 1H, N-H), 7.74 (d, <i>J</i> = 8.1 Hz, 2H, H<sub>Ar</sub>), 7.40–7.39 (m, 2H, H<sub>Ar</sub>), 7.37 (d, <i>J</i> = 8.05 Hz, 2H, H<sub>Ar</sub>), 7.27 (s, 2H, SO<sub>2</sub>NH<sub>2</sub>), 7.26–7.21 (s, 2H, H<sub>Ar</sub>), 4.40 (d, <i>J</i> = 6.25 Hz, 2H, HN-C<u class="uu">H</u><sub>2</sub>-Ph), 3.84 (s, 2H, Ph-CH<sub>2</sub>-C). General assignments were confirmed by <sup>1</sup>H–<sup>1</sup>H gCOSY. <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>C</sub> = 163.4 (C<sub>quat</sub>), 151.4 (C<sub>quat</sub>), 143.5 (C<sub>quat</sub>), 142.5 (C<sub>quat</sub>), 139.5 (C<sub>quat</sub>), 131.3 (CH<sub>Ar</sub>), 130.4 (CH<sub>Ar</sub>), 129.0 (CH<sub>Ar</sub>), 127.8 (CH<sub>Ar</sub>), 127.2 (2 × CH<sub>Ar</sub>), 125.6 (2 × CH<sub>Ar</sub>), 121.5 (C<sub>quat</sub>), 41.9 (HN-<u class="uu">C</u>H<sub>2</sub>-Ph), 28.8 (Ph-<u class="uu">C</u>H<sub>2</sub>-C). General assignments were confirmed by <sup>1</sup>H–<sup>13</sup>C HSQC. LRMS (ESI): <i>m</i>/<i>z</i> = 426, 428 [M + H, <sup>79</sup>Br, <sup>81</sup>Br]<sup>+</sup>. HRMS (ESI): calcd for [C<sub>16</sub>H<sub>16</sub>BrN<sub>3</sub>O<sub>4</sub>S – H, <sup>79</sup>Br]<sup>+</sup> 423.9972, found 423.9970, calcd for [C<sub>16</sub>H<sub>16</sub>BrN<sub>3</sub>O<sub>4</sub>S – H, <sup>81</sup>Br]<sup>+</sup> 425.9950, found 425.9954.</div></div><div id="sec4_6_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> (2<i>E</i>)-2-(<i>N</i>-Hydroxyimino)-3-(4-hydroxyphenyl)-<i>N</i>-[(4-sulfamoylphenyl)methyl]propanamide (<b>49</b>)</h3><div class="NLM_p last">Compound <b>49</b> was synthesized from compound <b>33</b> (0.24 g, 0.53 mmol) according to general procedure 4. The crude solid was purified by flash chromatography (gradient: 4–5% MeOH in DCM) to afford the title compound as a white solid (0.12 g, 63%). <i>R</i><sub><i>f</i></sub> = 0.17 (10% MeOH in DCM). Mp = 199–201 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>H</sub> = 11.76 (s, 1H, N-OH), 9.19 (s, 1H, Ph-OH), 8.58 (t, <i>J</i> = 6.35 Hz, 1H, N-H), 7.73 (d, <i>J</i> = 8.35 Hz, 2H, H<sub>Ar</sub>), 7.35 (d, <i>J</i> = 8.4 Hz, 2H, H<sub>Ar</sub>), 7.28 (s, 2H, SO<sub>2</sub>NH<sub>2</sub>), 7.00 (d, <i>J</i> = 8.5 Hz, 2H, H<sub>Ar</sub>), 6.64 (d, <i>J</i> = 8.5 Hz, 2H, H<sub>Ar</sub>), 4.38 (d, <i>J</i> = 6.3 Hz, 2H, HN-C<u class="uu">H</u><sub>2</sub>-Ph), 3.71 (s, 2H, Ph-CH<sub>2</sub>-C). General assignments were confirmed by <sup>1</sup>H–<sup>1</sup>H gCOSY. <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>C</sub> = 163.7 (C<sub>quat</sub>), 155.6 (C<sub>quat</sub>), 152.6 (C<sub>quat</sub>), 143.6 (C<sub>quat</sub>), 142.5 (C<sub>quat</sub>), 129.7 (2 × CH<sub>Ar</sub>), 127.2 (2 × CH<sub>Ar</sub>), 126.7 (C<sub>quat</sub>), 125.6 (2 × CH<sub>Ar</sub>), 115.0 (2 × CH<sub>Ar</sub>), 41.9 (HN-<u class="uu">C</u>H<sub>2</sub>-Ph), 28.1 (Ph-<u class="uu">C</u>H<sub>2</sub>-C). General assignments were confirmed by <sup>1</sup>H–<sup>13</sup>C HSQC. LRMS (ESI): <i>m</i>/<i>z</i> = 364 [M + H]<sup>+</sup>, 386 [M + Na]<sup>+</sup>. HRMS (ESI): calcd for [C<sub>16</sub>H<sub>17</sub>N<sub>3</sub>O<sub>5</sub>S + Na]<sup>+</sup> 386.0781, found 386.0786.</div></div><div id="sec4_6_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> (2<i>E</i>)-3-(3-Bromo-4-hydroxyphenyl)-2-(<i>N</i>-hydroxyimino)-<i>N</i>-[(4-sulfamoylphenyl)methyl]propanamide (<b>50</b>)</h3><div class="NLM_p last">Compound <b>50</b> was synthesized from compound <b>62</b> (0.1 g, 0.19 mmol) according to general procedure 5. The crude solid was purified by flash chromatography (gradient: 4–5% MeOH in DCM) to afford the title compound as a white solid (0.064 g, 76%). <i>R</i><sub><i>f</i></sub> = 0.20 (10% MeOH in DCM). Mp = 89–91 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>H</sub> = 11.88 (s, 1H, N-OH), 10.05 (s, 1H, Ph-OH), 8.64 (t, <i>J</i> = 6.35 Hz, 1H, N-H), 7.74 (d, <i>J</i> = 8.45 Hz, 2H, H<sub>Ar</sub>), 7.36 (d, <i>J</i> = 8.5 Hz, 2H, H<sub>Ar</sub>), 7.30 (d, <i>J</i> = 2.1 Hz, 1H, H<sub>Ar</sub>), 7.29 (s, 2H, SO<sub>2</sub>NH<sub>2</sub>), 7.02 (dd, <i>J</i> = 8.35, 2.1 Hz, 1H, H<sub>Ar</sub>), 6.84 (d, <i>J</i> = 8.25 Hz, 1H, H<sub>Ar</sub>), 4.39 (d, <i>J</i> = 6.3 Hz, 2H, HN-C<u class="uu">H</u><sub>2</sub>-Ph), 3.72 (s, 2H, Ph-CH<sub>2</sub>-C). General assignments were confirmed by <sup>1</sup>H–<sup>1</sup>H gCOSY. <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>C</sub> = 163.6 (C<sub>quat</sub>), 152.4 (C<sub>quat</sub>), 152.0 (C<sub>quat</sub>), 143.6 (C<sub>quat</sub>), 142.5 (C<sub>quat</sub>), 132.7 (CH<sub>Ar</sub>), 129.2 (CH<sub>Ar</sub>), 128.7 (C<sub>quat</sub>), 127.2 (2 × CH<sub>Ar</sub>), 125.6 (2 × CH<sub>Ar</sub>), 116.2 (CH<sub>Ar</sub>), 108.9 (C<sub>quat</sub>), 41.9 (HN-<u class="uu">C</u>H<sub>2</sub>-Ph), 27.8 (Ph-<u class="uu">C</u>H<sub>2</sub>-C). General assignments were confirmed by <sup>1</sup>H–<sup>13</sup>C HSQC. LRMS (ESI): <i>m</i>/<i>z</i> = 442, 444 [M + H, <sup>79</sup>Br, <sup>81</sup>Br]<sup>+</sup>. HRMS (ESI): calcd for [C<sub>16</sub>H<sub>16</sub>BrN<sub>3</sub>O<sub>5</sub>S – H, <sup>79</sup>Br]<sup>+</sup> 439.9921, found 439.9924, calcd for [C<sub>16</sub>H<sub>16</sub>BrN<sub>3</sub>O<sub>5</sub>S – H, <sup>81</sup>Br]<sup>+</sup> 441.9899, found 441.9904.</div></div><div id="sec4_6_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> (2<i>E</i>)-2-(<i>N</i>-Hydroxyimino)-3-phenyl-<i>N</i>-(4-sulfamoylphenyl)propanamide (<b>51</b>)</h3><div class="NLM_p last">Compound <b>51</b> was synthesized from compound <b>35</b> (0.05 g, 0.12 mmol) according to general procedure 4. The crude product was purified by flash chromatography (gradient: 3–5% MeOH in DCM) to afford the title compound as a white solid (0.025 g, 64%). <i>R</i><sub><i>f</i></sub> = 0.31 (10% MeOH in DCM). Mp = 218–220 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>H</sub> = 12.18 (bs, 1H, N-OH), 10.21 (s, 1H, N-H), 7.88 (d, <i>J</i> = 7.95 Hz, 2H, H<sub>Ar</sub>), 7.76 (d, <i>J</i> = 8.0 Hz, 2H, H<sub>Ar</sub>), 7.26–7.18 (m, 7H, H<sub>Ar</sub> and SO<sub>2</sub>NH<sub>2</sub>), 3.92 (s, 2H, Ph-CH<sub>2</sub>-C). General assignments were confirmed by <sup>1</sup>H–<sup>1</sup>H gCOSY. <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>C</sub> = 162.5 (C<sub>quat</sub>), 152.2 (C<sub>quat</sub>), 141.3 (C<sub>quat</sub>), 138.7 (C<sub>quat</sub>), 136.5 (C<sub>quat</sub>), 128.7 (2 × CH<sub>Ar</sub>), 128.4 (2 × CH<sub>Ar</sub>), 126.4 (2 × CH<sub>Ar</sub>), 126.2 (CH<sub>Ar</sub>), 119.6 (2 × CH<sub>Ar</sub>), 29.0 (Ph-<u class="uu">C</u>H<sub>2</sub>-C). General assignments were confirmed by <sup>1</sup>H–<sup>13</sup>C HSQC. LRMS (ESI): <i>m</i>/<i>z</i> = 334 [M + H]<sup>+</sup>, 356 [M + Na]<sup>+</sup>. HRMS (ESI): calcd for [C<sub>15</sub>H<sub>15</sub>N<sub>3</sub>O<sub>4</sub>S + Na]<sup>+</sup> 356.0675, found 356.0677.</div></div><div id="sec4_6_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> (2<i>E</i>)-3-(3-Bromophenyl)-2-(<i>N</i>-hydroxyimino)-<i>N</i>-(4-sulfamoylphenyl)propanamide (<b>52</b>)</h3><div class="NLM_p last">Compound <b>52</b> was synthesized from compound <b>63</b> (0.1 g, 0.20 mmol) according to general procedure 5. The crude product was purified by flash chromatography (gradient: 4–5% MeOH in DCM) to afford the title compound as a white solid (0.059 g, 71%). <i>R</i><sub><i>f</i></sub> = 0.21 (10% MeOH in DCM). Mp = 218–220 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>H</sub> = 12.29 (s, 1H, N-OH), 10.25 (s, 1H, N-H), 7.88 (d, <i>J</i> = 8.75 Hz, 2H, H<sub>Ar</sub>), 7.75 (d, <i>J</i> = 8.75 Hz, 2H, H<sub>Ar</sub>), 7.45 (s, 1H, H<sub>Ar</sub>), 7.41–7.38 (m, 1H, H<sub>Ar</sub>), 7.27–7.25 (m, 2H, H<sub>Ar</sub>), 7.24 (s, 2H, SO<sub>2</sub>NH<sub>2</sub>), 3.91 (s, 2H, Ph-CH<sub>2</sub>-C). General assignments were confirmed by <sup>1</sup>H–<sup>1</sup>H gCOSY. <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>C</sub> = 162.3 (C<sub>quat</sub>), 151.6 (C<sub>quat</sub>), 141.2 (C<sub>quat</sub>), 139.3 (C<sub>quat</sub>), 138.8 (C<sub>quat</sub>), 131.3 (CH<sub>Ar</sub>), 130.5 (CH<sub>Ar</sub>), 129.1 (CH<sub>Ar</sub>), 127.8 (CH<sub>Ar</sub>), 126.4 (2 × CH<sub>Ar</sub>), 121.5 (C<sub>quat</sub>), 119.7 (2 × CH<sub>Ar</sub>), 28.7 (Ph-<u class="uu">C</u>H<sub>2</sub>-C). General assignments were confirmed by <sup>1</sup>H–<sup>13</sup>C HSQC. LRMS (ESI): 412, 414 [M + H, <sup>79</sup>Br, <sup>81</sup>Br]<sup>+</sup>. HRMS (ESI): calcd for [C<sub>15</sub>H<sub>14</sub>BrN<sub>3</sub>O<sub>4</sub>S – H, <sup>79</sup>Br]<sup>+</sup> 409.9815, found 409.9818, calcd for [C<sub>15</sub>H<sub>14</sub>BrN<sub>3</sub>O<sub>4</sub>S – H, <sup>81</sup>Br]<sup>+</sup> 411.9794, found 411.9798.</div></div><div id="sec4_6_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> (2<i>E</i>)-2-(<i>N</i>-Hydroxyimino)-3-(4-hydroxyphenyl)-<i>N</i>-(4-sulfamoylphenyl)propanamide (<b>53</b>)</h3><div class="NLM_p last">Compound <b>53</b> was synthesized from compound <b>37</b> (0.2 g, 0.46 mmol) according to general procedure 4. The crude product was purified by flash chromatography (gradient: 4–5% MeOH in DCM) to afford the title compound as a white solid (0.032 g, 20%). <i>R</i><sub><i>f</i></sub> = 0.17 (10% MeOH in DCM). Mp = 220–225 °C, decomposition. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>H</sub> = 12.06 (s, 1H, N-OH), 10.16 (s, 1H, Ph-OH), 9.18 (s, 1H, N-H), 7.87 (d, <i>J</i> = 8.85 Hz, 2H, H<sub>Ar</sub>), 7.74 (d, <i>J</i> = 8.8 Hz, 2H, H<sub>Ar</sub>), 7.23 (s, 2H, SO<sub>2</sub>NH<sub>2</sub>), 7.05 (d, <i>J</i> = 8.45 Hz, 2H, H<sub>Ar</sub>), 6.65 (d, <i>J</i> = 8.4 Hz, 2H, H<sub>Ar</sub>), 3.79 (s, 2H, Ph-CH<sub>2</sub>-C). General assignments were confirmed by <sup>1</sup>H–<sup>1</sup>H gCOSY. <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>C</sub> = 162.5 (C<sub>quat</sub>), 155.7 (C<sub>quat</sub>), 152.7 (C<sub>quat</sub>), 141.3 (C<sub>quat</sub>), 138.7 (C<sub>quat</sub>), 129.7 (2 × CH<sub>Ar</sub>), 126.41 (2 × CH<sub>Ar</sub>), 126.39 (C<sub>quat</sub>), 119.6 (2 × CH<sub>Ar</sub>), 115.1 (2 × CH<sub>Ar</sub>), 28.0 (Ph-<u class="uu">C</u>H<sub>2</sub>-C). General assignments were confirmed by <sup>1</sup>H–<sup>13</sup>C HSQC. LRMS (ESI): 350 [M + H]<sup>+</sup>, 372 [M + Na]<sup>+</sup>. HRMS (ESI): calcd for [C<sub>15</sub>H<sub>15</sub>N<sub>3</sub>O<sub>5</sub>S + Na]<sup>+</sup> 372.0624, found 372.0626.</div></div><div id="sec4_6_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> (2<i>E</i>)-3-(3-Bromo-4-hydroxyphenyl)-2-(<i>N</i>-hydroxyimino)-<i>N</i>-(4-sulfamoylphenyl)propanamide (<b>54</b>)</h3><div class="NLM_p last">Compound <b>54</b> was synthesized from compound <b>64</b> (0.15 g, 0.29 mmol) according to general procedure 5. The crude product was purified by flash chromatography (gradient: 5–6% MeOH in DCM) to afford the title compound as a white solid (0.032 g, 25%). <i>R</i><sub><i>f</i></sub> = 0.25 (10% MeOH in DCM). Mp = 209–211 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>H</sub> = 12.20 (s, 1H, N-OH), 10.23 (s, 1H, Ph-OH), 10.08 (s, 1H, N-H), 7.88 (d, <i>J</i> = 8.85 Hz, 2H, H<sub>Ar</sub>), 7.75 (d, <i>J</i> = 8.85 Hz, 2H, H<sub>Ar</sub>), 7.35 (d, <i>J</i> = 2.05 Hz, 1H, H<sub>Ar</sub>), 7.25 (s, 2H, SO<sub>2</sub>NH<sub>2</sub>), 7.06 (dd, <i>J</i> = 8.3, 2.05 Hz, 1H, H<sub>Ar</sub>), 6.85 (d, <i>J</i> = 8.3 Hz, 1H, H<sub>Ar</sub>), 3.79 (s, 2H, Ph-CH<sub>2</sub>-C). General assignments were confirmed by <sup>1</sup>H–<sup>1</sup>H gCOSY. <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>C</sub> = 162.4 (C<sub>quat</sub>), 152.5 (C<sub>quat</sub>), 152.3 (C<sub>quat</sub>), 141.3 (C<sub>quat</sub>), 138.8 (C<sub>quat</sub>), 132.8 (CH<sub>Ar</sub>), 129.2 (CH<sub>Ar</sub>), 128.5 (C<sub>quat</sub>), 126.5 (2 × CH<sub>Ar</sub>), 119.7 (2 × CH<sub>Ar</sub>), 116.2 (CH<sub>Ar</sub>), 109.0 (C<sub>quat</sub>), 27.8 (Ph-<u class="uu">C</u>H<sub>2</sub>-C). General assignments were confirmed by <sup>1</sup>H–<sup>13</sup>C HSQC. LRMS (ESI): 428, 430 [M + H, <sup>79</sup>Br, <sup>81</sup>Br]<sup>+</sup>, 450, 452 [M + Na, <sup>79</sup>Br, <sup>81</sup>Br]<sup>+</sup>. HRMS (ESI): calcd for [C<sub>15</sub>H<sub>14</sub>BrN<sub>3</sub>O<sub>5</sub>S – H, <sup>79</sup>Br]<sup>+</sup> 425.9764, found 425.9767, calcd for [C<sub>15</sub>H<sub>14</sub>BrN<sub>3</sub>O<sub>5</sub>S – H, <sup>81</sup>Br]<sup>+</sup> 427.9743, found 427.9747.</div></div><div id="sec4_6_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> (2<i>E</i>)-2-(<i>N</i>-Hydroxyimino)-3-phenyl-<i>N</i>-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)propanamide (<b>55</b>)</h3><div class="NLM_p last">Compound <b>55</b> was synthesized from compound <b>65</b> (0.125 g, 0.29 mmol) according to general procedure 5. The crude solid was purified by flash chromatography (gradient: 5–7% MeOH in DCM) to afford the title compound as a white solid (0.070 g, 70%). <i>R</i><sub><i>f</i></sub> = 0.28 (10% MeOH in DCM). Mp = 260–270 °C, decomposition. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>H</sub> = 12.96 (s, 1H, N-H), 12.73 (s, 1H, N-OH), 8.34 (s, 2H, SO<sub>2</sub>NH<sub>2</sub>), 7.29–7.26 (m, 2H, H<sub>Ar</sub>), 7.24–7.23 (m, 2H, H<sub>Ar</sub>), 7.21–7.17 (m, 1H, H<sub>Ar</sub>), 3.94 (s, 2H, Ph-CH<sub>2</sub>-C). General assignments were confirmed by <sup>1</sup>H–<sup>1</sup>H gCOSY. <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>C</sub> = 164.7 (C<sub>quat</sub>), 163.2 (C<sub>quat</sub>), 161.1 (C<sub>quat</sub>), 150.4 (C<sub>quat</sub>), 136.1 (C<sub>quat</sub>), 128.6 (2 × CH<sub>Ar</sub>), 128.5 (2 × CH<sub>Ar</sub>), 126.4 (CH<sub>Ar</sub>), 29.3 (Ph-<u class="uu">C</u>H<sub>2</sub>-C). General assignments were confirmed by <sup>1</sup>H–<sup>13</sup>C HSQC. LRMS (ESI): <i>m</i>/<i>z</i> = 342 [M + H]<sup>+</sup>, 364 [M + Na]<sup>+</sup>. HRMS (ESI): calcd for [C<sub>11</sub>H<sub>11</sub>N<sub>5</sub>O<sub>4</sub>S<sub>2</sub> – H]<sup>+</sup> 340.0179, found 340.0180.</div></div><div id="sec4_6_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> (2<i>E</i>)-3-(3-Bromophenyl)-2-(<i>N</i>-hydroxyimino)-<i>N</i>-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)propanamide (<b>56</b>)</h3><div class="NLM_p last">Compound <b>56</b> was synthesized from compound <b>66</b> (0.1 g, 0.20 mmol) according to general procedure 5. The crude solid was purified by flash chromatography (gradient: 4–5% MeOH in DCM) to afford the title compound as a white solid (0.048 g, 58%). <i>R</i><sub><i>f</i></sub> = 0.12 (10% MeOH in DCM). Mp = 215–217 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>H</sub> = 12.96 (s, 1H, N-H), 12.81 (s, 1H, N-OH), 8.32 (s, 2H, SO<sub>2</sub>NH<sub>2</sub>), 7.43 (s, 1H, H<sub>Ar</sub>), 7.41–7.40 (m, 1H, H<sub>Ar</sub>), 7.27–7.25 (m, 2H, H<sub>Ar</sub>), 3.94 (s, 2H, Ph-CH<sub>2</sub>-C). General assignments were confirmed by <sup>1</sup>H–<sup>1</sup>H gCOSY. <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>C</sub> = 164.7 (C<sub>quat</sub>), 163.1 (C<sub>quat</sub>), 161.1 (C<sub>quat</sub>), 149.8 (C<sub>quat</sub>), 138.8 (C<sub>quat</sub>), 131.2 (CH<sub>Ar</sub>), 130.6 (CH<sub>Ar</sub>), 129.3 (CH<sub>Ar</sub>), 127.7 (CH<sub>Ar</sub>), 121.6 (C<sub>quat</sub>), 29.0 (Ph-<u class="uu">C</u>H<sub>2</sub>-C). General assignments were confirmed by <sup>1</sup>H–<sup>13</sup>C HSQC. LRMS (ESI): 420, 422 [M + H, <sup>79</sup>Br, <sup>81</sup>Br]<sup>+</sup>, 442, 444 [M + Na, <sup>79</sup>Br, <sup>81</sup>Br]<sup>+</sup>. HRMS (ESI): calcd for [C<sub>11</sub>H<sub>10</sub>BrN<sub>5</sub>O<sub>4</sub>S<sub>2</sub> – H, <sup>79</sup>Br]<sup>+</sup> 417.9284, found 417.9286, calcd [C<sub>11</sub>H<sub>10</sub>BrN<sub>5</sub>O<sub>4</sub>S<sub>2</sub> – H, <sup>81</sup>Br]<sup>+</sup> 419.9262, found 419.9267.</div></div><div id="sec4_6_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> (2<i>E</i>)-2-(<i>N</i>-Hydroxyimino)-3-(4-hydroxyphenyl)-<i>N</i>-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)propanamide (<b>57</b>)</h3><div class="NLM_p last">Compound <b>57</b> was synthesized from compound <b>67</b> (0.09 g, 0.20 mmol) according to general procedure 5. The crude solid was purified by flash chromatography (gradient: 5–7% MeOH in DCM) to afford the title compound as a white solid (0.034 g, 47%). <i>R</i><sub><i>f</i></sub> = 0.12 (10% MeOH in DCM). Mp = 225–235 °C, decomposition. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>H</sub> = 12.91 (s, 1H, N-H), 12.61 (s, 1H, N-OH), 9.23 (s, 1H, Ph-OH), 8.34 (s, 2H, SO<sub>2</sub>NH<sub>2</sub>), 7.03 (d, <i>J</i> = 8.55 Hz, 2H, H<sub>Ar</sub>), 6.65 (d, <i>J</i> = 8.55 Hz, 2H, H<sub>Ar</sub>), 3.81 (s, 2H, Ph-CH<sub>2</sub>-C). General assignments were confirmed by <sup>1</sup>H–<sup>1</sup>H gCOSY. <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>C</sub> = 164.6 (C<sub>quat</sub>), 163.3 (C<sub>quat</sub>), 161.2 (C<sub>quat</sub>), 155.9 (C<sub>quat</sub>), 151.0 (C<sub>quat</sub>), 129.7 (2 × CH<sub>Ar</sub>), 126.0 (C<sub>quat</sub>), 115.2 (2 × CH<sub>Ar</sub>), 28.4 (Ph-<u class="uu">C</u>H<sub>2</sub>-C). General assignments were confirmed by <sup>1</sup>H–<sup>13</sup>C HSQC. LRMS (ESI): 358 [M + H]<sup>+</sup>, 380 [M + Na]<sup>+</sup>. HRMS (ESI): calcd for [C<sub>11</sub>H<sub>11</sub>N<sub>5</sub>O<sub>5</sub>S<sub>2</sub> – H]<sup>+</sup> 356.0128, found 356.0132.</div></div><div id="sec4_6_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> (2<i>E</i>)-3-(3-Bromophenyl)-2-[(oxan-2-yloxy)imino]-<i>N</i>-[2-(4-sulfamoylphenyl)ethyl]propanamide (<b>59</b>)</h3><div class="NLM_p last">Compound <b>59</b> was synthesized from compound <b>12</b> (0.19 g, 0.56 mmol) according to general procedure 3. The crude solid was purified by flash chromatography (gradient: 1.5–2% MeOH in DCM) to afford the title compound as a white solid (0.144 g, 76%). <i>R</i><sub><i>f</i></sub> = 0.18 (10% MeOH in DCM). Mp = 128–130 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>H</sub> = 8.28 (t, <i>J</i> = 5.75 Hz, 1H, N-H), 7.73 (d, <i>J</i> = 8.0 Hz, 2H, H<sub>Ar</sub>), 7.47 (s, 1H, H<sub>Ar</sub>), 7.41 (d, <i>J</i> = 7.9 Hz, 1H, H<sub>Ar</sub>), 7.37 (d, <i>J</i> = 8.15 Hz, 2H, H<sub>Ar</sub>), 7.28–7.25 (m, 3H, SO<sub>2</sub>NH<sub>2</sub> and H<sub>Ar</sub>), 7.21 (d, <i>J</i> = 7.65 Hz, 1H, H<sub>Ar</sub>), 5.35 (s, 1H, CH<sub>THP</sub>), 3.89 (d, <i>J</i> = 13.35 Hz, 1H, Ph-C<u class="uu">H</u>H-C), 3.82 (d, <i>J</i> = 13.35 Hz, 1H, Ph-CH<u class="uu">H</u>-C), 3.47–3.38 (m, 4H, HN-C<u class="uu">H</u><sub>2</sub>-CH<sub>2</sub> and H<sub>THP</sub>), 2.86 (t, <i>J</i> = 7.25 Hz, 2H, HN-CH<sub>2</sub>-C<u class="uu">H</u><sub>2</sub>), 1.75–1.73 (m, 3H, H<sub>THP</sub>), 1.60–1.54 (m, 2H, H<sub>THP</sub>), 1.46–1.44 (m, 1H, H<sub>THP</sub>). General assignments were confirmed by <sup>1</sup>H–<sup>1</sup>H gCOSY. <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>C</sub> = 162.3 (C<sub>quat</sub>), 152.8 (C<sub>quat</sub>), 143.4 (C<sub>quat</sub>), 142.0 (C<sub>quat</sub>), 139.1 (C<sub>quat</sub>), 131.7 (CH<sub>Ar</sub>), 130.5 (CH<sub>Ar</sub>), 129.2 (CH<sub>Ar</sub>), 129.0 (2 × CH<sub>Ar</sub>), 127.8 (CH<sub>Ar</sub>), 125.7 (2 × CH<sub>Ar</sub>), 121.5 (C<sub>quat</sub>), 100.5 (CH<sub>THP</sub>), 61.1 (CH<sub>2</sub>-THP), 40.1 (HN-<u class="uu">C</u>H<sub>2</sub>-CH<sub>2</sub>), 34.5 (HN-CH<sub>2</sub>-<u class="uu">C</u>H<sub>2</sub>), 29.8 (Ph-<u class="uu">C</u>H<sub>2</sub>-C), 28.1 (CH<sub>2</sub>-THP), 24.6 (CH<sub>2</sub>-THP), 18.3 (CH<sub>2</sub>-THP). General assignments were confirmed by <sup>1</sup>H–<sup>13</sup>C HSQC. LRMS (ESI): <i>m</i>/<i>z</i> = 546, 548 [M + Na, <sup>79</sup>Br, <sup>81</sup>Br]<sup>+</sup>. HRMS (ESI): calcd for [C<sub>22</sub>H<sub>26</sub>BrN<sub>3</sub>O<sub>5</sub>S – H, <sup>79</sup>Br]<sup>+</sup> 522.0703, found 522.0698, calcd for [C<sub>22</sub>H<sub>26</sub>BrN<sub>3</sub>O<sub>5</sub>S – H, <sup>81</sup>Br]<sup>+</sup> 524.0682, found 524.0678.</div></div><div id="sec4_6_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> (2<i>E</i>)-3-(3-Bromo-4-hydroxyphenyl)-2-[(oxan-2-yloxy)imino]-<i>N</i>-[2-(4-sulfamoylphenyl)ethyl]propanamide (<b>60</b>)</h3><div class="NLM_p last">Compound <b>60</b> was synthesized from compound <b>14</b> (0.415 g, 1.16 mmol) according to general procedure 3. The crude solid was purified by flash chromatography (gradient: 3–4% MeOH in DCM) to afford the title compound as a white solid (0.251 g, 40%). <i>R</i><sub><i>f</i></sub> = 0.34 (10% MeOH in DCM). Mp = 85–87 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>H</sub> = 10.05 (s, 1H, Ph-OH), 8.22 (t, <i>J</i> = 5.9 Hz, 1H, N-H), 7.73 (d, <i>J</i> = 8.15 Hz, 2H, H<sub>Ar</sub>), 7.38–7.36 (m, 3H, H<sub>Ar</sub>), 7.26 (s, 2H, SO<sub>2</sub>NH<sub>2</sub>), 7.03 (dd, <i>J</i> = 8.3, 1.85 Hz, 1H, H<sub>Ar</sub>), 6.86 (d, <i>J</i> = 8.3 Hz, 1H, H<sub>Ar</sub>), 5.34 (s, 1H, CH<sub>THP</sub>), 3.77 (d, <i>J</i> = 13.15 Hz, 1H, Ph-C<u class="uu">H</u>H-C), 3.70 (d, <i>J</i> = 13.15 Hz, 1H, Ph-CH<u class="uu">H</u>-C), 3.52–3.46 (m, 2H, H<sub>THP</sub>), 3.39 (q, <i>J</i> = 6.1 Hz, 2H, HN-C<u class="uu">H</u><sub>2</sub>-CH<sub>2</sub>), 2.84 (t, <i>J</i> = 7.3 Hz, 2H, HN-CH<sub>2</sub>-C<u class="uu">H</u><sub>2</sub>), 1.76–1.73 (m, 3H, H<sub>THP</sub>), 1.63–1.54 (m, 2H, H<sub>THP</sub>), 1.49–1.46 (m, 1H, H<sub>THP</sub>). General assignments were confirmed by <sup>1</sup>H–<sup>1</sup>H gCOSY. <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>C</sub> = 162.4 (C<sub>quat</sub>), 153.4 (C<sub>quat</sub>), 152.5 (C<sub>quat</sub>), 143.5 (C<sub>quat</sub>), 142.0 (C<sub>quat</sub>), 133.2 (CH<sub>Ar</sub>), 129.1 (CH<sub>Ar</sub>), 129.0 (2 × CH<sub>Ar</sub>), 128.2 (C<sub>quat</sub>), 125.7 (2 × CH<sub>Ar</sub>), 116.2 (CH<sub>Ar</sub>), 108.9 (C<sub>quat</sub>), 100.5 (CH<sub>THP</sub>), 61.1 (CH<sub>2</sub>-THP), 40.1 (HN-<u class="uu">C</u>H<sub>2</sub>-CH<sub>2</sub>), 34.6 (HN-CH<sub>2</sub>-<u class="uu">C</u>H<sub>2</sub>), 28.8 (Ph-<u class="uu">C</u>H<sub>2</sub>-C), 28.2 (CH<sub>2</sub>-THP), 24.6 (CH<sub>2</sub>-THP), 18.4 (CH<sub>2</sub>-THP). General assignments were confirmed by <sup>1</sup>H–<sup>13</sup>C HSQC. LRMS (ESI): <i>m</i>/<i>z</i> = 562, 564 [M + Na, <sup>79</sup>Br, <sup>81</sup>Br]<sup>+</sup>. HRMS (ESI): calcd for [C<sub>22</sub>H<sub>26</sub>BrN<sub>3</sub>O<sub>6</sub>S – H, <sup>79</sup>Br]<sup>+</sup> 538.0652, found 538.0651, calcd for [C<sub>22</sub>H<sub>26</sub>BrN<sub>3</sub>O<sub>6</sub>S – H, <sup>81</sup>Br]<sup>+</sup> 540.0631, found 540.0631.</div></div><div id="sec4_6_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> (2<i>E</i>)-3-(3-Bromophenyl)-2-[(oxan-2-yloxy)imino]-<i>N</i>-[(4-sulfamoylphenyl)methyl]propanamide (<b>61</b>)</h3><div class="NLM_p last">Compound <b>61</b> was synthesized from compound <b>12</b> (0.265 g, 0.78 mmol) according to general procedure 3. The crude solid was purified by flash chromatography (gradient: 1.5–2% MeOH in DCM) to afford the title compound as a white solid (0.305 g, 77%). <i>R</i><sub><i>f</i></sub> = 0.27 (5% MeOH in DCM). Mp = 169–171 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>H</sub> = 8.85 (t, <i>J</i> = 6.25 Hz, 1H, N-H), 7.76 (d, <i>J</i> = 8.5 Hz, 2H, H<sub>Ar</sub>), 7.47 (s, 1H, H<sub>Ar</sub>), 7.42–7.41 (m, 1H, H<sub>Ar</sub>), 7.39 (d, <i>J</i> = 8.25 Hz, 2H, H<sub>Ar</sub>), 7.28 (s, 2H, SO<sub>2</sub>NH<sub>2</sub>), 7.27–7.24 (m, 2H, H<sub>Ar</sub>), 5.38 (s, 1H, CH<sub>THP</sub>), 4.45–4.36 (m, 2H, HN-C<u class="uu">H</u><sub>2</sub>-Ph), 3.92 (d, <i>J</i> = 13.4 Hz, 1H, Ph-C<u class="uu">H</u>H-C), 3.86 (d, <i>J</i> = 13.4 Hz, 1H, Ph-CH<u class="uu">H</u>-C), 3.47–3.44 (m, 2H, H<sub>THP</sub>), 1.76–1.70 (m, 3H, H<sub>THP</sub>), 1.63–1.53 (m, 2H, H<sub>THP</sub>), 1.47–1.45 (m, 1H, H<sub>THP</sub>). General assignments were confirmed by <sup>1</sup>H–<sup>1</sup>H gCOSY. <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>C</sub> = 162.6 (C<sub>quat</sub>), 152.8 (C<sub>quat</sub>), 143.2 (C<sub>quat</sub>), 142.6 (C<sub>quat</sub>), 139.0 (C<sub>quat</sub>), 131.6 (CH<sub>Ar</sub>), 130.5 (CH<sub>Ar</sub>), 129.2 (CH<sub>Ar</sub>), 127.8 (CH<sub>Ar</sub>), 127.5 (2 × CH<sub>Ar</sub>), 125.6 (2 × CH<sub>Ar</sub>), 121.5 (C<sub>quat</sub>), 100.6 (CH<sub>THP</sub>), 61.1 (CH<sub>2</sub>-THP), 42.1 (HN-<u class="uu">C</u>H<sub>2</sub>-Ph), 29.9 (Ph-<u class="uu">C</u>H<sub>2</sub>-C), 28.1 (CH<sub>2</sub>-THP), 24.6 (CH<sub>2</sub>-THP), 18.3 (CH<sub>2</sub>-THP). General assignments were confirmed by <sup>1</sup>H–<sup>13</sup>C HSQC. LRMS (ESI): <i>m</i>/<i>z</i> = 510, 512 [M + H, <sup>79</sup>Br, <sup>81</sup>Br]<sup>+</sup>, 532, 534 [M + Na, <sup>79</sup>Br, <sup>81</sup>Br]<sup>+</sup>. HRMS (ESI): calcd for [C<sub>21</sub>H<sub>24</sub>BrN<sub>3</sub>O<sub>5</sub>S – H, <sup>79</sup>Br]<sup>+</sup> 508.0547, found 508.0545, calcd for [C<sub>21</sub>H<sub>24</sub>BrN<sub>3</sub>O<sub>5</sub>S – H, <sup>81</sup>Br]<sup>+</sup> 510.0525, found 510.0527.</div></div><div id="sec4_6_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> (2<i>E</i>)-3-(3-Bromo-4-hydroxyphenyl)-2-[(oxan-2-yloxy)imino]-<i>N</i>-[(4-sulfamoylphenyl)methyl]propanamide (<b>62</b>)</h3><div class="NLM_p last">Compound <b>62</b> was synthesized from compound <b>14</b> (0.405 g, 1.13 mmol) according to general procedure 3. The crude solid was purified by flash chromatography (3–4% MeOH in DCM) to afford the title compound as a white solid (0.195 g, 32%). <i>R</i><sub><i>f</i></sub> = 0.47 (10% MeOH in DCM). Mp = 89–91 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>H</sub> = 10.08 (s, 1H, Ph-OH), 8.80 (t, <i>J</i> = 6.15 Hz, 1H, N-H), 7.76 (d, <i>J</i> = 8.2 Hz, 2H, H<sub>Ar</sub>), 7.40–7.38 (m, 3H, H<sub>Ar</sub>), 7.28 (s, 2H, SO<sub>2</sub>NH<sub>2</sub>), 7.06 (dd, <i>J</i> = 8.3, 1.65 Hz, 1H, H<sub>Ar</sub>), 6.87 (d, <i>J</i> = 8.25 Hz, 1H, H<sub>Ar</sub>), 5.38 (s, 1H, CH<sub>THP</sub>), 4.45–4.36 (m, 2H, H-10), 3.80 (d, <i>J</i> = 13.2 Hz, 1H, Ph-C<u class="uu">H</u>H-C), 3.75 (d, <i>J</i> = 13.15 Hz, 1H, Ph-CH<u class="uu">H</u>-C), 3.56–3.47 (m, 2H, H<sub>THP</sub>), 1.78–1.75 (m, 3H, H<sub>THP</sub>), 1.65–1.54 (m, 2H, H<sub>THP</sub>), 1.51–1.48 (m, 1H, H<sub>THP</sub>). General assignments were confirmed by <sup>1</sup>H–<sup>1</sup>H gCOSY. <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>C</sub> = 162.7 (C<sub>quat</sub>), 153.4 (C<sub>quat</sub>), 152.5 (C<sub>quat</sub>), 143.2 (C<sub>quat</sub>), 142.6 (C<sub>quat</sub>), 133.1 (CH<sub>Ar</sub>), 129.1 (CH<sub>Ar</sub>), 128.1 (C<sub>quat</sub>), 127.5 (2 × CH<sub>Ar</sub>), 125.6 (2 × CH<sub>Ar</sub>), 116.2 (CH<sub>Ar</sub>), 108.9 (CH<sub>Ar</sub>), 100.5 (CH<sub>THP</sub>), 61.2 (CH<sub>2</sub>-THP), 42.1 (HN-<u class="uu">C</u>H<sub>2</sub>-Ph), 28.9 (Ph-<u class="uu">C</u>H<sub>2</sub>-C), 28.2 (CH<sub>2</sub>-THP), 24.6 (CH<sub>2</sub>-THP), 18.4 (CH<sub>2</sub>-THP). General assignments were confirmed by <sup>1</sup>H–<sup>13</sup>C HSQC. LRMS (ESI): <i>m</i>/<i>z</i> = 548, 550 [M + Na, <sup>79</sup>Br, <sup>81</sup>Br]<sup>+</sup>. HRMS (ESI): calcd for [C<sub>21</sub>H<sub>24</sub>BrN<sub>3</sub>O<sub>6</sub>S – H, <sup>79</sup>Br]<sup>+</sup> 524.0496, found 524.0495, calcd for [C<sub>21</sub>H<sub>24</sub>BrN<sub>3</sub>O<sub>6</sub>S – H, <sup>81</sup>Br]<sup>+</sup> 526.0475, found 526.0475.</div></div><div id="sec4_6_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> (2<i>E</i>)-3-(3-Bromophenyl)-2-[(oxan-2-yloxy)imino]-<i>N</i>-(4-sulfamoylphenyl)propanamide (<b>63</b>)</h3><div class="NLM_p last">Compound <b>63</b> was synthesized from compound <b>12</b> (0.28 g, 0.82 mmol) according to general procedure 3. The crude product was purified by flash chromatography (gradient: 1.5–2% MeOH in DCM) to afford the title compound as a white solid (0.30 g, 74%). <i>R</i><sub><i>f</i></sub> = 0.21 (5% MeOH in DCM). Mp = 200–202 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>H</sub> = 10.37 (bs, 1H, NH), 7.91 (d, <i>J</i> = 8.6 Hz, 2H, H<sub>Ar</sub>), 7.79 (d, <i>J</i> = 8.55 Hz, 2H, H<sub>Ar</sub>), 7.53 (s, 1H, H<sub>Ar</sub>), 7.43–7.42 (m, 1H, H<sub>Ar</sub>), 7.32–7.26 (m, 4H, H<sub>Ar</sub> and SO<sub>2</sub>NH<sub>2</sub>), 5.51–5.49 (m, 1H, CH<sub>THP</sub>), 3.99 (d, <i>J</i> = 13.7 Hz, 1H, Ph-C<u class="uu">H</u>H-C), 3.92 (d, <i>J</i> = 13.7 Hz, 1H, Ph-CH<u class="uu">H</u>-C) 3.51–3.41 (m, 2H, H<sub>THP</sub>), 1.80–1.71 (m, 3H, H<sub>THP</sub>), 1.63–1.54 (m, 2H, H<sub>THP</sub>), 1.48–1.46 (m, 1H, H<sub>THP</sub>). General assignments were confirmed by <sup>1</sup>H–<sup>1</sup>H gCOSY. <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>C</sub> = 161.6 (C<sub>quat</sub>), 153.0 (C<sub>quat</sub>), 140.9 (C<sub>quat</sub>), 139.1 (C<sub>quat</sub>), 138.8 (C<sub>quat</sub>), 131.7 (CH<sub>Ar</sub>), 130.6 (CH<sub>Ar</sub>), 129.3 (CH<sub>Ar</sub>), 127.8 (CH<sub>Ar</sub>), 126.4 (2 × CH<sub>Ar</sub>), 121.6 (C<sub>quat</sub>), 120.0 (2 × CH<sub>Ar</sub>), 100.9 (CH<sub>THP</sub>), 61.1 (CH<sub>2</sub>-THP), 30.0 (Ph-<u class="uu">C</u>H<sub>2</sub>-C), 28.1 (CH<sub>2</sub>-THP), 24.6 (CH<sub>2</sub>-THP), 18.2 (CH<sub>2</sub>-THP). General assignments were confirmed by <sup>1</sup>H–<sup>13</sup>C HSQC. LRMS (ESI): 518, 520 [M + Na, <sup>79</sup>Br, <sup>81</sup>Br]<sup>+</sup>. HRMS (ESI): calcd for [C<sub>20</sub>H<sub>22</sub>BrN<sub>3</sub>O<sub>5</sub>S – H, <sup>79</sup>Br]<sup>+</sup> 494.0390, found 494.0391, calcd for [C<sub>20</sub>H<sub>22</sub>BrN<sub>3</sub>O<sub>5</sub>S – H, <sup>81</sup>Br]<sup>+</sup> 496.0369, found 496.0371.</div></div><div id="sec4_6_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> (2<i>E</i>)-3-(3-Bromo-4-hydroxyphenyl)-2-[(oxan-2-yloxy)imino]-<i>N</i>-(4-sulfamoylphenyl)propanamide (<b>64</b>)</h3><div class="NLM_p last">Compound <b>64</b> was synthesized from compound <b>14</b> (0.57 g, 1.60 mmol) according to general procedure 3. The crude product was purified by flash chromatography (gradient: 3–4% MeOH in DCM) to afford the title compound as a white solid (0.165 g, 20%). <i>R</i><sub><i>f</i></sub> = 0.33 (10% MeOH in DCM). Mp = 96–98 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>H</sub> = 10.36 (s, 1H, Ph-OH), 10.12 (s, 1H, N-H), 7.89 (d, <i>J</i> = 8.95 Hz, 2H, H<sub>Ar</sub>), 7.77 (d, <i>J</i> = 8.9 Hz, 2H, H<sub>Ar</sub>), 7.43 (d, <i>J</i> = 2.1 Hz, 1H, H<sub>Ar</sub>), 7.27 (s, 2H, SO<sub>2</sub>NH<sub>2</sub>), 7.10 (dd, <i>J</i> = 8.35, 2.1 Hz, 1H, H<sub>Ar</sub>), 6.87 (d, <i>J</i> = 8.3 Hz, 1H, H<sub>Ar</sub>), 5.50–5.49 (m, 1H, CH<sub>THP</sub>), 3.85 (d, <i>J</i> = 13.45 Hz, 1H, Ph-C<u class="uu">H</u>H-C), 3.79 (d, <i>J</i> = 13.45 Hz, 1H, Ph-CH<u class="uu">H</u>-C), 3.52–3.50 (m, 2H, H<sub>THP</sub>), 3.17 (d, <i>J</i> = 4.7 Hz, 1H, H<sub>THP</sub>), 1.81–1.77 (m, 3H, H<sub>THP</sub>), 1.64–1.56 (m, 2H, H<sub>THP</sub>), 1.51–1.47 (m, 1H, H<sub>THP</sub>). General assignments were confirmed by <sup>1</sup>H–<sup>1</sup>H gCOSY. <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>C</sub> = 161.7 (C<sub>quat</sub>), 153.6 (C<sub>quat</sub>), 152.7 (C<sub>quat</sub>), 141.0 (C<sub>quat</sub>), 139.1 (C<sub>quat</sub>), 133.3 (CH<sub>Ar</sub>), 129.2 (CH<sub>Ar</sub>), 127.9 (C<sub>quat</sub>), 126.5 (2 × CH<sub>Ar</sub>), 120.0 (2 × CH<sub>Ar</sub>), 116.3 (CH<sub>Ar</sub>), 109.0 (C<sub>quat</sub>), 100.8 (CH<sub>THP</sub>), 61.2 (CH<sub>2</sub>-THP), 29.0 (Ph-<u class="uu">C</u>H<sub>2</sub>-C), 28.2 (CH<sub>2</sub>-THP), 24.6 (CH<sub>2</sub>-THP), 18.3 (CH<sub>2</sub>-THP). General assignments were confirmed by <sup>1</sup>H–<sup>13</sup>C HSQC. LRMS (ESI): 512, 514 [M + H, <sup>79</sup>Br, <sup>81</sup>Br]<sup>+</sup>, 534, 536 [M + Na, <sup>79</sup>Br, <sup>81</sup>Br]<sup>+</sup>. HRMS (ESI): calcd for [C<sub>20</sub>H<sub>22</sub>BrN<sub>3</sub>O<sub>6</sub>S – H, <sup>79</sup>Br]<sup>+</sup> 510.0339, found 510.0339, calcd for [C<sub>20</sub>H<sub>22</sub>BrN<sub>3</sub>O<sub>6</sub>S – H, <sup>81</sup>Br]<sup>+</sup> 512.0318, found 512.0320.</div></div><div id="sec4_6_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> (2<i>E</i>)-2-[(Oxan-2-yloxy)imino]-3-phenyl-<i>N</i>-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)propanamide (<b>65</b>)</h3><div class="NLM_p last">Compound <b>65</b> was synthesized from compound <b>11</b> (0.245 g, 0.93 mmol) according to general procedure 3. The crude solid was purified by flash chromatography (gradient: 2–2.5% MeOH in DCM) to afford the title compound as a white solid (0.217 g, 55%). <i>R</i><sub><i>f</i></sub> = 0.23 (5% MeOH in DCM). Mp = 92–94 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>H</sub> = 13.22 (s, 1H, N-H), 8.36 (s, 2H, SO<sub>2</sub>NH<sub>2</sub>), 7.32–7.25 (m, 4H, H<sub>Ar</sub>), 7.23–7.19 (m, 1H, H<sub>Ar</sub>), 5.53 (t, <i>J</i> = 3.2 Hz, 1H, CH<sub>THP</sub>), 4.01 (d, <i>J</i> = 13.9 Hz, 1H, Ph-C<u class="uu">H</u>H-C), 3.94 (d, <i>J</i> = 13.9 Hz, 1H, Ph-CH<u class="uu">H</u>-C), 3.49–3.46 (m, 2H, H<sub>THP</sub>), 1.80–1.77 (m, 2H, H<sub>THP</sub>), 1.75–1.68 (m, 1H, H<sub>THP</sub>), 1.62–1.53 (m, 2H, H<sub>THP</sub>), 1.47–1.44 (m, 1H, H<sub>THP</sub>). General assignments were confirmed by <sup>1</sup>H–<sup>1</sup>H gCOSY. <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>C</sub> = 164.8 (C<sub>quat</sub>), 162.5 (C<sub>quat</sub>), 161.2 (C<sub>quat</sub>), 151.5 (C<sub>quat</sub>), 135.6 (C<sub>quat</sub>), 128.7 (2 × CH<sub>Ar</sub>), 128.6 (2 × CH<sub>Ar</sub>), 126.6 (CH<sub>Ar</sub>), 101.4 (CH<sub>THP</sub>), 61.4 (CH<sub>2</sub>-THP), 30.4 (Ph-<u class="uu">C</u>H<sub>2</sub>-C), 28.0 (CH<sub>2</sub>-THP), 24.5 (CH<sub>2</sub>-THP), 18.2 (CH<sub>2</sub>-THP). General assignments were confirmed by <sup>1</sup>H–<sup>13</sup>C HSQC. LRMS (ESI): <i>m</i>/<i>z</i> = 426 [M + H]<sup>+</sup>, 448 [M + Na]<sup>+</sup>. HRMS (ESI): calcd for [C<sub>16</sub>H<sub>19</sub>N<sub>5</sub>O<sub>5</sub>S<sub>2</sub> – H]<sup>+</sup> 424.0754, found 424.0752.</div></div><div id="sec4_6_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> (2<i>E</i>)-3-(3-Bromophenyl)-2-[(oxan-2-yloxy)imino]-<i>N</i>-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)propanamide (<b>66</b>)</h3><div class="NLM_p last">Compound <b>66</b> was synthesized from compound <b>12</b> (0.275 g, 0.81 mmol) according to general procedure 3. The crude solid was purified by flash chromatography (gradient: 1.5–2% MeOH in DCM) to afford the title compound as a white solid (0.235 g, 58%). <i>R</i><sub><i>f</i></sub> = 0.22 (5% MeOH in DCM). Mp = 185–187 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>H</sub> = 13.21 (s, 1H, N-H), 8.34 (s, 2H, SO<sub>2</sub>NH<sub>2</sub>), 7.53 (s, 1H, H<sub>Ar</sub>), 7.44–7.42 (m, 1H, H<sub>Ar</sub>), 7.30–7.27 (m, 2H, H<sub>Ar</sub>), 5.53 (t, <i>J</i> = 2.9 Hz, 1H, CH<sub>THP</sub>), 3.99 (d, <i>J</i> = 14.05 Hz, 1H, Ph-C<u class="uu">H</u>H-C), 3.94 (d, <i>J</i> = 14.1 Hz, 1H, Ph-CH<u class="uu">H</u>-C), 3.51–3.48 (m, 1H, H<sub>THP</sub>), 3.41 (td, <i>J</i> = 10.7, 2.6 Hz, 1H, H<sub>THP</sub>), 1.80–1.77 (m, 2H, H<sub>THP</sub>), 1.72–1.66 (m, 1H, H<sub>THP</sub>), 1.63–1.53 (m, 2H, H<sub>THP</sub>), 1.47–1.45 (m, 1H, H<sub>THP</sub>). General assignments were confirmed by <sup>1</sup>H–<sup>1</sup>H gCOSY. <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>C</sub> = 164.8 (C<sub>quat</sub>), 162.4 (C<sub>quat</sub>), 161.2 (C<sub>quat</sub>), 150.8 (C<sub>quat</sub>), 138.4 (C<sub>quat</sub>), 131.7 (CH<sub>Ar</sub>), 130.6 (CH<sub>Ar</sub>), 129.4 (CH<sub>Ar</sub>), 127.8 (CH<sub>Ar</sub>), 121.6 (C<sub>quat</sub>), 101.5 (CH<sub>THP</sub>), 61.2 (CH<sub>2</sub>-THP), 30.1 (Ph-<u class="uu">C</u>H<sub>2</sub>-C), 27.9 (CH<sub>2</sub>-THP), 24.5 (CH<sub>2</sub>-THP), 18.0 (CH<sub>2</sub>-THP). General assignments were confirmed by <sup>1</sup>H–<sup>13</sup>C HSQC. LRMS (ESI): 504, 506 [M + H, <sup>79</sup>Br, <sup>81</sup>Br]<sup>+</sup>, 526, 528 [M + Na, <sup>79</sup>Br, <sup>81</sup>Br]<sup>+</sup>. HRMS (ESI): calcd for [C<sub>16</sub>H<sub>18</sub>BrN<sub>5</sub>O<sub>5</sub>S<sub>2</sub> – H, <sup>79</sup>Br]<sup>+</sup> 501.9860, found 501.9858, calcd for [C<sub>16</sub>H<sub>18</sub>BrN<sub>5</sub>O<sub>5</sub>S<sub>2</sub> – H, <sup>81</sup>Br]<sup>+</sup> 503.9837, found 503.9839.</div></div><div id="sec4_6_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> (2<i>E</i>)-3-(4-Hydroxyphenyl)-2-[(oxan-2-yloxy)imino]-<i>N</i>-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)propanamide (<b>67</b>)</h3><div class="NLM_p last">Compound <b>67</b> was synthesized from compound <b>13</b> (0.2 g, 0.72 mmol) according to general procedure 3. The crude solid was purified by flash chromatography (gradient: 2–2.5% MeOH in DCM) to afford the title compound as a white solid (0.137 g, 43%). <i>R</i><sub><i>f</i></sub> = 0.18 (5% MeOH in DCM). Mp = 123–125 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>H</sub> = 13.17 (s, 1H, N-H), 9.28 (s, 1H, Ph-OH), 8.36 (s, 2H, SO<sub>2</sub>NH<sub>2</sub>), 7.07 (d, <i>J</i> = 8.5 Hz, 2H, H<sub>Ar</sub>), 6.68 (d, <i>J</i> = 8.55 Hz, 2H, H<sub>Ar</sub>), 5.52–5.51 (m, 1H, CH<sub>THP</sub>), 3.88 (d, <i>J</i> = 13.75 Hz, 1H, Ph-C<u class="uu">H</u>H-C), 3.81 (d, <i>J</i> = 13.75 Hz, 1H, Ph-CH<u class="uu">H</u>-C), 3.58–3.50 (m, 2H, H<sub>THP</sub>), 1.79–1.73 (m, 3H, H<sub>THP</sub>), 1.63–1.55 (m, 2H, H<sub>THP</sub>), 1.50–1.48 (m, 1H, H<sub>THP</sub>). General assignments were confirmed by <sup>1</sup>H–<sup>1</sup>H gCOSY. <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ<sub>C</sub> = 164.8 (C<sub>quat</sub>), 162.6 (C<sub>quat</sub>), 161.1 (C<sub>quat</sub>), 156.0 (C<sub>quat</sub>), 151.9 (C<sub>quat</sub>), 129.8 (2 × CH<sub>Ar</sub>), 125.4 (C<sub>quat</sub>), 115.3 (2 × CH<sub>Ar</sub>), 101.4 (CH<sub>THP</sub>), 61.4 (CH<sub>2</sub>-THP), 29.4 (Ph-<u class="uu">C</u>H<sub>2</sub>-C), 28.1 (CH<sub>2</sub>-THP), 24.6 (CH<sub>2</sub>-THP), 18.3 (CH<sub>2</sub>-THP). General assignments were confirmed by <sup>1</sup>H–<sup>13</sup>C HSQC. LRMS (ESI): 442 [M + H]<sup>+</sup>, 464 [M + Na]<sup>+</sup>. HRMS (ESI): calcd for [C<sub>16</sub>H<sub>19</sub>N<sub>5</sub>O<sub>6</sub>S<sub>2</sub> – H]<sup>+</sup> 440.0704, found 440.0703.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> CA Inhibition Assay</h3><div class="NLM_p last">An applied Photophysics stopped-flow instrument was used for assaying the CA-catalyzed CO<sub>2</sub> hydration activity.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> IC<sub>50</sub> values were obtained from dose–response curves working at seven different concentrations of the test compound, by fitting the curves using PRISM (<a href="http://www.graphpad.com" class="extLink">www.graphpad.com</a>) and nonlinear least-squares methods; values represent the mean of at least three different determinations as described by us previously.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> The inhibition constants (<i>K</i><sub>i</sub>) were then derived by using the Cheng–Prusoff equation as follows: <i>K</i><sub>i</sub> = IC<sub>50</sub>/(1 + [S]/<i>K</i><sub>m</sub>), where [S] represents the CO<sub>2</sub> concentration at which the measurement was carried out, and <i>K</i><sub>m</sub> is the concentration of substrate at which the enzyme activity is at half-maximal. All enzymes used were recombinant, produced in <i>Escherichia coli</i> as reported earlier.<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29,30)</a> The hCA isoform concentrations in the assay system ranged between 7.5 and 15.0 nM.</div></div><div id="sec4_8_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> Biology. Reagents and Plasticware</h3><div class="NLM_p last">Plasticware for cell cultures was obtained from Falcon (Becton Dickinson, Franklin Lakes, NJ). Electrophoresis reagents were obtained from Bio-Rad Laboratories (Hercules, CA). The protein content of cell lysates was assessed using a BCA kit from Sigma Chemicals Co. (St. Louis, MO). Unless specified otherwise, all reagents were purchased from Sigma Chemicals Co.</div></div><div id="sec4_8_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> Cells</h3><div class="NLM_p last">Primary human glioblastoma cells (CV17, 010627, No3) were obtained from surgical samples from Neurosurgical Units, Universities of Torino and Novara, after written informed consent and were used within passage 5. The samples were designated as unknown patient numbers (UPN) 1, 2, and 3. Researchers performing the experiments were unaware of the genetic background or clinical outcome of the patients. The study was performed in accordance with the Declaration of Helsinki and was approved by the Bio-Ethical Committee of University of Torino (No. ORTO11WNST). The histological diagnosis of glioblastoma was performed according to World Health Organization guidelines. Cells were cultured AC or NS as previously described.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> For AC, DMEM supplemented with 1% v/v penicillin–streptomycin and 10% v/v fetal bovine serum (FBS; Lonza, Basel, Switzerland) was used. For NS, DMEM-F12 medium was supplemented with 1 M HEPES, 0.3 mg/mL glucose, 75 μg/mL NaHCO<sub>3</sub>, 2 mg/mL heparin, 2 mg/mL bovine serum albumin, 2 mM progesterone, 20 ng/mL EGF, 10 ng/mL b-FGF. ACs were obtained from dissociated NS cells, centrifuged at 1200<i>g</i> for 5 min and seeded in AC medium. In vitro clonogenicity and self-renewal and in vivo tumorigenicity were reported in ref <a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a>. Cell phenotypic characterization is reported previously.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a><i>Mycoplasma</i> spp. contamination was assessed by PCR every 3 weeks; contaminated cells were discharged.</div></div><div id="sec4_8_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> Immunoblotting</h3><div class="NLM_p last">An amount of 20 μg of protein extracts from whole cell lysate was subjected to SDS–PAGE and probed with the following antibodies: anti-CAXII (goat, no. ab219641; Abcam, Cambridge, U.K.), anti-Pgp (mouse, clone C219; Millipore, Billerica, MA), anti-caspase 3 (mouse, clone C33, GeneTex, Hsinhu City, Taiwan). Plasma membrane-associated proteins were evaluated in biotinylation assays.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Anti-β-tubulin (rabbit, no. ab6046; Abcam) and anti-pancadherin (mouse, clone CH-19; Santa Cruz Biotechnology Inc., Santa Cruz, CA) antibody were used to confirm equal protein loading in whole cell and plasma-membrane associated extracts. In co-immunoprecipitation experiments, an amount of 100 μg of plasma membrane-associated proteins was immunoprecipitated with anti-CAXII or anti-Pgp antibodies, using PureProteome protein A and protein G Magnetic Beads (Millipore), then immunoblotted for Pgp or CA XII, respectively.</div></div><div id="sec4_8_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> Doxorubicin and Temozolomide Accumulation</h3><div class="NLM_p last">Doxorubicin content was measured fluorimetrically.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> The results were expressed as nmol of doxorubicin/mg of cell proteins. TMZ content was measured by liquid scintillation counting in cells incubated with 10 μM [<sup>3</sup>H]temozolomide (0.7 μCi/ml; Moravek Biochemical Inc., Brea, CA) for 24 h. The results were expressed as nmol of [<sup>3</sup>H]temozolomide/mg of cell proteins.</div></div><div id="sec4_8_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> LDH Release</h3><div class="NLM_p last">The extracellular release of LDH, considered an index of cell damage, was measured as detailed previously.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> The extracellular LDH activity was calculated as a percentage of the total LDH activity in the dish.</div></div><div id="sec4_8_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> Cell Viability</h3><div class="NLM_p last">Cell viability was evaluated using an ATPLite kit (PerkinElmer, Waltham, MA), as per the manufacturer’s instructions. The results were expressed as percentage of viable cells in each experimental condition versus untreated cells (considered 100% viable).</div></div><div id="sec4_8_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> Pgp ATPase Activity</h3><div class="NLM_p last">The assay was performed on Pgp-enriched membrane vesicles as detailed previously.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> The rate of ATP hydrolysis, an index of the Pgp catalytic cycle and a necessary step for substrate efflux, was measured. Results were expressed as (nmol of hydrolyzed phosphate (Pi)/min)/mg proteins.</div></div><div id="sec4_8_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> Generation of <i>Pgp</i>-Knocked-Out (KO) Clones</h3><div class="NLM_p last">5 ×10<sup>5</sup> cells were transduced with 1 μg of CRISPR pCas vectors (Origene, Rockville, MD) targeting <i>ABCB1/Pgp</i> or <i>CAXII</i>, respectively, or with 1 μg of nontargeting vector (Origene), following the manufacturer’s instructions. Stable KO cells were selected from the medium containing 1 μg/mL puromycin for 4 weeks.</div></div><div id="sec4_8_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> In Vivo Tumor Growth</h3><div class="NLM_p">1 ×10<sup>6</sup> NS cells, stably transfected with the pGL4.51[luc2/CMV/Neo] vector encoding for luciferase (Promega Corporation), mixed with 150 μL of sterile physiological solution, were stereotactically injected into the right caudatus nucleus into 6–8 week old female BALB/c <i>nu</i>/<i>nu</i> mice (weight: 20.3 g ± 2.4), anesthetized with sodium phenobarbital (60 mg/kg) ip. Tumor growth was monitored by in vivo bioluminescence (Xenogen IVIS Spectrum, PerkinElmer, Waltham, MA) at days 6, 14, and 24 postimplantation. At day 7, animals were randomized (6 animals/group) and treated with 2 cycles of 5 consecutive days (days: 7–11; 17–21 after randomization) as indicated in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>. Animals were euthanized at day 30. Brains were fixed in 40 μg/mL paraformaldehyde at 4 °C overnight. Tumors were excised, and the volume was determined using calipers, according to the equation (<i>L</i> × <i>W</i><sup>2</sup>)/2, where <i>L</i> = tumor length, <i>W</i> = tumor width. Tumor sections were fixed overnight in 4% paraformaldehyde and stained with hematoxylin and eosin or immunostained Ki67 (mouse, clone KiS5; Millipore), cleaved (Asp175) caspase 3 (rabbit, no. 9661; Cell Signaling Technology Inc., Danvers, MA), followed by a peroxidase-conjugated secondary antibody (Dako, Glostrup, Denmark). Stained sections were examined with a Leica DC100 microscope. In a second experimental set, animals with orthotopic tumors were monitored after the treatment detailed in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>. Animals were euthanized when they showed signs of significantly compromised neurological function or loss of body weight of >20%. Overall survival was defined as the time interval between tumor implant and euthanasia.</div><div class="NLM_p last">Animal care and experimental procedures were approved by the Bio-Ethical Committee of the Italian Ministry of Health (No. 122/2015-PR).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i80"><a href="/doi/suppl/10.1021/acs.jmedchem.9b00282" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12210" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12210" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.9b00282" class="ext-link">10.1021/acs.jmedchem.9b00282</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline"><sup>1</sup>H and <sup>13</sup>C NMR spectral data images of all compounds, Supporting Information Figure 1 showing biological activity of <b>1</b> and <b>55</b> in doxorubicin-treated cells, Supporting Information Table 1 listing in vitro mouse plasma stability and mouse microsome stability data for compound <b>55</b>, and supporting Information Table 2 listing expression profile of Pgp and CA XII in AC and NS glioblastoma cells (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00282/suppl_file/jm9b00282_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">SMILES format representations of compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00282/suppl_file/jm9b00282_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00282/suppl_file/jm9b00282_si_001.pdf">jm9b00282_si_001.pdf (5.15 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00282/suppl_file/jm9b00282_si_002.csv">jm9b00282_si_002.csv (4.3 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b00282" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26482" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26482" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chiara Riganti</span> - <span class="hlFld-Affiliation affiliation">Department
of Oncology, University of Torino, Via Santena 5/bis, 10126 Torino, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9787-4836" title="Orcid link">http://orcid.org/0000-0001-9787-4836</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#9ffcf7f6feedfeb1edf6f8fef1ebf6dfeaf1f6ebf0b1f6eb"><span class="__cf_email__" data-cfemail="bbd8d3d2dac9da95c9d2dcdad5cfd2fbced5d2cfd495d2cf">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sally-Ann Poulsen</span> - <span class="hlFld-Affiliation affiliation">Griffith
Institute for Drug Discovery, Griffith University, Don Young Road,
Nathan, Brisbane, Queensland 4111, Australia</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4494-3687" title="Orcid link">http://orcid.org/0000-0003-4494-3687</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#2754095748524b5442496740554e41414e534f09424352094652"><span class="__cf_email__" data-cfemail="7a09540a150f16091f143a1d08131c1c130e12541f1e0f541b0f">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Prashant Mujumdar</span> - <span class="hlFld-Affiliation affiliation">Griffith
Institute for Drug Discovery, Griffith University, Don Young Road,
Nathan, Brisbane, Queensland 4111, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joanna Kopecka</span> - <span class="hlFld-Affiliation affiliation">Department
of Oncology, University of Torino, Via Santena 5/bis, 10126 Torino, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Silvia Bua</span> - <span class="hlFld-Affiliation affiliation">NEUROFARBA
Department, Sezione di Scienze Farmaceutiche, Università degli Studi di Firenze, Via Ugo Schiff 6, 50019 Sesto Fiorentino, Florence, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Claudiu T. Supuran</span> - <span class="hlFld-Affiliation affiliation">NEUROFARBA
Department, Sezione di Scienze Farmaceutiche, Università degli Studi di Firenze, Via Ugo Schiff 6, 50019 Sesto Fiorentino, Florence, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4262-0323" title="Orcid link">http://orcid.org/0000-0003-4262-0323</a></span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e13617-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i81">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04126" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04126" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This research was financed by the Australian Research Council (Grant DP140101495 to S.-A.P., Fellowship FT10100185 to S.-A.P.) and by the Italian Association for Cancer Research (Grant IF21408 to C.R.). We are grateful to Griffith University for a PhD scholarship to P.M. We thank Dr. Panagiotis K. Chrysanthopoulos for high resolution mass spectrometry measurements. The table of contents graphic was prepared using ChemSpeller, <a href="https://www.chemspeller.com" class="extLink">https://www.chemspeller.com</a>.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">AZA</td><td class="NLM_def"><p class="first last">acetazolamide</p></td></tr><tr><td class="NLM_term">CA</td><td class="NLM_def"><p class="first last">carbonic anhydrase</p></td></tr><tr><td class="NLM_term"><i>K</i><sub>i</sub></td><td class="NLM_def"><p class="first last">inhibition constant</p></td></tr><tr><td class="NLM_term">NH<sub>2</sub>OBn·HCl</td><td class="NLM_def"><p class="first last">benzyloxyamine hydrochloride</p></td></tr><tr><td class="NLM_term">EDC·HCl</td><td class="NLM_def"><p class="first last"><i>N</i>-(3-(dimethylamino)propyl)-<i>N</i>′-ethylcarbodiimide hydrochloride</p></td></tr><tr><td class="NLM_term">HOBt·H<sub>2</sub>O</td><td class="NLM_def"><p class="first last">1-hydroxybenzotriazole hydrate</p></td></tr><tr><td class="NLM_term">HOSu</td><td class="NLM_def"><p class="first last"><i>N</i>-hydroxysuccinimide</p></td></tr><tr><td class="NLM_term">NH<sub>2</sub>OTHP</td><td class="NLM_def"><p class="first last"><i>O</i>-(tetrahydro-2<i>H</i>-pyran-2-yl)hydroxylamine</p></td></tr><tr><td class="NLM_term">THP</td><td class="NLM_def"><p class="first last">tetrahydropyran-2-yl</p></td></tr><tr><td class="NLM_term">TMSI</td><td class="NLM_def"><p class="first last">trimethylsilyl iodide</p></td></tr><tr><td class="NLM_term">SC</td><td class="NLM_def"><p class="first last">stem cell</p></td></tr><tr><td class="NLM_term">Pgp</td><td class="NLM_def"><p class="first last">P-glycoprotein</p></td></tr><tr><td class="NLM_term">TMZ</td><td class="NLM_def"><p class="first last">temozolomide</p></td></tr><tr><td class="NLM_term">UPN</td><td class="NLM_def"><p class="first last">unknown patient number</p></td></tr><tr><td class="NLM_term">AC</td><td class="NLM_def"><p class="first last">adherent cell</p></td></tr><tr><td class="NLM_term">NS</td><td class="NLM_def"><p class="first last">neurosphere</p></td></tr><tr><td class="NLM_term">dox</td><td class="NLM_def"><p class="first last">doxorubicin</p></td></tr><tr><td class="NLM_term">LDH</td><td class="NLM_def"><p class="first last">lactate dehydrohgenase</p></td></tr><tr><td class="NLM_term">PDX</td><td class="NLM_def"><p class="first last">patient-derived xenografts</p></td></tr><tr><td class="NLM_term">MGMT</td><td class="NLM_def"><p class="first last">O<sup>6</sup>-methylguanine DNA methyltransferase</p></td></tr><tr><td class="NLM_term">IDH2</td><td class="NLM_def"><p class="first last">isocitrate dehydrogenase 2</p></td></tr><tr><td class="NLM_term">EGFR</td><td class="NLM_def"><p class="first last">epithelial growth factor receptor.</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i83">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85388" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85388" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 31 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neri, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supuran, C. T.</span></span> <span> </span><span class="NLM_article-title">Interfering with pH regulation in tumours as a therapeutic strategy</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">767</span>– <span class="NLM_lpage">777</span>, <span class="refDoi"> DOI: 10.1038/nrd3554</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=10.1038%2Fnrd3554" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=21921921" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFOlsL7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=767-777&author=D.+Neriauthor=C.+T.+Supuran&title=Interfering+with+pH+regulation+in+tumours+as+a+therapeutic+strategy&doi=10.1038%2Fnrd3554"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Interfering with pH regulation in tumours as a therapeutic strategy</span></div><div class="casAuthors">Neri, Dario; Supuran, Claudiu T.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">767-777</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The high metabolic rate of tumors often leads to acidosis and hypoxia in poorly perfused regions.  Tumor cells have thus evolved the ability to function in a more acidic environment than normal cells.  Key pH regulators in tumor cells include: isoforms 2, 9 and 12 of carbonic anhydrase, isoforms of anion exchangers, Na+/HCO3- co-transporters, Na+/H+ exchangers, monocarboxylate transporters and the vacuolar ATPase.  Both small mols. and antibodies targeting these pH regulators are currently at various stages of clin. development.  These antitumor mechanisms are not exploited by the classical cancer drugs and therefore represent a new anticancer drug discovery strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrl7enRfSHzprVg90H21EOLACvtfcHk0lgVVsUWec0buw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFOlsL7L&md5=7a1e1b7badcf7d2e26bd70da2bfe0925</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrd3554&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3554%26sid%3Dliteratum%253Aachs%26aulast%3DNeri%26aufirst%3DD.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DInterfering%2520with%2520pH%2520regulation%2520in%2520tumours%2520as%2520a%2520therapeutic%2520strategy%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D767%26epage%3D777%26doi%3D10.1038%2Fnrd3554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alterio, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Fiore, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Ambrosio, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supuran, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Simone, G.</span></span> <span> </span><span class="NLM_article-title">Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">4421</span>– <span class="NLM_lpage">4468</span>, <span class="refDoi"> DOI: 10.1021/cr200176r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr200176r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=1%3ACAS%3A528%3ADC%252BC38Xnt1Wrsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2012&pages=4421-4468&author=V.+Alterioauthor=A.+Di+Fioreauthor=K.+D%E2%80%99Ambrosioauthor=C.+T.+Supuranauthor=G.+De+Simone&title=Multiple+binding+modes+of+inhibitors+to+carbonic+anhydrases%3A+how+to+design+specific+drugs+targeting+15+different+isoforms%3F&doi=10.1021%2Fcr200176r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms?</span></div><div class="casAuthors">Alterio, Vincenzo; Di Fiore, Anna; D'Ambrosio, Katia; Supuran, Claudiu T.; De Simone, Giuseppina</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4421-4468</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The aim of this review is to provide an exhaustive description of the structural studies on α-CAs (carbonic anhydrases) so far reported.  In particular, the main structural features of the catalytically active α-CA isoenzymes characterized to date will be described and the current state of the art on complexes of hCA II with the principal classes of inhibitors will be summarized.  A comparison with the corresponding adducts of other isoforms, when available, will be also performed, in order to find for each isoform the key residues responsible for enzyme/inhibitor interaction.  Finally, recent advances in the field of drug design of selective CAIs will be illustrated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA0GdtMHwlZ7Vg90H21EOLACvtfcHk0ljyHEDDe7DH3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xnt1Wrsbg%253D&md5=eb45ffb5efe07980f1388d99bf51406a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Fcr200176r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr200176r%26sid%3Dliteratum%253Aachs%26aulast%3DAlterio%26aufirst%3DV.%26aulast%3DDi%2BFiore%26aufirst%3DA.%26aulast%3DD%25E2%2580%2599Ambrosio%26aufirst%3DK.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26aulast%3DDe%2BSimone%26aufirst%3DG.%26atitle%3DMultiple%2520binding%2520modes%2520of%2520inhibitors%2520to%2520carbonic%2520anhydrases%253A%2520how%2520to%2520design%2520specific%2520drugs%2520targeting%252015%2520different%2520isoforms%253F%26jtitle%3DChem.%2520Rev.%26date%3D2012%26volume%3D112%26spage%3D4421%26epage%3D4468%26doi%3D10.1021%2Fcr200176r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Salaroglio, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mujumdar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Annovazzi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopecka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mellai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiffer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulsen, S.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riganti, C.</span></span> <span> </span><span class="NLM_article-title">Carbonic anhydrase XII inhibitors overcome P-glycoprotein-mediated resistance to temozolomide in glioblastoma</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">2598</span>– <span class="NLM_lpage">2609</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-18-0533</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=10.1158%2F1535-7163.MCT-18-0533" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=30254183" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjs1eltrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2018&pages=2598-2609&author=I.+C.+Salaroglioauthor=P.+Mujumdarauthor=L.+Annovazziauthor=J.+Kopeckaauthor=M.+Mellaiauthor=D.+Schifferauthor=S.-A.+Poulsenauthor=C.+Riganti&title=Carbonic+anhydrase+XII+inhibitors+overcome+P-glycoprotein-mediated+resistance+to+temozolomide+in+glioblastoma&doi=10.1158%2F1535-7163.MCT-18-0533"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Carbonic anhydrase XII inhibitors overcome P-glycoprotein-mediated resistance to temozolomide in glioblastoma</span></div><div class="casAuthors">Salaroglio, Iris C.; Mujumdar, Prashant; Annovazzi, Laura; Kopecka, Joanna; Mellai, Marta; Schiffer, Davide; Poulsen, Sally-Ann; Riganti, Chiara</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2598-2609</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The role of carbonic anhydrase XII (CAXII) in the chemoresistance of glioblastoma is unexplored.  We found CAXII and P-glycoprotein (Pgp) coexpressed in neurospheres derived from 3 of 3 patients with different genetic backgrounds and low response to temozolomide (time to recurrence: 6-9 mo).  CAXII was necessary for the Pgp efflux of temozolomide and second-line chemotherapeutic drugs, detg. chemoresistance in neurospheres.  Psammaplin C, a potent inhibitor of CAXII, resensitized primary neurospheres to temozolomide by reducing temozolomide efflux via Pgp.  This effect was independent of other known temozolomide resistance factors present in the patients.  The overall survival in orthotopic patient-derived xenografts of temozolomide-resistant neurospheres, rodosed with Psammaplin C and lemozolotnide, was significantly increased over temozolomide-treated (P < 0.05) and untreated animals (P < 0.02), without detectable signs of systemic toxicity.  We propose that a CAXII inhibitor in combination with temozolomide may provide a new and effective approach to reverse chemoresistance in glioblastoma stem cells.  This novel mechanism of action, via the interaction of CAXII and Pgp, ultimately blocks the efflux function of Pgp to improve glioblastoma patient outcomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDIcAWXhSfg7Vg90H21EOLACvtfcHk0ljyHEDDe7DH3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjs1eltrw%253D&md5=205f8163653f1c7431068eb6301d5f78</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-18-0533&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-18-0533%26sid%3Dliteratum%253Aachs%26aulast%3DSalaroglio%26aufirst%3DI.%2BC.%26aulast%3DMujumdar%26aufirst%3DP.%26aulast%3DAnnovazzi%26aufirst%3DL.%26aulast%3DKopecka%26aufirst%3DJ.%26aulast%3DMellai%26aufirst%3DM.%26aulast%3DSchiffer%26aufirst%3DD.%26aulast%3DPoulsen%26aufirst%3DS.-A.%26aulast%3DRiganti%26aufirst%3DC.%26atitle%3DCarbonic%2520anhydrase%2520XII%2520inhibitors%2520overcome%2520P-glycoprotein-mediated%2520resistance%2520to%2520temozolomide%2520in%2520glioblastoma%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2018%26volume%3D17%26spage%3D2598%26epage%3D2609%26doi%3D10.1158%2F1535-7163.MCT-18-0533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Riganti, C.</span>; <span class="NLM_string-name">Salaroglio, I. C.</span>; <span class="NLM_string-name">Mujumdar, P.</span>; <span class="NLM_string-name">Poulsen, S.-A.</span></span> <span> </span><span class="NLM_article-title">Carbonic Anhydrase Inhibitors</span>. <span class="NLM_patent">WO 2018/204987 A1</span>, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=C.+Riganti&author=I.+C.+Salaroglio&author=P.+Mujumdar&author=S.-A.+Poulsen&title=Carbonic+Anhydrase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRiganti%26aufirst%3DC.%26atitle%3DCarbonic%2520Anhydrase%2520Inhibitors%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mujumdar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulsen, S.-A.</span></span> <span> </span><span class="NLM_article-title">Natural product primary sulfonamides and primary sulfamates</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">1470</span>– <span class="NLM_lpage">1477</span>, <span class="refDoi"> DOI: 10.1021/np501015m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np501015m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpsFartrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2015&pages=1470-1477&author=P.+Mujumdarauthor=S.-A.+Poulsen&title=Natural+product+primary+sulfonamides+and+primary+sulfamates&doi=10.1021%2Fnp501015m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Natural product primary sulfonamides and primary sulfamates</span></div><div class="casAuthors">Mujumdar, Prashant; Poulsen, Sally-Ann</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1470-1477</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">A review.  Primary sulfonamide and primary sulfamate functional groups feature prominently in the structures of U.S. FDA-approved drugs.  However, the natural product chem. space contains few examples of these well-known Zn-binding chemotypes, with just 2 primary sulfonamide and 5 primary sulfamate natural products isolated and characterized to date.  One of these natural products was isolated from a marine sponge, with the remainder isolated from Streptomyces species.  Here, are outlined for the 1st time the discovery, isolation, striking breadth of bioactivity, and total synthesis (where available) for this rare group of natural products.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotEzlMKHzLBbVg90H21EOLACvtfcHk0ljyHEDDe7DH3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpsFartrc%253D&md5=bc2d65ecf920a69108d85c65955b2427</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Fnp501015m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp501015m%26sid%3Dliteratum%253Aachs%26aulast%3DMujumdar%26aufirst%3DP.%26aulast%3DPoulsen%26aufirst%3DS.-A.%26atitle%3DNatural%2520product%2520primary%2520sulfonamides%2520and%2520primary%2520sulfamates%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2015%26volume%3D78%26spage%3D1470%26epage%3D1477%26doi%3D10.1021%2Fnp501015m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mujumdar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teruya, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tonissen, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vullo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supuran, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peat, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulsen, S.-A.</span></span> <span> </span><span class="NLM_article-title">An unusual natural product primary sulfonamide: synthesis, carbonic anhydrase inhibition, and protein X-ray structures of psammaplin C</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">5462</span>– <span class="NLM_lpage">5470</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00443</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00443" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=1%3ACAS%3A528%3ADC%252BC28XnslGjs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=5462-5470&author=P.+Mujumdarauthor=K.+Teruyaauthor=K.+F.+Tonissenauthor=D.+Vulloauthor=C.+T.+Supuranauthor=T.+S.+Peatauthor=S.-A.+Poulsen&title=An+unusual+natural+product+primary+sulfonamide%3A+synthesis%2C+carbonic+anhydrase+inhibition%2C+and+protein+X-ray+structures+of+psammaplin+C&doi=10.1021%2Facs.jmedchem.6b00443"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">An Unusual Natural Product Primary Sulfonamide: Synthesis, Carbonic Anhydrase Inhibition, and Protein X-ray Structures of Psammaplin C</span></div><div class="casAuthors">Mujumdar, Prashant; Teruya, Kanae; Tonissen, Kathryn F.; Vullo, Daniela; Supuran, Claudiu T.; Peat, Thomas S.; Poulsen, Sally-Ann</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5462-5470</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Psammaplin C (I) is one of only two described natural product primary sulfonamides.  Here we report the synthesis of psammaplin C and evaluate the inhibition profile against therapeutically relevant carbonic anhydrase (CA) zinc metalloenzymes.  The compd. exhibited unprecedented inhibition of an important cancer-assocd. isoenzyme, hCA XII, with a Ki of 0.79 nM.  The compd. also displayed good isoform selectivity for hCA XII over other CAs.  We present the first reported protein X-ray crystal structures of psammaplin C in complex with human CAs.  We engineered the easily crystd. hCA II enzyme to mimic both the hCA IX and hCA XII binding sites and then utilized protein X-ray crystallog. to det. the binding pose of psammaplin C within the hCA II, hCA IX, and hCA XII mimic active sites, all to high resoln.  This is the first time a natural product primary sulfonamide inhibitor has been assessed for inhibition and binding to CAs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJ-Lgnq0P26rVg90H21EOLACvtfcHk0lhcRUe4P7Cy-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnslGjs7s%253D&md5=46f6934e7d0e393bf97130f688475d05</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00443&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00443%26sid%3Dliteratum%253Aachs%26aulast%3DMujumdar%26aufirst%3DP.%26aulast%3DTeruya%26aufirst%3DK.%26aulast%3DTonissen%26aufirst%3DK.%2BF.%26aulast%3DVullo%26aufirst%3DD.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26aulast%3DPeat%26aufirst%3DT.%2BS.%26aulast%3DPoulsen%26aufirst%3DS.-A.%26atitle%3DAn%2520unusual%2520natural%2520product%2520primary%2520sulfonamide%253A%2520synthesis%252C%2520carbonic%2520anhydrase%2520inhibition%252C%2520and%2520protein%2520X-ray%2520structures%2520of%2520psammaplin%2520C%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D5462%26epage%3D5470%26doi%3D10.1021%2Facs.jmedchem.6b00443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nicolaou, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfefferkorn, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barluenga, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roecker, A. J.</span></span> <span> </span><span class="NLM_article-title">Combinatorial synthesis through disulfide exchange: discovery of potent psammaplin A type antibacterial agents active against methicillin-resistant staphylococcus aureus (MRSA)</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">4280</span>– <span class="NLM_lpage">4295</span>, <span class="refDoi"> DOI: 10.1002/1521-3765(20011001)7:19<4280::AID-CHEM4280>3.0.CO;2-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=10.1002%2F1521-3765%2820011001%297%3A19%3C4280%3A%3AAID-CHEM4280%3E3.0.CO%3B2-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=11686609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnsFOnu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2001&pages=4280-4295&author=K.+C.+Nicolaouauthor=R.+Hughesauthor=J.+A.+Pfefferkornauthor=S.+Barluengaauthor=A.+J.+Roecker&title=Combinatorial+synthesis+through+disulfide+exchange%3A+discovery+of+potent+psammaplin+A+type+antibacterial+agents+active+against+methicillin-resistant+staphylococcus+aureus+%28MRSA%29&doi=10.1002%2F1521-3765%2820011001%297%3A19%3C4280%3A%3AAID-CHEM4280%3E3.0.CO%3B2-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Combinatorial synthesis through disulfide exchange: discovery of potent psammaplin A type antibacterial agents active against methicillin-resistant Staphylococcus aureus (MRSA)</span></div><div class="casAuthors">Nicolaou, K. C.; Hughes, Robert; Pfefferkorn, Jeffrey A.; Barluenga, Sofia; Roecker, A. J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">4280-4295</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH</span>)
        </div><div class="casAbstract">Psammaplin A is a sym. bromotyrosine-derived disulfide natural product isolated from the Psammaplysilla sponge, which exhibits in vitro antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA).  Inspired by the structure of this marine natural product, a combinatorial scrambling strategy for the construction of heterodimeric disulfide analogs was developed and applied to the construction of a 3828-membered library starting from 88 homodimeric disulfides.  These psammaplin A analogs were screened directly against various gram pos. bacterial strains leading to the discovery of a series of potent antibacterial agents active against methicillin-resistant Staphylococcus aureus (MRSA).  The present, catalytically-induced, disulfide exchange strategy may be extendable to other types of building blocks bearing thiol groups facilitating the construction of diverse discovery-oriented combinatorial libraries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6vvVgaxa2ObVg90H21EOLACvtfcHk0lhcRUe4P7Cy-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnsFOnu7Y%253D&md5=691cbd6c23343a8eb50ad99cef99e493</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1002%2F1521-3765%2820011001%297%3A19%3C4280%3A%3AAID-CHEM4280%3E3.0.CO%3B2-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1521-3765%252820011001%25297%253A19%253C4280%253A%253AAID-CHEM4280%253E3.0.CO%253B2-3%26sid%3Dliteratum%253Aachs%26aulast%3DNicolaou%26aufirst%3DK.%2BC.%26aulast%3DHughes%26aufirst%3DR.%26aulast%3DPfefferkorn%26aufirst%3DJ.%2BA.%26aulast%3DBarluenga%26aufirst%3DS.%26aulast%3DRoecker%26aufirst%3DA.%2BJ.%26atitle%3DCombinatorial%2520synthesis%2520through%2520disulfide%2520exchange%253A%2520discovery%2520of%2520potent%2520psammaplin%2520A%2520type%2520antibacterial%2520agents%2520active%2520against%2520methicillin-resistant%2520staphylococcus%2520aureus%2520%2528MRSA%2529%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2001%26volume%3D7%26spage%3D4280%26epage%3D4295%26doi%3D10.1002%2F1521-3765%2820011001%297%3A19%3C4280%3A%3AAID-CHEM4280%3E3.0.CO%3B2-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baud, M. G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leiser, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer-Almes, F.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchter, M. J.</span></span> <span> </span><span class="NLM_article-title">New synthetic strategies towards psammaplin A, access to natural product analogues for biological evaluation</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">659</span>– <span class="NLM_lpage">662</span>, <span class="refDoi"> DOI: 10.1039/C0OB00824A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=10.1039%2FC0OB00824A" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2011&pages=659-662&author=M.+G.+J.+Baudauthor=T.+Leiserauthor=F.-J.+Meyer-Almesauthor=M.+J.+Fuchter&title=New+synthetic+strategies+towards+psammaplin+A%2C+access+to+natural+product+analogues+for+biological+evaluation&doi=10.1039%2FC0OB00824A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1039%2FC0OB00824A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC0OB00824A%26sid%3Dliteratum%253Aachs%26aulast%3DBaud%26aufirst%3DM.%2BG.%2BJ.%26aulast%3DLeiser%26aufirst%3DT.%26aulast%3DMeyer-Almes%26aufirst%3DF.-J.%26aulast%3DFuchter%26aufirst%3DM.%2BJ.%26atitle%3DNew%2520synthetic%2520strategies%2520towards%2520psammaplin%2520A%252C%2520access%2520to%2520natural%2520product%2520analogues%2520for%2520biological%2520evaluation%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2011%26volume%3D9%26spage%3D659%26epage%3D662%26doi%3D10.1039%2FC0OB00824A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tanpure, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peat, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornaghi, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vullo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supuran, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulsen, S.-A.</span></span> <span> </span><span class="NLM_article-title">Carbonic anhydrase inhibitors with dual-tail moieties to match the hydrophobic and hydrophilic halves of the carbonic anhydrase active site</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">1494</span>– <span class="NLM_lpage">1501</span>, <span class="refDoi"> DOI: 10.1021/jm501798g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501798g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=1%3ACAS%3A528%3ADC%252BC2MXns12nsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=1494-1501&author=R.+P.+Tanpureauthor=B.+Renauthor=T.+S.+Peatauthor=L.+F.+Bornaghiauthor=D.+Vulloauthor=C.+T.+Supuranauthor=S.-A.+Poulsen&title=Carbonic+anhydrase+inhibitors+with+dual-tail+moieties+to+match+the+hydrophobic+and+hydrophilic+halves+of+the+carbonic+anhydrase+active+site&doi=10.1021%2Fjm501798g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Carbonic Anhydrase Inhibitors with Dual-Tail Moieties To Match the Hydrophobic and Hydrophilic Halves of the Carbonic Anhydrase Active Site</span></div><div class="casAuthors">Tanpure, Rajendra P.; Ren, Bin; Peat, Thomas S.; Bornaghi, Laurent F.; Vullo, Daniela; Supuran, Claudiu T.; Poulsen, Sally-Ann</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1494-1501</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We present a new approach to carbonic anhydrase II (CA II) inhibitor design that enables close interrogation of the regions of the CA active site where there is the greatest variability in amino acid residues among the different CA isoenzymes.  By appending dual tail groups onto the par excellence CA inhibitor acetazolamide, compds. that may interact with the distinct hydrophobic and hydrophilic halves of the CA II active site were prepd.  The dual-tail combinations selected included (i) two hydrophobic moieties, (ii) two hydrophilic moieties, and (iii) one hydrophobic and one hydrophilic moiety.  The CA enzyme inhibition profile as well as the protein X-ray crystal structure of compd. 3, comprising one hydrophobic and one hydrophilic tail moiety, in complex with CA II is described.  This novel dual-tail approach has provided an enhanced opportunity to more fully exploit interactions with the CA active site by enabling these mols. to interact with the distinct halves of the active site.  In addn. to the dual-tail compds., a corresponding set of single-tail derivs. was synthesized, enabling a comparative anal. of the single-tail vs. dual-tail compd. CA inhibition profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQo8V_UTRKTLVg90H21EOLACvtfcHk0lhcRUe4P7Cy-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXns12nsg%253D%253D&md5=ffaa9d1f27d04638bece79430e9ba663</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm501798g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501798g%26sid%3Dliteratum%253Aachs%26aulast%3DTanpure%26aufirst%3DR.%2BP.%26aulast%3DRen%26aufirst%3DB.%26aulast%3DPeat%26aufirst%3DT.%2BS.%26aulast%3DBornaghi%26aufirst%3DL.%2BF.%26aulast%3DVullo%26aufirst%3DD.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26aulast%3DPoulsen%26aufirst%3DS.-A.%26atitle%3DCarbonic%2520anhydrase%2520inhibitors%2520with%2520dual-tail%2520moieties%2520to%2520match%2520the%2520hydrophobic%2520and%2520hydrophilic%2520halves%2520of%2520the%2520carbonic%2520anhydrase%2520active%2520site%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D1494%26epage%3D1501%26doi%3D10.1021%2Fjm501798g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanessian, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liak, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanasse, B.</span></span> <span> </span><span class="NLM_article-title">Facile cleavage of benzyl ethers by catalytic transfer hydrogenation</span>. <i>Synthesis</i> <span class="NLM_year" style="font-weight: bold;">1981</span>,  <span class="NLM_volume"><i>1981</i></span>,  <span class="NLM_fpage">396</span>– <span class="NLM_lpage">397</span>, <span class="refDoi"> DOI: 10.1055/s-1981-29467</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=10.1055%2Fs-1981-29467" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1981&publication_year=1981&pages=396-397&author=S.+Hanessianauthor=T.+J.+Liakauthor=B.+Vanasse&title=Facile+cleavage+of+benzyl+ethers+by+catalytic+transfer+hydrogenation&doi=10.1055%2Fs-1981-29467"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1055%2Fs-1981-29467&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1981-29467%26sid%3Dliteratum%253Aachs%26aulast%3DHanessian%26aufirst%3DS.%26aulast%3DLiak%26aufirst%3DT.%2BJ.%26aulast%3DVanasse%26aufirst%3DB.%26atitle%3DFacile%2520cleavage%2520of%2520benzyl%2520ethers%2520by%2520catalytic%2520transfer%2520hydrogenation%26jtitle%3DSynthesis%26date%3D1981%26volume%3D1981%26spage%3D396%26epage%3D397%26doi%3D10.1055%2Fs-1981-29467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prasad, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slade, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clemens, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Repič, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blacklock, T. J.</span></span> <span> </span><span class="NLM_article-title">New trends in palladium-catalyzed transfer hydrogenations using formic acid</span>. <i>Adv. Synth. Catal.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>347</i></span>,  <span class="NLM_fpage">1769</span>– <span class="NLM_lpage">1773</span>, <span class="refDoi"> DOI: 10.1002/adsc.200505132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=10.1002%2Fadsc.200505132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1OgtrvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2005&pages=1769-1773&author=K.+Prasadauthor=X.+Jiangauthor=J.+S.+Sladeauthor=J.+Clemensauthor=O.+Repi%C4%8Dauthor=T.+J.+Blacklock&title=New+trends+in+palladium-catalyzed+transfer+hydrogenations+using+formic+acid&doi=10.1002%2Fadsc.200505132"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">New trends in palladium-catalyzed transfer hydrogenations using formic acid</span></div><div class="casAuthors">Prasad, Kapa; Jiang, Xinglong; Slade, Joel S.; Clemens, Jennifer; Repic, Oljan; Blacklock, Thomas J.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Synthesis & Catalysis</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1769-1773</span>CODEN:
                <span class="NLM_cas:coden">ASCAF7</span>;
        ISSN:<span class="NLM_cas:issn">1615-4150</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">In the presence of a catalytic amt. of org. bases, Pd-catalyzed transfer hydrogenations with formic acid are facile processes.  These new conditions produce innocuous CO2 as the byproduct compared to the use of ammonium formate, which generates NH3 and CO2 as gaseous byproducts which recombine to create unsafe conditions.  Examples include nitro-to-amino conversion of 4-(3-methoxy-4-nitrophenyl)morpholine and 1-(3-methoxy-4-nitrophenyl)-4-methylpiperazine, N-deprotection of (2S)-N-(5-fluoropyridin-2-yl)-1-(benzyloxycarbonyl)pyrrolidine-2-carboxamide, deesterification of benzyl (2R)-(trans-4-propoxycyclohexyl)[[(4-ethoxyphenyl)sulfonyl][(pyridin-4-yl)methyl]amino]acetate and didebenzylation of [cis-3-(dibenzylamino)cyclobutyl]methyl benzoate.  When the substrate is basic enough to form salts with formic acid, no addnl. base is necessary.  In certain cases, the product of the reaction was used to accelerate the transfer hydrogenation process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhFz9e0ubUK7Vg90H21EOLACvtfcHk0ljS1wgHA7QBhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1OgtrvK&md5=4169b7fded09e1af4f9212c4377dffe6</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1002%2Fadsc.200505132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fadsc.200505132%26sid%3Dliteratum%253Aachs%26aulast%3DPrasad%26aufirst%3DK.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DSlade%26aufirst%3DJ.%2BS.%26aulast%3DClemens%26aufirst%3DJ.%26aulast%3DRepi%25C4%258D%26aufirst%3DO.%26aulast%3DBlacklock%26aufirst%3DT.%2BJ.%26atitle%3DNew%2520trends%2520in%2520palladium-catalyzed%2520transfer%2520hydrogenations%2520using%2520formic%2520acid%26jtitle%3DAdv.%2520Synth.%2520Catal.%26date%3D2005%26volume%3D347%26spage%3D1769%26epage%3D1773%26doi%3D10.1002%2Fadsc.200505132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morimoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adachi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kashimura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asaka, T.</span></span> <span> </span><span class="NLM_article-title">Chemical modification of erythromycins IX. selective methylation at the C-6 hydroxyl group of erythromycin A oxime derivatives and preparation of clarithromycin</span>. <i>J. Antibiot.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">647</span>– <span class="NLM_lpage">660</span>, <span class="refDoi"> DOI: 10.7164/antibiotics.46.647</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=10.7164%2Fantibiotics.46.647" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1993&pages=647-660&author=Y.+Watanabeauthor=S.+Morimotoauthor=T.+Adachiauthor=M.+Kashimuraauthor=T.+Asaka&title=Chemical+modification+of+erythromycins+IX.+selective+methylation+at+the+C-6+hydroxyl+group+of+erythromycin+A+oxime+derivatives+and+preparation+of+clarithromycin&doi=10.7164%2Fantibiotics.46.647"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.7164%2Fantibiotics.46.647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7164%252Fantibiotics.46.647%26sid%3Dliteratum%253Aachs%26aulast%3DWatanabe%26aufirst%3DY.%26aulast%3DMorimoto%26aufirst%3DS.%26aulast%3DAdachi%26aufirst%3DT.%26aulast%3DKashimura%26aufirst%3DM.%26aulast%3DAsaka%26aufirst%3DT.%26atitle%3DChemical%2520modification%2520of%2520erythromycins%2520IX.%2520selective%2520methylation%2520at%2520the%2520C-6%2520hydroxyl%2520group%2520of%2520erythromycin%2520A%2520oxime%2520derivatives%2520and%2520preparation%2520of%2520clarithromycin%26jtitle%3DJ.%2520Antibiot.%26date%3D1993%26volume%3D46%26spage%3D647%26epage%3D660%26doi%3D10.7164%2Fantibiotics.46.647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murakata, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoshino, O.</span></span> <span> </span><span class="NLM_article-title">Asymmetric oxidative cyclization of <i>o</i>-phenolic oxime-esters: first synthesis of enantiomerically enriched spiroisoxazoline methyl esters</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">4428</span>– <span class="NLM_lpage">4433</span>, <span class="refDoi"> DOI: 10.1021/jo970082i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo970082i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=1%3ACAS%3A528%3ADyaK2sXjvVSqtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1997&pages=4428-4433&author=M.+Murakataauthor=M.+Tamuraauthor=O.+Hoshino&title=Asymmetric+oxidative+cyclization+of+o-phenolic+oxime-esters%3A+first+synthesis+of+enantiomerically+enriched+spiroisoxazoline+methyl+esters&doi=10.1021%2Fjo970082i"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Asymmetric Oxidative Cyclization of o-Phenolic Oxime-Esters: First Synthesis of Enantiomerically Enriched Spiroisoxazoline Methyl Esters</span></div><div class="casAuthors">Murakata, Masatoshi; Tamura, Masafumi; Hoshino, Osamu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4428-4433</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new method for the synthesis of enantiomerically enriched cyclohexadienonespiroisoxazoline (-)-I [R = OMe] has been described.  Asym. intramol. oxidative cyclization of the o-phenolic oxime-ester II using a novel optically active tertiary alc., R1OH, as a chiral auxiliary proceeded smoothly to afford I [R = OR1] in 83% yield.  R1OH was synthesized from (1S*,8R*,9R*,10R*)-8-phenyl-1-decalol by optical resoln.  Removal of the chiral auxiliary in I [R = OR1] with CF3CO2H followed by methylation gave I [R = OMe] in 74% ee (71% chem. yield).  The abs. configuration of I [R = OMe] was detd. by the synthesis of the marine natural product (+)-aerothionin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzS_EFJSBiBbVg90H21EOLACvtfcHk0lhGipwBNBmwIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjvVSqtrw%253D&md5=8d94166a6bea81da9f6b895517163042</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjo970082i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo970082i%26sid%3Dliteratum%253Aachs%26aulast%3DMurakata%26aufirst%3DM.%26aulast%3DTamura%26aufirst%3DM.%26aulast%3DHoshino%26aufirst%3DO.%26atitle%3DAsymmetric%2520oxidative%2520cyclization%2520of%2520o-phenolic%2520oxime-esters%253A%2520first%2520synthesis%2520of%2520enantiomerically%2520enriched%2520spiroisoxazoline%2520methyl%2520esters%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1997%26volume%3D62%26spage%3D4428%26epage%3D4433%26doi%3D10.1021%2Fjo970082i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kottakota, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benton, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evangelopoulos, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhakta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McHugh, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groundwater, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marrs, E. C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harburn, J. J.</span></span> <span> </span><span class="NLM_article-title">Versatile routes to marine sponge metabolites through benzylidene rhodanines</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">6310</span>– <span class="NLM_lpage">6313</span>, <span class="refDoi"> DOI: 10.1021/ol303057a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol303057a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=6310-6313&author=S.+K.+Kottakotaauthor=M.+Bentonauthor=D.+Evangelopoulosauthor=J.+D.+Guzmanauthor=S.+Bhaktaauthor=T.+D.+McHughauthor=M.+Grayauthor=P.+W.+Groundwaterauthor=E.+C.+L.+Marrsauthor=J.+D.+Perryauthor=J.+J.+Harburn&title=Versatile+routes+to+marine+sponge+metabolites+through+benzylidene+rhodanines&doi=10.1021%2Fol303057a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fol303057a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol303057a%26sid%3Dliteratum%253Aachs%26aulast%3DKottakota%26aufirst%3DS.%2BK.%26aulast%3DBenton%26aufirst%3DM.%26aulast%3DEvangelopoulos%26aufirst%3DD.%26aulast%3DGuzman%26aufirst%3DJ.%2BD.%26aulast%3DBhakta%26aufirst%3DS.%26aulast%3DMcHugh%26aufirst%3DT.%2BD.%26aulast%3DGray%26aufirst%3DM.%26aulast%3DGroundwater%26aufirst%3DP.%2BW.%26aulast%3DMarrs%26aufirst%3DE.%2BC.%2BL.%26aulast%3DPerry%26aufirst%3DJ.%2BD.%26aulast%3DHarburn%26aufirst%3DJ.%2BJ.%26atitle%3DVersatile%2520routes%2520to%2520marine%2520sponge%2520metabolites%2520through%2520benzylidene%2520rhodanines%26jtitle%3DOrg.%2520Lett.%26date%3D2012%26volume%3D14%26spage%3D6310%26epage%3D6313%26doi%3D10.1021%2Fol303057a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Olah, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narang, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, B. G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malhotra, R.</span></span> <span> </span><span class="NLM_article-title">Synthetic methods and reactions. 62. transformations with chlorotrimethylsilane/sodium iodide, a convenient in situ iodotrimethylsilane reagent</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1979</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">1247</span>– <span class="NLM_lpage">1251</span>, <span class="refDoi"> DOI: 10.1021/jo01322a012</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo01322a012" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=1%3ACAS%3A528%3ADyaE1MXhs1yltLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1979&pages=1247-1251&author=G.+A.+Olahauthor=S.+C.+Narangauthor=B.+G.+B.+Guptaauthor=R.+Malhotra&title=Synthetic+methods+and+reactions.+62.+transformations+with+chlorotrimethylsilane%2Fsodium+iodide%2C+a+convenient+in+situ+iodotrimethylsilane+reagent&doi=10.1021%2Fjo01322a012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic methods and reactions.  62.  Transformations with chlorotrimethylsilane/sodium iodide, a convenient in situ iodotrimethylsilane reagent</span></div><div class="casAuthors">Olah, George A.; Narang, Subhash C.; Gupta, B. G. Balaram; Malhotra, Ripudaman</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1247-51</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">A new, convenient, inexpensive alternative to Me3SiI reagent is explored.  A mixt. of Me3SiCl-NaI in MeCN is a better reagent than Me3SiI for the cleavage of esters, lactones, carbamates and ethers.  Cleavage of esters and lactones (10 examples) occurred somewhat slower with the present system than with Me3SiI.  On the other hand, ethers (7 examples) cleaved much more readily with the present system.  A feasible mechanism is proposed for this disparity.  Carbamates (6 examples) also underwent facile cleavage to give the corresponding amines.  The general applicability of the method was shown using various types of substrates.  The facile conversion of alcs. to iodides using the present method is also reported.  Conversion of alcs. to iodides is much faster with Me3SiCl-NaI than with Me3SiI, and iodides are formed in excellent yield.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeVBGIYr12XLVg90H21EOLACvtfcHk0lhGipwBNBmwIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1MXhs1yltLo%253D&md5=b392acf5b7cfd15c06b48afea62cfc21</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjo01322a012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01322a012%26sid%3Dliteratum%253Aachs%26aulast%3DOlah%26aufirst%3DG.%2BA.%26aulast%3DNarang%26aufirst%3DS.%2BC.%26aulast%3DGupta%26aufirst%3DB.%2BG.%2BB.%26aulast%3DMalhotra%26aufirst%3DR.%26atitle%3DSynthetic%2520methods%2520and%2520reactions.%252062.%2520transformations%2520with%2520chlorotrimethylsilane%252Fsodium%2520iodide%252C%2520a%2520convenient%2520in%2520situ%2520iodotrimethylsilane%2520reagent%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1979%26volume%3D44%26spage%3D1247%26epage%3D1251%26doi%3D10.1021%2Fjo01322a012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akiyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirofuji, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozaki, S.</span></span> <span> </span><span class="NLM_article-title">AlCl<sub>3</sub>-<i>N</i>,<i>N</i>-dimethylaniline: a new benzyl and allyl ether cleavage reagent</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">1321</span>– <span class="NLM_lpage">1324</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(00)79656-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=10.1016%2FS0040-4039%2800%2979656-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1991&pages=1321-1324&author=T.+Akiyamaauthor=H.+Hirofujiauthor=S.+Ozaki&title=AlCl3-N%2CN-dimethylaniline%3A+a+new+benzyl+and+allyl+ether+cleavage+reagent&doi=10.1016%2FS0040-4039%2800%2979656-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2800%2979656-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252800%252979656-0%26sid%3Dliteratum%253Aachs%26aulast%3DAkiyama%26aufirst%3DT.%26aulast%3DHirofuji%26aufirst%3DH.%26aulast%3DOzaki%26aufirst%3DS.%26atitle%3DAlCl3-N%252CN-dimethylaniline%253A%2520a%2520new%2520benzyl%2520and%2520allyl%2520ether%2520cleavage%2520reagent%26jtitle%3DTetrahedron%2520Lett.%26date%3D1991%26volume%3D32%26spage%3D1321%26epage%3D1324%26doi%3D10.1016%2FS0040-4039%2800%2979656-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fletcher, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunning, P. T.</span></span> <span> </span><span class="NLM_article-title">Mild, efficient and rapid <i>O</i>-debenzylation of <i>ortho</i>-substituted phenols with trifluoroacetic acid</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">4817</span>– <span class="NLM_lpage">4819</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2008.06.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=10.1016%2Fj.tetlet.2008.06.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=1%3ACAS%3A528%3ADC%252BD1cXotFehuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2008&pages=4817-4819&author=S.+Fletcherauthor=P.+T.+Gunning&title=Mild%2C+efficient+and+rapid+O-debenzylation+of+ortho-substituted+phenols+with+trifluoroacetic+acid&doi=10.1016%2Fj.tetlet.2008.06.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Mild, efficient and rapid O-debenzylation of ortho-substituted phenols with trifluoroacetic acid</span></div><div class="casAuthors">Fletcher, Steven; Gunning, Patrick T.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">4817-4819</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The mild and efficient deblocking of aryl benzyl ethers with TFA is reported.  Cleavage was fastest with ortho-electron-withdrawing groups on the phenolic ring, which was attributed to a proton chelation effect, furnishing the deprotected phenols in excellent yields.  The corresponding 4-methoxybenzyl, allyl, and iso-Pr ethers were also cleanly removed under these conditions.  In addn., the selective aryl benzyl ether debenzylation in the presence of benzyl ester, Cbz carbamate, and Boc carbamate functionalities was also obsd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptgd_Cyfonp7Vg90H21EOLACvtfcHk0lhGipwBNBmwIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXotFehuro%253D&md5=11569899fcd5bbf68234091890c06179</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2008.06.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2008.06.022%26sid%3Dliteratum%253Aachs%26aulast%3DFletcher%26aufirst%3DS.%26aulast%3DGunning%26aufirst%3DP.%2BT.%26atitle%3DMild%252C%2520efficient%2520and%2520rapid%2520O-debenzylation%2520of%2520ortho-substituted%2520phenols%2520with%2520trifluoroacetic%2520acid%26jtitle%3DTetrahedron%2520Lett.%26date%3D2008%26volume%3D49%26spage%3D4817%26epage%3D4819%26doi%3D10.1016%2Fj.tetlet.2008.06.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vankar, Y. D.</span></span> <span> </span><span class="NLM_article-title">A one-pot selective deprotective acetylation of benzyl ethers and OTBDMS ethers using the BF<sub>3</sub>·Et<sub>2</sub>O–NaI–Ac<sub>2</sub>O reagent system</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">5207</span>– <span class="NLM_lpage">5210</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2006.05.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=10.1016%2Fj.tetlet.2006.05.016" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2006&pages=5207-5210&author=A.+Brarauthor=Y.+D.+Vankar&title=A+one-pot+selective+deprotective+acetylation+of+benzyl+ethers+and+OTBDMS+ethers+using+the+BF3%C2%B7Et2O%E2%80%93NaI%E2%80%93Ac2O+reagent+system&doi=10.1016%2Fj.tetlet.2006.05.016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2006.05.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2006.05.016%26sid%3Dliteratum%253Aachs%26aulast%3DBrar%26aufirst%3DA.%26aulast%3DVankar%26aufirst%3DY.%2BD.%26atitle%3DA%2520one-pot%2520selective%2520deprotective%2520acetylation%2520of%2520benzyl%2520ethers%2520and%2520OTBDMS%2520ethers%2520using%2520the%2520BF3%25C2%25B7Et2O%25E2%2580%2593NaI%25E2%2580%2593Ac2O%2520reagent%2520system%26jtitle%3DTetrahedron%2520Lett.%26date%3D2006%26volume%3D47%26spage%3D5207%26epage%3D5210%26doi%3D10.1016%2Fj.tetlet.2006.05.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujino, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doi, T.</span></span> <span> </span><span class="NLM_article-title">A concise total synthesis of biologically active frutinones via tributylphosphine-catalyzed tandem acyl transfer-cyclization</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">3452</span>– <span class="NLM_lpage">3458</span>, <span class="refDoi"> DOI: 10.1016/j.tet.2014.03.073</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=10.1016%2Fj.tet.2014.03.073" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmtFWjt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2014&pages=3452-3458&author=M.+Yoshidaauthor=K.+Saitoauthor=Y.+Fujinoauthor=T.+Doi&title=A+concise+total+synthesis+of+biologically+active+frutinones+via+tributylphosphine-catalyzed+tandem+acyl+transfer-cyclization&doi=10.1016%2Fj.tet.2014.03.073"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">A concise total synthesis of biologically active frutinones via tributylphosphine-catalyzed tandem acyl transfer-cyclization</span></div><div class="casAuthors">Yoshida, Masahito; Saito, Koya; Fujino, Yuta; Doi, Takayuki</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">3452-3458</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A concise and step-economical total synthesis of biol. active frutinones has been achieved.  Tributylphosphine (PBu3) efficiently induced the tandem acyl transfer-cyclization of carbonates I (R1 = R2 = H; R1 = H, R2 = OMe; R1 = OTHP, R2 = H) to afford 3-(methoxycarbonyl)flavone derivs. II in excellent yields.  Finally, concomitant deprotection and lactonization under acidic conditions furnished the desired frutinones A, B, and the proposed structure of frutinone C, III, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8gYBYGBhIXbVg90H21EOLACvtfcHk0lgu0Vhh7HUGqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmtFWjt7g%253D&md5=0df799c5a4d246eddf546f08dd30ae44</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2014.03.073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2014.03.073%26sid%3Dliteratum%253Aachs%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DSaito%26aufirst%3DK.%26aulast%3DFujino%26aufirst%3DY.%26aulast%3DDoi%26aufirst%3DT.%26atitle%3DA%2520concise%2520total%2520synthesis%2520of%2520biologically%2520active%2520frutinones%2520via%2520tributylphosphine-catalyzed%2520tandem%2520acyl%2520transfer-cyclization%26jtitle%3DTetrahedron%26date%3D2014%26volume%3D70%26spage%3D3452%26epage%3D3458%26doi%3D10.1016%2Fj.tet.2014.03.073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Auffinger, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pytel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, A. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesniak, M. S.</span></span> <span> </span><span class="NLM_article-title">The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence AU - Auffinger, Brenda</span>. <i>Expert Rev. Neurother.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">741</span>– <span class="NLM_lpage">752</span>, <span class="refDoi"> DOI: 10.1586/14737175.2015.1051968</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=10.1586%2F14737175.2015.1051968" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=26027432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVKntbfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=741-752&author=B.+Auffingerauthor=D.+Spencerauthor=P.+Pytelauthor=A.+U.+Ahmedauthor=M.+S.+Lesniak&title=The+role+of+glioma+stem+cells+in+chemotherapy+resistance+and+glioblastoma+multiforme+recurrence+AU+-+Auffinger%2C+Brenda&doi=10.1586%2F14737175.2015.1051968"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence</span></div><div class="casAuthors">Auffinger, Brenda; Spencer, Drew; Pytel, Peter; Ahmed, Atique U.; Lesniak, Maciej S.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Neurotherapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">741-752</span>CODEN:
                <span class="NLM_cas:coden">ERNXAR</span>;
        ISSN:<span class="NLM_cas:issn">1473-7175</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Glioma stem cells (GSCs) constitute a slow-dividing, small population within a heterogeneous glioblastoma.  They are able to self-renew, recapitulate a whole tumor, and differentiate into other specific glioblastoma multiforme (GBM) subpopulations.  Therefore, they have been held responsible for malignant relapse after primary std. therapy and the poor prognosis of recurrent GBM.  The failure of current therapies to eliminate specific GSC subpopulations has been considered a major factor contributing to the inevitable recurrence in GBM patients after treatment.  Here, we discuss the mol. mechanisms of chemoresistance of GSCs and the reasons why complete eradication of GSCs is so difficult to achieve.  We will also describe the targeted therapies currently available for GSCs and possible mechanisms to overcome such chemoresistance and avoid therapeutic relapse.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsdXouJjY2qrVg90H21EOLACvtfcHk0lgu0Vhh7HUGqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVKntbfI&md5=b6bd28f8916f99ef3813999ee111fddc</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1586%2F14737175.2015.1051968&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F14737175.2015.1051968%26sid%3Dliteratum%253Aachs%26aulast%3DAuffinger%26aufirst%3DB.%26aulast%3DSpencer%26aufirst%3DD.%26aulast%3DPytel%26aufirst%3DP.%26aulast%3DAhmed%26aufirst%3DA.%2BU.%26aulast%3DLesniak%26aufirst%3DM.%2BS.%26atitle%3DThe%2520role%2520of%2520glioma%2520stem%2520cells%2520in%2520chemotherapy%2520resistance%2520and%2520glioblastoma%2520multiforme%2520recurrence%2520AU%2520-%2520Auffinger%252C%2520Brenda%26jtitle%3DExpert%2520Rev.%2520Neurother.%26date%3D2015%26volume%3D15%26spage%3D741%26epage%3D752%26doi%3D10.1586%2F14737175.2015.1051968" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bosia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghigo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiffer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salaroglio, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campia, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopecka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Annovazzi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mellai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldera, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riganti, C.</span></span> <span> </span><span class="NLM_article-title">Temozolomide downregulates P-glycoprotein expression in glioblastoma stem cells by interfering with the Wnt3a/glycogen synthase-3 kinase/β-catenin pathway</span>. <i>Neuro-Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1502</span>– <span class="NLM_lpage">1517</span>, <span class="refDoi"> DOI: 10.1093/neuonc/not104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=10.1093%2Fneuonc%2Fnot104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=23897632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslWqsbzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=1502-1517&author=A.+Bosiaauthor=D.+Ghigoauthor=D.+Schifferauthor=I.+C.+Salaroglioauthor=I.+Campiaauthor=J.+Kopeckaauthor=L.+Annovazziauthor=M.+Mellaiauthor=V.+Calderaauthor=C.+Riganti&title=Temozolomide+downregulates+P-glycoprotein+expression+in+glioblastoma+stem+cells+by+interfering+with+the+Wnt3a%2Fglycogen+synthase-3+kinase%2F%CE%B2-catenin+pathway&doi=10.1093%2Fneuonc%2Fnot104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Temozolomide downregulates P-glycoprotein expression in glioblastoma stem cells by interfering with the Wnt3a/glycogen synthase-3 kinase/β-catenin pathway</span></div><div class="casAuthors">Riganti, Chiara; Salaroglio, Iris Chiara; Caldera, Valentina; Campia, Ivana; Kopecka, Joanna; Mellai, Marta; Annovazzi, Laura; Bosia, Amalia; Ghigo, Dario; Schiffer, Davide</div><div class="citationInfo"><span class="NLM_cas:title">Neuro-Oncology (Cary, NC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1502-1517</span>CODEN:
                <span class="NLM_cas:coden">NEURJR</span>;
        ISSN:<span class="NLM_cas:issn">1522-8517</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background: Glioblastoma multiforme stem cells display a highly chemoresistant phenotype, whose mol. basis is poorly known.  We aim to clarify this issue and to investigate the effects of temozolomide on chemoresistant stem cells.  Methods: A panel of human glioblastoma cultures, grown as stem cells (neurospheres) and adherent cells, was used.  Results Neurospheres had a multidrug resistant phenotype compared with adherent cells.  Such chemoresistance was overcome by apparently noncytotoxic doses of temozolomide, which chemosensitized glioblastoma cells to doxorubicin, vinblastine, and etoposide.  This effect was selective for P-glycoprotein (Pgp) substrates and for stem cells, leading to an investigation of whether there was a correlation between the expression of Pgp and the activity of typical stemness pathways.  We found that Wnt3a and ABCB1, which encodes for Pgp, were both highly expressed in glioblastoma stem cells and reduced by temozolomide.  Temozolomide-treated cells had increased methylation of the cytosine-phosphate-guanine islands in the Wnt3a gene promoter, decreased expression of Wnt3a, disrupted glycogen synthase-3 kinase/β-catenin axis, reduced transcriptional activation of ABCB1, and a lower amt. and activity of Pgp.  Wnt3a overexpression was sufficient to transform adherent cells into neurospheres and to simultaneously increase proliferation and ABCB1 expression.  On the contrary, glioblastoma stem cells silenced for Wnt3a lost the ability to form neurospheres and reduced at the same time the proliferation rate and ABCB1 levels.  Conclusions: Our work suggests that Wnt3a is an autocrine mediator of stemness, proliferation, and chemoresistance in human glioblastoma and that temozolomide may chemosensitize the stem cell population by downregulating Wnt3a signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAuefnXFCx4bVg90H21EOLACvtfcHk0ljPlhMd1A3cYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslWqsbzF&md5=f310d3cb5a5da76b8cbc9f479a41eb51</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1093%2Fneuonc%2Fnot104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fneuonc%252Fnot104%26sid%3Dliteratum%253Aachs%26aulast%3DBosia%26aufirst%3DA.%26aulast%3DGhigo%26aufirst%3DD.%26aulast%3DSchiffer%26aufirst%3DD.%26aulast%3DSalaroglio%26aufirst%3DI.%2BC.%26aulast%3DCampia%26aufirst%3DI.%26aulast%3DKopecka%26aufirst%3DJ.%26aulast%3DAnnovazzi%26aufirst%3DL.%26aulast%3DMellai%26aufirst%3DM.%26aulast%3DCaldera%26aufirst%3DV.%26aulast%3DRiganti%26aufirst%3DC.%26atitle%3DTemozolomide%2520downregulates%2520P-glycoprotein%2520expression%2520in%2520glioblastoma%2520stem%2520cells%2520by%2520interfering%2520with%2520the%2520Wnt3a%252Fglycogen%2520synthase-3%2520kinase%252F%25CE%25B2-catenin%2520pathway%26jtitle%3DNeuro-Oncol.%26date%3D2013%26volume%3D15%26spage%3D1502%26epage%3D1517%26doi%3D10.1093%2Fneuonc%2Fnot104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gottesman, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fojo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bates, S. E.</span></span> <span> </span><span class="NLM_article-title">Multidrug resistance in cancer: role of ATP-dependent transporters</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">48</span>– <span class="NLM_lpage">58</span>, <span class="refDoi"> DOI: 10.1038/nrc706</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=10.1038%2Fnrc706" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=11902585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=1%3ACAS%3A528%3ADC%252BD38XhvF2jtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=48-58&author=M.+M.+Gottesmanauthor=T.+Fojoauthor=S.+E.+Bates&title=Multidrug+resistance+in+cancer%3A+role+of+ATP-dependent+transporters&doi=10.1038%2Fnrc706"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Multidrug resistance in cancer: role of ATP-dependent transporters</span></div><div class="casAuthors">Gottesman, Michael M.; Fojo, Tito; Bates, Susan E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">48-58</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Chemotherapeutics are the most effective treatment for metastatic tumors.  However, the ability of cancer cells to become simultaneously resistant to different drugs, a trait known as multidrug resistance, remains a significant impediment to successful chemotherapy.  Three decades of multidrug-resistance research have identified a myriad of ways in which cancer cells can elude chemotherapy, and it has become apparent that resistance exists against every effective drug, even our newest agents.  Therefore, the ability to predict and circumvent drug resistance is likely to improve chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRJtnCZv-ZtrVg90H21EOLACvtfcHk0ljPlhMd1A3cYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhvF2jtL8%253D&md5=ec5284e1fe4a878c5ffc30ee83bccc9d</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fnrc706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc706%26sid%3Dliteratum%253Aachs%26aulast%3DGottesman%26aufirst%3DM.%2BM.%26aulast%3DFojo%26aufirst%3DT.%26aulast%3DBates%26aufirst%3DS.%2BE.%26atitle%3DMultidrug%2520resistance%2520in%2520cancer%253A%2520role%2520of%2520ATP-dependent%2520transporters%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2002%26volume%3D2%26spage%3D48%26epage%3D58%26doi%3D10.1038%2Fnrc706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Munoz, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scotto, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rameshwar, P.</span></span> <span> </span><span class="NLM_article-title">Temozolomide competes for P-glycoprotein and contributes to chemoresistance in glioblastoma cells</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>367</i></span>,  <span class="NLM_fpage">69</span>– <span class="NLM_lpage">75</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2015.07.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=10.1016%2Fj.canlet.2015.07.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=26208431" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1amsb%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=367&publication_year=2015&pages=69-75&author=J.+L.+Munozauthor=N.+D.+Walkerauthor=K.+W.+Scottoauthor=P.+Rameshwar&title=Temozolomide+competes+for+P-glycoprotein+and+contributes+to+chemoresistance+in+glioblastoma+cells&doi=10.1016%2Fj.canlet.2015.07.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Temozolomide competes for P-glycoprotein and contributes to chemoresistance in glioblastoma cells</span></div><div class="casAuthors">Munoz, Jessian L.; Walker, Nykia D.; Scotto, Kathleen W.; Rameshwar, Pranela</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">367</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">69-75</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Chemotherapeutic resistance can occur by P-glycoprotein (P-gp), a 12-transmembrane ATP-dependent drug efflux pump.  Glioblastoma (GBM) has poor survival rate and uniformly acquired chemoresistance to its frontline agent, Temozolomide (TMZ).  Despite much effort, overcoming TMZ resistance remains a challenge.  We reported on autonomous induction of TMZ resistance by increased transcription MDR1, the gene for P-gp.  This study investigated how P-gp and TMZ interact to gain resistance.  Using an exptl. model of Adriamycin-resistant DC3F cells (DC3F/Adx), we showed that increased P-gp caused TMZ resistance.  Increasing concns. of TMZ competed with Calcein for P-gp, resulting in reduced efflux in the DC3F/Adx cells.  Three different inhibitors of P-gp reversed the resistance to TMZ in two different GBM cell lines, by increasing active Caspase 3.  Mol. modeling predicted the binding sites to be the intracellular region of P-gp and also identified specific amino acids and kinetics of energy for the efflux of TMZ.  Taken together, we confirmed P-gp targeting of TMZ, a crucial regulator of TMZ resistance in GBM.  This study provides insights on the effectiveness by which TMZ competes with other P-gp substrates, thereby opening the door for combined targeted therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoE7c_rrAe1XrVg90H21EOLACvtfcHk0ljPlhMd1A3cYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1amsb%252FE&md5=a1f74f27ab415df04ec4acfcf1e3b367</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2015.07.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2015.07.013%26sid%3Dliteratum%253Aachs%26aulast%3DMunoz%26aufirst%3DJ.%2BL.%26aulast%3DWalker%26aufirst%3DN.%2BD.%26aulast%3DScotto%26aufirst%3DK.%2BW.%26aulast%3DRameshwar%26aufirst%3DP.%26atitle%3DTemozolomide%2520competes%2520for%2520P-glycoprotein%2520and%2520contributes%2520to%2520chemoresistance%2520in%2520glioblastoma%2520cells%26jtitle%3DCancer%2520Lett.%26date%3D2015%26volume%3D367%26spage%3D69%26epage%3D75%26doi%3D10.1016%2Fj.canlet.2015.07.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robey, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pluchino, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fojo, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bates, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gottesman, M. M.</span></span> <span> </span><span class="NLM_article-title">Revisiting the role of ABC transporters in multidrug-resistant cancer</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">452</span>– <span class="NLM_lpage">464</span>, <span class="refDoi"> DOI: 10.1038/s41568-018-0005-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=10.1038%2Fs41568-018-0005-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=29643473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=1%3ACAS%3A528%3ADC%252BC1cXosVCgt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2018&pages=452-464&author=R.+W.+Robeyauthor=K.+M.+Pluchinoauthor=M.+D.+Hallauthor=A.+T.+Fojoauthor=S.+E.+Batesauthor=M.+M.+Gottesman&title=Revisiting+the+role+of+ABC+transporters+in+multidrug-resistant+cancer&doi=10.1038%2Fs41568-018-0005-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Revisiting the role of ABC transporters in multidrug-resistant cancer</span></div><div class="casAuthors">Robey, Robert W.; Pluchino, Kristen M.; Hall, Matthew D.; Fojo, Antonio T.; Bates, Susan E.; Gottesman, Michael M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">452-464</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">A review.  Most patients who die of cancer have disseminated disease that has become resistant to multiple therapeutic modalities.  Ample evidence suggests that the expression of ATP-binding cassette (ABC) transporters, esp. the multidrug resistance protein 1 (MDR1, also known as P-glycoprotein or P-gp), which is encoded by ABC subfamily B member 1 (ABCB1), can confer resistance to cytotoxic and targeted chemotherapy.  However, the development of MDR1 as a therapeutic target has been unsuccessful.  At the time of its discovery, appropriate tools for the characterization and clin. development of MDR1 as a therapeutic target were lacking.  Thirty years after the initial cloning and characterization of MDR1 and the implication of two addnl. ABC transporters, the multidrug resistance-assocd. protein 1 (MRP1; encoded by ABCC1)), and ABCG2, in multidrug resistance, interest in investigating these transporters as therapeutic targets has waned.  However, with the emergence of new data and advanced techniques, we propose to re-evaluate whether these transporters play a clin. role in multidrug resistance.  With this Opinion article, we present recent evidence indicating that it is time to revisit the investigation into the role of ABC transporters in efficient drug delivery in various cancer types and at the blood-brain barrier.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTrmO71Nb38rVg90H21EOLACvtfcHk0ljPlhMd1A3cYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXosVCgt7Y%253D&md5=9c4b00f17a7ae98158862504bf1a8292</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fs41568-018-0005-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41568-018-0005-8%26sid%3Dliteratum%253Aachs%26aulast%3DRobey%26aufirst%3DR.%2BW.%26aulast%3DPluchino%26aufirst%3DK.%2BM.%26aulast%3DHall%26aufirst%3DM.%2BD.%26aulast%3DFojo%26aufirst%3DA.%2BT.%26aulast%3DBates%26aufirst%3DS.%2BE.%26aulast%3DGottesman%26aufirst%3DM.%2BM.%26atitle%3DRevisiting%2520the%2520role%2520of%2520ABC%2520transporters%2520in%2520multidrug-resistant%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2018%26volume%3D18%26spage%3D452%26epage%3D464%26doi%3D10.1038%2Fs41568-018-0005-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kopecka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campia, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frei, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghigo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wollscheid, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riganti, C.</span></span> <span> </span><span class="NLM_article-title">Carbonic anhydrase XII is a new therapeutic target to overcome chemoresistance in cancer cells</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">6776</span>– <span class="NLM_lpage">6793</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.2882</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=10.18632%2Foncotarget.2882" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=6776-6793&author=J.+Kopeckaauthor=I.+Campiaauthor=A.+Jacobsauthor=A.+P.+Freiauthor=D.+Ghigoauthor=B.+Wollscheidauthor=C.+Riganti&title=Carbonic+anhydrase+XII+is+a+new+therapeutic+target+to+overcome+chemoresistance+in+cancer+cells&doi=10.18632%2Foncotarget.2882"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.2882&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.2882%26sid%3Dliteratum%253Aachs%26aulast%3DKopecka%26aufirst%3DJ.%26aulast%3DCampia%26aufirst%3DI.%26aulast%3DJacobs%26aufirst%3DA.%26aulast%3DFrei%26aufirst%3DA.%2BP.%26aulast%3DGhigo%26aufirst%3DD.%26aulast%3DWollscheid%26aufirst%3DB.%26aulast%3DRiganti%26aufirst%3DC.%26atitle%3DCarbonic%2520anhydrase%2520XII%2520is%2520a%2520new%2520therapeutic%2520target%2520to%2520overcome%2520chemoresistance%2520in%2520cancer%2520cells%26jtitle%3DOncotarget%26date%3D2015%26volume%3D6%26spage%3D6776%26epage%3D6793%26doi%3D10.18632%2Foncotarget.2882" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibahara, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugiyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanamori, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonoda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tominaga, T.</span></span> <span> </span><span class="NLM_article-title">Temozolomide reverses doxorubicin resistance by inhibiting P-glycoprotein in malignant glioma cells</span>. <i>J. Neuro-Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">235</span>– <span class="NLM_lpage">242</span>, <span class="refDoi"> DOI: 10.1007/s11060-015-1968-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=10.1007%2Fs11060-015-1968-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=26530267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVaqsr7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2016&pages=235-242&author=R.+Zhangauthor=R.+Saitoauthor=I.+Shibaharaauthor=S.+Sugiyamaauthor=M.+Kanamoriauthor=Y.+Sonodaauthor=T.+Tominaga&title=Temozolomide+reverses+doxorubicin+resistance+by+inhibiting+P-glycoprotein+in+malignant+glioma+cells&doi=10.1007%2Fs11060-015-1968-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Temozolomide reverses doxorubicin resistance by inhibiting P-glycoprotein in malignant glioma cells</span></div><div class="casAuthors">Zhang, Rong; Saito, Ryuta; Shibahara, Ichiyo; Sugiyama, Shinichiro; Kanamori, Masayuki; Sonoda, Yukihiko; Tominaga, Teiji</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuro-Oncology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">235-242</span>CODEN:
                <span class="NLM_cas:coden">JNODD2</span>;
        ISSN:<span class="NLM_cas:issn">0167-594X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Temozolomide is a std. chemotherapy agent for malignant gliomas, but the efficacy is still not satisfactory.  Therefore, combination chemotherapy using temozolomide with other anti-tumor compds. is now under investigation.  Here we studied the mechanism of the synergistic anti-tumor effect achieved by temozolomide and doxorubicin, and elucidated the inhibitory effect of temozolomide on P-glycoprotein (P-gp).  Temozolomide significantly enhanced sensitivity to P-gp substrate in glioma cells, particularly in P-gp-overexpressed cells.  Synergetic effects, as detd. by isobologram anal., were obsd. by combining temozolomide and doxorubicin.  Subsequently, flow cytometry was utilized to assess the intracellular retention of doxorubicin in cells treated with doxorubicin with or without temozolomide.  Temozolomide significantly increased the accumulation of doxorubicin in these cells.  The P-gp ATPase (ATPase) assay showed that temozolomide inhibited the ATPase activity of P-gp.  In addn., temozolomide combined with doxorubicin significantly prolonged the survival of 9L intracranial allografted glioma-bearing rats compared to single agent treatment.  Collectively, our findings suggest that temozolomide can reverse doxorubicin resistance by directly affecting P-gp transport activity.  Combination chemotherapy using temozolomide with other agents may be effective against gliomas in clin. applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrReNjnit1DUrVg90H21EOLACvtfcHk0ljLzK84dUMydA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVaqsr7P&md5=53920a514ad0859a2c02eedc7b64710b</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1007%2Fs11060-015-1968-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11060-015-1968-x%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DSaito%26aufirst%3DR.%26aulast%3DShibahara%26aufirst%3DI.%26aulast%3DSugiyama%26aufirst%3DS.%26aulast%3DKanamori%26aufirst%3DM.%26aulast%3DSonoda%26aufirst%3DY.%26aulast%3DTominaga%26aufirst%3DT.%26atitle%3DTemozolomide%2520reverses%2520doxorubicin%2520resistance%2520by%2520inhibiting%2520P-glycoprotein%2520in%2520malignant%2520glioma%2520cells%26jtitle%3DJ.%2520Neuro-Oncol.%26date%3D2016%26volume%3D126%26spage%3D235%26epage%3D242%26doi%3D10.1007%2Fs11060-015-1968-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khalifah, R. G.</span></span> <span> </span><span class="NLM_article-title">The carbon dioxide hydration activity of carbonic anhydrase</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1971</span>,  <span class="NLM_volume"><i>246</i></span>,  <span class="NLM_fpage">2561</span>– <span class="NLM_lpage">2573</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=10.1016%2FS0021-9258%2818%2962326-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=4994926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=1%3ACAS%3A528%3ADyaE3MXhtlGmu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=246&publication_year=1971&pages=2561-2573&author=R.+G.+Khalifah&title=The+carbon+dioxide+hydration+activity+of+carbonic+anhydrase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Carbon dioxide hydration activity of carbonic anhydrase.  I.  Stop-flow kinetic studies on the native human isoenzymes B and C</span></div><div class="casAuthors">Khalifah, Raja G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1971</span>),
    <span class="NLM_cas:volume">246</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2561-73</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">The kinetics of catalysis of carbon dioxide hydration by human carbonic anhydrases B and C (EC 4.2.1.1) has been reinvestigated with the use of an improved pH indicator stop-flow approach that was checked by studying the uncatalyzed rate of hydration, with Michaelis-Menten parameters being detd. between pH 5.8 and 8.8 in noninhibitory buffers.  For both isoenzymes, Km was independent of pH, whereas Vmax increased with increasing pH with results being similar to the finding of others on bovine carbonic anhydrase, but differing from earlier reports of Gibbons and Edsall (1964) in the finding that Km was pH-independent.  Despite the differences between the low and high activity forms of the enzyme, there were close kinetic similarities between them that indicated underlying similarities in active site structure.  Imidazole (I) (0.22-1.32M) inhibited the B enzyme, apparently competitively, and had no effect on the C enzyme.  N-Methyl substitution of I abolished its inhibitory effect.  Nitrous oxide (11-45mM) did not inhibit catalysis of carbon dioxide hydration by either of the 2 human isoenzymes, or by bovine carbonic anhydrase.  The enzyme-catalyzed hydration of carbon dioxide probably requires not only water activation by a basic group, but also charge neutralization in the transition state by an electron acceptor function.  The zinc-bound water in carbonic anhydrase could be involved in both donor and acceptor roles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGri57EkpgPMx7Vg90H21EOLACvtfcHk0ljLzK84dUMydA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3MXhtlGmu7k%253D&md5=2764970fcd4f08250b28b9e8e9474681</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2FS0021-9258%2818%2962326-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9258%252818%252962326-9%26sid%3Dliteratum%253Aachs%26aulast%3DKhalifah%26aufirst%3DR.%2BG.%26atitle%3DThe%2520carbon%2520dioxide%2520hydration%2520activity%2520of%2520carbonic%2520anhydrase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1971%26volume%3D246%26spage%3D2561%26epage%3D2573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drillaud, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornaghi, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulsen, S.-A.</span></span> <span> </span><span class="NLM_article-title">Synthesis of S-glycosyl primary sulfonamides</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">2811</span>– <span class="NLM_lpage">2816</span>, <span class="refDoi"> DOI: 10.1021/jo9000367</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo9000367" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2009&pages=2811-2816&author=M.+Lopezauthor=N.+Drillaudauthor=L.+F.+Bornaghiauthor=S.-A.+Poulsen&title=Synthesis+of+S-glycosyl+primary+sulfonamides&doi=10.1021%2Fjo9000367"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjo9000367&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo9000367%26sid%3Dliteratum%253Aachs%26aulast%3DLopez%26aufirst%3DM.%26aulast%3DDrillaud%26aufirst%3DN.%26aulast%3DBornaghi%26aufirst%3DL.%2BF.%26aulast%3DPoulsen%26aufirst%3DS.-A.%26atitle%3DSynthesis%2520of%2520S-glycosyl%2520primary%2520sulfonamides%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2009%26volume%3D74%26spage%3D2811%26epage%3D2816%26doi%3D10.1021%2Fjo9000367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Winum, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vullo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montero, J.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scozzafava, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supuran, C. T.</span></span> <span> </span><span class="NLM_article-title">Carbonic anhydrase inhibitors. Inhibition of cytosolic isozymes I and II and transmembrane, tumor-associated isozyme IX with sulfamates including EMATE also acting as steroid sulfatase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">2197</span>– <span class="NLM_lpage">2204</span>, <span class="refDoi"> DOI: 10.1021/jm021124k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm021124k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtFagtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=2197-2204&author=J.-Y.+Winumauthor=D.+Vulloauthor=A.+Casiniauthor=J.-L.+Monteroauthor=A.+Scozzafavaauthor=C.+T.+Supuran&title=Carbonic+anhydrase+inhibitors.+Inhibition+of+cytosolic+isozymes+I+and+II+and+transmembrane%2C+tumor-associated+isozyme+IX+with+sulfamates+including+EMATE+also+acting+as+steroid+sulfatase+inhibitors&doi=10.1021%2Fjm021124k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Carbonic Anhydrase Inhibitors. Inhibition of Cytosolic Isozymes I and II and Transmembrane, Tumor-Associated Isozyme IX with Sulfamates Including EMATE Also Acting as Steroid Sulfatase Inhibitors</span></div><div class="casAuthors">Winum, Jean-Yves; Vullo, Daniela; Casini, Angela; Montero, Jean-Louis; Scozzafava, Andrea; Supuran, Claudiu T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2197-2204</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of sulfamates or bis-sulfamates incorporating aliph., arom., polycyclic (steroidal), and sugar moieties in their mols. has been synthesized and assayed as inhibitors of the zinc enzyme carbonic anhydrase (CA), and more precisely of the cytosolic isoenzymes CA I andII, and the transmembrane, tumor-assocd. isoenzymes CA IX.  Some of these compds. were previously reported to act as inhibitors of steroid sulfatases, among which estrone sulfatase (ES) and dehydroepiandrosterone sulfatase (DHEAS) are the key therapeutic targets for estrogen-dependent tumors.  Very potent (nanomolar) inhibitors were detected against the three investigated CA isoenzymes.  Best CA I inhibitors were phenylsulfamate and some of its 4-halogeno derivs., as well as the aliph. compd. n-octyl sulfamate.  Against CA II, low nanomolar inhibitors (1.1 - 5 nM) were phenylsulfamate and some of its 4-halogeno/nitro derivs., n-octyl sulfamate, and estradiol 3,17β-disulfamate among others.  All the investigated sulfamates showed efficient CA IX inhibitory properties, with inhibition consts. in the range of 18 - 63 nM.  The best CA IX inhibitor detected so far was 4-chlorophenylsulfamate.  These data are crit. for the design of novel antitumor properties, mainly for hypoxic tumors that overexpress CA IX, which are nonresponsive to radiation or chemotherapy.  The antitumor properties of the ES/DHEAS inhibitors in clin. trials may on the other hand also be due to their potent inhibitory properties of CA isoenzymes involved in tumorigenicity, such as CA II and CA IX.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5jPZo4GLHsbVg90H21EOLACvtfcHk0liV9lEn-Xc7zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtFagtrk%253D&md5=409f29b6cc34daa89727aeb0b258ee9d</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm021124k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm021124k%26sid%3Dliteratum%253Aachs%26aulast%3DWinum%26aufirst%3DJ.-Y.%26aulast%3DVullo%26aufirst%3DD.%26aulast%3DCasini%26aufirst%3DA.%26aulast%3DMontero%26aufirst%3DJ.-L.%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DCarbonic%2520anhydrase%2520inhibitors.%2520Inhibition%2520of%2520cytosolic%2520isozymes%2520I%2520and%2520II%2520and%2520transmembrane%252C%2520tumor-associated%2520isozyme%2520IX%2520with%2520sulfamates%2520including%2520EMATE%2520also%2520acting%2520as%2520steroid%2520sulfatase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D2197%26epage%3D2204%26doi%3D10.1021%2Fjm021124k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vullo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Innocenti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishimori, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pastorek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scozzafava, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pastoreková, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supuran, C. T.</span></span> <span> </span><span class="NLM_article-title">Carbonic anhydrase inhibitors. Inhibition of the transmembrane isozyme XII with sulfonamides—a new target for the design of antitumor and antiglaucoma drugs?</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">963</span>– <span class="NLM_lpage">969</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2004.12.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=10.1016%2Fj.bmcl.2004.12.053" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=963-969&author=D.+Vulloauthor=A.+Innocentiauthor=I.+Nishimoriauthor=J.+Pastorekauthor=A.+Scozzafavaauthor=S.+Pastorekov%C3%A1author=C.+T.+Supuran&title=Carbonic+anhydrase+inhibitors.+Inhibition+of+the+transmembrane+isozyme+XII+with+sulfonamides%E2%80%94a+new+target+for+the+design+of+antitumor+and+antiglaucoma+drugs%3F&doi=10.1016%2Fj.bmcl.2004.12.053"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2004.12.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2004.12.053%26sid%3Dliteratum%253Aachs%26aulast%3DVullo%26aufirst%3DD.%26aulast%3DInnocenti%26aufirst%3DA.%26aulast%3DNishimori%26aufirst%3DI.%26aulast%3DPastorek%26aufirst%3DJ.%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DPastorekov%25C3%25A1%26aufirst%3DS.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DCarbonic%2520anhydrase%2520inhibitors.%2520Inhibition%2520of%2520the%2520transmembrane%2520isozyme%2520XII%2520with%2520sulfonamides%25E2%2580%2594a%2520new%2520target%2520for%2520the%2520design%2520of%2520antitumor%2520and%2520antiglaucoma%2520drugs%253F%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D963%26epage%3D969%26doi%3D10.1016%2Fj.bmcl.2004.12.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kopecka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salzano, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campia, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lusa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghigo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Rosa, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riganti, C.</span></span> <span> </span><span class="NLM_article-title">Insights in the chemical components of liposomes responsible for P-glycoprotein inhibition</span>. <i>Nanomedicine</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">77</span>– <span class="NLM_lpage">87</span>, <span class="refDoi"> DOI: 10.1016/j.nano.2013.06.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=10.1016%2Fj.nano.2013.06.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=23850894" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1altLnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=77-87&author=J.+Kopeckaauthor=G.+Salzanoauthor=I.+Campiaauthor=S.+Lusaauthor=D.+Ghigoauthor=G.+De+Rosaauthor=C.+Riganti&title=Insights+in+the+chemical+components+of+liposomes+responsible+for+P-glycoprotein+inhibition&doi=10.1016%2Fj.nano.2013.06.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Insights in the chemical components of liposomes responsible for P-glycoprotein inhibition</span></div><div class="casAuthors">Kopecka, Joanna; Salzano, Giuseppina; Campia, Ivana; Lusa, Sara; Ghigo, Dario; De Rosa, Giuseppe; Riganti, Chiara</div><div class="citationInfo"><span class="NLM_cas:title">Nanomedicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">77-87</span>CODEN:
                <span class="NLM_cas:coden">NANOBF</span>;
        ISSN:<span class="NLM_cas:issn">1549-9634</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">In this work we investigated how the surface charge and the presence of polyethylene glycol (PEG) on liposome carriers affect the delivery of the encapsulated doxorubicin in P-glycoprotein (Pgp)-overexpressing cells.  We found that neutral net charge was crit. to favor the liposome uptake and decrease the Vmax of doxorubicin efflux.  PEG-coating was necessary to increase the Km of doxorubicin for Pgp.  In particular the PEGylated phospholipid present in neutral liposomes, i.e.  PEGylated distearoyl-phosphatidylethanolamine (DSPE-PEG), was a Pgp allosteric inhibitor, increased doxorubicin Km and inhibited Pgp ATPase activity.  Site-directed mutagenesis expts. suggested that the domain centered around glycine 185 of Pgp was necessary for these inhibitory properties of DSPE-PEG and PEGylated neutral liposomes.  We conclude that both surface charge and PEGylation must be considered to optimize the doxorubicin delivery within chemoresistant cells.  DSPE-PEG-enriched particles may represent promising tools for therapeutic and diagnostic applications in tissues with high levels of Pgp.  From the Clin. Editor: These authors investigated how surface charge and PEGylation of liposome carriers affect the delivery of encapsulated doxorubicin to Pgp-overexpressing cells, concluding that both factors need to be considered to optimize doxorubicin delivery to chemoresistant cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPloIAvjdG3bVg90H21EOLACvtfcHk0liV9lEn-Xc7zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1altLnO&md5=8ac17aeda34790cf65afb79d53003b8b</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.nano.2013.06.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nano.2013.06.013%26sid%3Dliteratum%253Aachs%26aulast%3DKopecka%26aufirst%3DJ.%26aulast%3DSalzano%26aufirst%3DG.%26aulast%3DCampia%26aufirst%3DI.%26aulast%3DLusa%26aufirst%3DS.%26aulast%3DGhigo%26aufirst%3DD.%26aulast%3DDe%2BRosa%26aufirst%3DG.%26aulast%3DRiganti%26aufirst%3DC.%26atitle%3DInsights%2520in%2520the%2520chemical%2520components%2520of%2520liposomes%2520responsible%2520for%2520P-glycoprotein%2520inhibition%26jtitle%3DNanomedicine%26date%3D2014%26volume%3D10%26spage%3D77%26epage%3D87%26doi%3D10.1016%2Fj.nano.2013.06.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 12 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rodion  Khotimchenko</span>, <span class="hlFld-ContribAuthor ">Igor  Bryukhovetskiy</span>, <span class="hlFld-ContribAuthor ">Maksim  Khotimchenko</span>, <span class="hlFld-ContribAuthor ">Yuri  Khotimchenko</span>. </span><span class="cited-content_cbyCitation_article-title">Bioactive Compounds with Antiglioma Activity from Marine Species. </span><span class="cited-content_cbyCitation_journal-name">Biomedicines</span><span> <strong>2021,</strong> <em>9 </em>
                                    (8)
                                     , 886. <a href="https://doi.org/10.3390/biomedicines9080886" title="DOI URL">https://doi.org/10.3390/biomedicines9080886</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biomedicines9080886&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiomedicines9080886%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedicines%26atitle%3DBioactive%252BCompounds%252Bwith%252BAntiglioma%252BActivity%252Bfrom%252BMarine%252BSpecies%26aulast%3DKhotimchenko%26aufirst%3DRodion%26date%3D2021%26date%3D2021%26volume%3D9%26issue%3D8%26spage%3D886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">R.E.  Kast</span>. </span><span class="cited-content_cbyCitation_article-title">Adding high-dose celecoxib to increase effectiveness of standard glioblastoma chemoirradiation. </span><span class="cited-content_cbyCitation_journal-name">Annales Pharmaceutiques Françaises</span><span> <strong>2021,</strong> <em>332 </em><a href="https://doi.org/10.1016/j.pharma.2021.03.001" title="DOI URL">https://doi.org/10.1016/j.pharma.2021.03.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharma.2021.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharma.2021.03.001%26sid%3Dliteratum%253Aachs%26jtitle%3DAnnales%2520Pharmaceutiques%2520Fran%25C3%25A7aises%26atitle%3DAdding%252Bhigh-dose%252Bcelecoxib%252Bto%252Bincrease%252Beffectiveness%252Bof%252Bstandard%252Bglioblastoma%252Bchemoirradiation%26aulast%3DKast%26aufirst%3DR.E.%26date%3D2021%26volume%3D332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">R.  Meenashi</span>, <span class="hlFld-ContribAuthor ">K.  Selvaraju</span>, <span class="hlFld-ContribAuthor ">P.  Jayalakshmi</span>, <span class="hlFld-ContribAuthor ">P.V.  Nidhin</span>, <span class="hlFld-ContribAuthor ">A. David  Stephen</span>. </span><span class="cited-content_cbyCitation_article-title">Docking and Molecular Dynamic Simulation of
Temozolomide with Carbonic Anhydrase XIII. </span><span class="cited-content_cbyCitation_journal-name">Asian Journal of Organic & Medicinal Chemistry</span><span> <strong>2021,</strong> <em>5 </em>
                                    (4)
                                     , 332-339. <a href="https://doi.org/10.14233/ajomc.2020." title="DOI URL">https://doi.org/10.14233/ajomc.2020.</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.14233/ajomc.2020.&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.14233%2Fajomc.2020.%26sid%3Dliteratum%253Aachs%26jtitle%3DAsian%2520Journal%2520of%2520Organic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDocking%252Band%252BMolecular%252BDynamic%252BSimulation%252Bof%252BTemozolomide%252Bwith%252BCarbonic%252BAnhydrase%252BXIII%26aulast%3DMeenashi%26aufirst%3DR.%26date%3D2021%26date%3D2020%26volume%3D5%26issue%3D4%26spage%3D332%26epage%3D339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Simone  Carradori</span>, <span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>. </span><span class="cited-content_cbyCitation_article-title">Small molecules and monoclonal antibodies as selective hCA XII inhibitors: An update. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 79-94. <a href="https://doi.org/10.1016/B978-0-12-820701-7.00015-4" title="DOI URL">https://doi.org/10.1016/B978-0-12-820701-7.00015-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-820701-7.00015-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-820701-7.00015-4%26sid%3Dliteratum%253Aachs%26atitle%3DSmall%252Bmolecules%252Band%252Bmonoclonal%252Bantibodies%252Bas%252Bselective%252BhCA%252BXII%252Binhibitors%25253A%252BAn%252Bupdate%26aulast%3DCarradori%26aufirst%3DSimone%26date%3D2021%26spage%3D79%26epage%3D94%26pub%3DElsevier%26atitle%3DpH-Interfering%252BAgents%252Bas%252BChemosensitizers%252Bin%252BCancer%252BTherapy%26date%3D2021%26volume%3D98" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guanzhang  Li</span>, <span class="hlFld-ContribAuthor ">Ting-Wei  Chen</span>, <span class="hlFld-ContribAuthor ">Ann-Christin  Nickel</span>, <span class="hlFld-ContribAuthor ">Sajjad  Muhammad</span>, <span class="hlFld-ContribAuthor ">Hans-Jakob  Steiger</span>, <span class="hlFld-ContribAuthor ">Theophilos  Tzaridis</span>, <span class="hlFld-ContribAuthor ">Daniel  Hänggi</span>, <span class="hlFld-ContribAuthor ">Reinhard  Zeidler</span>, <span class="hlFld-ContribAuthor ">Wei  Zhang</span>, <span class="hlFld-ContribAuthor ">Ulf Dietrich  Kahlert</span>. </span><span class="cited-content_cbyCitation_article-title">Carbonic Anhydrase XII is a Clinically Significant, Molecular Tumor-Subtype Specific Therapeutic Target in Glioma with the Potential to Combat Invasion of Brain Tumor Cells. </span><span class="cited-content_cbyCitation_journal-name">OncoTargets and Therapy</span><span> <strong>2021,</strong> <em>Volume 14 </em>, 1707-1718. <a href="https://doi.org/10.2147/OTT.S300623" title="DOI URL">https://doi.org/10.2147/OTT.S300623</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2147/OTT.S300623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2147%2FOTT.S300623%26sid%3Dliteratum%253Aachs%26jtitle%3DOncoTargets%2520and%2520Therapy%26atitle%3DCarbonic%252BAnhydrase%252BXII%252Bis%252Ba%252BClinically%252BSignificant%25252C%252BMolecular%252BTumor-Subtype%252BSpecific%252BTherapeutic%252BTarget%252Bin%252BGlioma%252Bwith%252Bthe%252BPotential%252Bto%252BCombat%252BInvasion%252Bof%252BBrain%252BTumor%252BCells%26aulast%3DLi%26aufirst%3DGuanzhang%26date%3D2021%26date%3D2021%26volume%3DVolume%252014%26spage%3D1707%26epage%3D1718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xu  Tan</span>, <span class="hlFld-ContribAuthor ">Wei  Song</span>, <span class="hlFld-ContribAuthor ">Xiulai  Chen</span>, <span class="hlFld-ContribAuthor ">Liming  Liu</span>, <span class="hlFld-ContribAuthor ">Jing  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in biocatalytic derivatization of l-tyrosine. </span><span class="cited-content_cbyCitation_journal-name">Applied Microbiology and Biotechnology</span><span> <strong>2020,</strong> <em>104 </em>
                                    (23)
                                     , 9907-9920. <a href="https://doi.org/10.1007/s00253-020-10949-6" title="DOI URL">https://doi.org/10.1007/s00253-020-10949-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00253-020-10949-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00253-020-10949-6%26sid%3Dliteratum%253Aachs%26jtitle%3DApplied%2520Microbiology%2520and%2520Biotechnology%26atitle%3DRecent%252Badvances%252Bin%252Bbiocatalytic%252Bderivatization%252Bof%252Bl-tyrosine%26aulast%3DTan%26aufirst%3DXu%26date%3D2020%26date%3D2020%26volume%3D104%26issue%3D23%26spage%3D9907%26epage%3D9920" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Claudio  Luparello</span>, <span class="hlFld-ContribAuthor ">Manuela  Mauro</span>, <span class="hlFld-ContribAuthor ">Vincenzo  Arizza</span>, <span class="hlFld-ContribAuthor ">Mirella  Vazzana</span>. </span><span class="cited-content_cbyCitation_article-title">Histone Deacetylase Inhibitors from Marine Invertebrates. </span><span class="cited-content_cbyCitation_journal-name">Biology</span><span> <strong>2020,</strong> <em>9 </em>
                                    (12)
                                     , 429. <a href="https://doi.org/10.3390/biology9120429" title="DOI URL">https://doi.org/10.3390/biology9120429</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biology9120429&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiology9120429%26sid%3Dliteratum%253Aachs%26jtitle%3DBiology%26atitle%3DHistone%252BDeacetylase%252BInhibitors%252Bfrom%252BMarine%252BInvertebrates%26aulast%3DLuparello%26aufirst%3DClaudio%26date%3D2020%26date%3D2020%26volume%3D9%26issue%3D12%26spage%3D429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dimas Carolina  Belisario</span>, <span class="hlFld-ContribAuthor ">Joanna  Kopecka</span>, <span class="hlFld-ContribAuthor ">Martina  Pasino</span>, <span class="hlFld-ContribAuthor ">Muhlis  Akman</span>, <span class="hlFld-ContribAuthor ">Enrico  De Smaele</span>, <span class="hlFld-ContribAuthor ">Massimo  Donadelli</span>, <span class="hlFld-ContribAuthor ">Chiara  Riganti</span>. </span><span class="cited-content_cbyCitation_article-title">Hypoxia Dictates Metabolic Rewiring of Tumors: Implications for Chemoresistance. </span><span class="cited-content_cbyCitation_journal-name">Cells</span><span> <strong>2020,</strong> <em>9 </em>
                                    (12)
                                     , 2598. <a href="https://doi.org/10.3390/cells9122598" title="DOI URL">https://doi.org/10.3390/cells9122598</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cells9122598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcells9122598%26sid%3Dliteratum%253Aachs%26jtitle%3DCells%26atitle%3DHypoxia%252BDictates%252BMetabolic%252BRewiring%252Bof%252BTumors%25253A%252BImplications%252Bfor%252BChemoresistance%26aulast%3DBelisario%26aufirst%3DDimas%2BCarolina%26date%3D2020%26date%3D2020%26volume%3D9%26issue%3D12%26spage%3D2598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amarjyoti  Das Mahapatra</span>, <span class="hlFld-ContribAuthor ">Aarfa  Queen</span>, <span class="hlFld-ContribAuthor ">Mohd  Yousuf</span>, <span class="hlFld-ContribAuthor ">Parvez  Khan</span>, <span class="hlFld-ContribAuthor ">Afzal  Hussain</span>, <span class="hlFld-ContribAuthor ">Md. Tabish  Rehman</span>, <span class="hlFld-ContribAuthor ">Mohamed F.  Alajmi</span>, <span class="hlFld-ContribAuthor ">Bhaskar  Datta</span>, <span class="hlFld-ContribAuthor ">Md. Imtaiyaz  Hassan</span>. </span><span class="cited-content_cbyCitation_article-title">Design and development of 5-(4H)-oxazolones as potential inhibitors of human carbonic anhydrase VA: towards therapeutic management of diabetes and obesity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2020,</strong> <em>28 </em>, 1-11. <a href="https://doi.org/10.1080/07391102.2020.1845803" title="DOI URL">https://doi.org/10.1080/07391102.2020.1845803</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2020.1845803&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2020.1845803%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DDesign%252Band%252Bdevelopment%252Bof%252B5-%2525284H%252529-oxazolones%252Bas%252Bpotential%252Binhibitors%252Bof%252Bhuman%252Bcarbonic%252Banhydrase%252BVA%25253A%252Btowards%252Btherapeutic%252Bmanagement%252Bof%252Bdiabetes%252Band%252Bobesity%26aulast%3DDas%2BMahapatra%26aufirst%3DAmarjyoti%26date%3D2020%26date%3D2020%26volume%3D28%26spage%3D1%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katarina  Koruza</span>, <span class="hlFld-ContribAuthor ">A. Briana  Murray</span>, <span class="hlFld-ContribAuthor ">Brian P.  Mahon</span>, <span class="hlFld-ContribAuthor ">Jesse B.  Hopkins</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Knecht</span>, <span class="hlFld-ContribAuthor ">Robert  McKenna</span>, <span class="hlFld-ContribAuthor ">S. Zoë  Fisher</span>. </span><span class="cited-content_cbyCitation_article-title">Biophysical Characterization of Cancer-Related Carbonic Anhydrase IX. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (15)
                                     , 5277. <a href="https://doi.org/10.3390/ijms21155277" title="DOI URL">https://doi.org/10.3390/ijms21155277</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21155277&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21155277%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DBiophysical%252BCharacterization%252Bof%252BCancer-Related%252BCarbonic%252BAnhydrase%252BIX%26aulast%3DKoruza%26aufirst%3DKatarina%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D15%26spage%3D5277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joonas  Haapasalo</span>, <span class="hlFld-ContribAuthor ">Kristiina  Nordfors</span>, <span class="hlFld-ContribAuthor ">Hannu  Haapasalo</span>, <span class="hlFld-ContribAuthor ">Seppo  Parkkila</span>. </span><span class="cited-content_cbyCitation_article-title">The Expression of Carbonic Anhydrases II, IX and XII in Brain Tumors. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2020,</strong> <em>12 </em>
                                    (7)
                                     , 1723. <a href="https://doi.org/10.3390/cancers12071723" title="DOI URL">https://doi.org/10.3390/cancers12071723</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers12071723&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers12071723%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DThe%252BExpression%252Bof%252BCarbonic%252BAnhydrases%252BII%25252C%252BIX%252Band%252BXII%252Bin%252BBrain%252BTumors%26aulast%3DHaapasalo%26aufirst%3DJoonas%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D7%26spage%3D1723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Claudiu T  Supuran</span>. </span><span class="cited-content_cbyCitation_article-title"><p>Experimental Carbonic Anhydrase Inhibitors for the Treatment of Hypoxic Tumors</p>. </span><span class="cited-content_cbyCitation_journal-name">Journal of Experimental Pharmacology</span><span> <strong>2020,</strong> <em>Volume 12 </em>, 603-617. <a href="https://doi.org/10.2147/JEP.S265620" title="DOI URL">https://doi.org/10.2147/JEP.S265620</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2147/JEP.S265620&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2147%2FJEP.S265620%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Experimental%2520Pharmacology%26atitle%3D%25253Cp%25253EExperimental%252BCarbonic%252BAnhydrase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BHypoxic%252BTumors%25253C%25252Fp%25253E%26aulast%3DSupuran%26aufirst%3DClaudiu%2BT%26date%3D2020%26date%3D2020%26volume%3DVolume%252012%26spage%3D603%26epage%3D617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.9b00282/20190418/images/medium/jm-2019-002823_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.9b00282/20190418/images/large/jm-2019-002823_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00282&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.9b00282/20190418/images/medium/jm-2019-002823_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.9b00282/20190418/images/large/jm-2019-002823_0001.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Psammaplin C <b>1</b>, a natural product primary sulfonamide, is a subnanomolar inhibitor of the cancer related carbonic anhydrase isozyme, CA XII (<i>K</i><sub>i</sub> = 0.79 nM).<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> There are three distinct structural components, (a) a 3-bromo-4-hydroxybenzyl group, red, (b) an aminoethyl primary sulfonamide functional group, blue, and (c) a free oxime moiety, green.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.9b00282/20190418/images/large/jm-2019-002823_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00282&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.9b00282/20190418/images/medium/jm-2019-002823_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.9b00282/20190418/images/large/jm-2019-002823_0002.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Library precursor compounds sulfonamides <b>2</b>–<b>6</b> and protected oximes <b>7</b>–<b>14</b> were used toward the preparation of psammaplin C derivatives: protected oximes <b>27</b>–<b>42</b>, <b>59</b>–<b>68</b>, <b>72</b>–<b>76</b> and free oximes <b>43</b>–<b>58</b> and <b>69</b>–<b>71</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.9b00282/20190418/images/large/jm-2019-002823_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00282&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.9b00282/20190418/images/medium/jm-2019-002823_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.9b00282/20190418/images/large/jm-2019-002823_0006.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of <i>O</i>-Bn and <i>O</i>-THP Protected Oximes <b>7</b>–<b>10</b> and <b>11</b>–<b>14</b>, Respectively, from Commercially Available Aldehydes <b>15</b>–<b>18</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.9b00282/20190418/images/large/jm-2019-002823_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00282&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) <i>N</i>-acetylglycine, NaOAc, Ac<sub>2</sub>O, 120 °C, 3 h; (ii) aq HCl (10%), reflux, 15 h; (iii) pyridine, H<sub>2</sub>NOBn·HCl, rt, 15 h; (iv) pyridine, H<sub>2</sub>NOTHP, rt, 15 h. R<sup>1</sup> and R<sup>2</sup> = H if not specified otherwise. Yields of <b>7</b>–<b>14</b> are over two steps from <b>19</b>–<b>22</b>.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.9b00282/20190418/images/medium/jm-2019-002823_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.9b00282/20190418/images/large/jm-2019-002823_0007.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis toward Psammaplin C Derivatives <b>27</b>–<b>58</b> from <i>O</i>-Bn Precursors <b>7</b>–<b>10</b> and Sulfonamides <b>2</b>–<b>5</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.9b00282/20190418/images/large/jm-2019-002823_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00282&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) EDC·HCl, HOBt·H<sub>2</sub>O, <b>2</b>–<b>5</b>, dry DMF, rt, 24 h; (ii) cyclohexene, Pd(OH)<sub>2</sub>, absolute EtOH, reflux, 2–6 h. R<sup>1</sup>, R<sup>2</sup> = H unless otherwise specified. Compounds <b>55</b>–<b>58</b> were not obtained.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.9b00282/20190418/images/medium/jm-2019-002823_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.9b00282/20190418/images/large/jm-2019-002823_0008.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis toward Psammaplin C Derivatives <b>44</b>, <b>46</b>, <b>48</b>, <b>50</b>, <b>52</b>, <b>54</b>, and <b>55</b>–<b>68</b> from the Corresponding <i>O</i>-THP Precursors <b>11</b>–<b>14</b> and Sulfonamides <b>2</b>–<b>5</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.9b00282/20190418/images/large/jm-2019-002823_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00282&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) EDC·HCl, HOBt·H<sub>2</sub>O, <b>2</b>–<b>5</b>, dry DMF, rt, 24 h; (ii) 4 M HCl in 1,4-dioxane, 0 °C, 4–10 h. R<sup>1</sup>, R<sup>2</sup> = H unless otherwise specified.</p></p></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.9b00282/20190418/images/medium/jm-2019-002823_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.9b00282/20190418/images/large/jm-2019-002823_0003.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Aminoethyl primary sulfonamides: natural product <b>1</b>, protected oxime derivatives <b>72</b>–<b>76</b>, and free oxime derivatives <b>69</b>, <b>70</b>, and <b>71</b>.<a onclick="showRef(event, 'ref3 ref6'); return false;" href="javascript:void(0);" class="ref ref3 ref6">(3,6)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.9b00282/20190418/images/large/jm-2019-002823_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00282&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.9b00282/20190418/images/medium/jm-2019-002823_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.9b00282/20190418/images/large/jm-2019-002823_0004.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Compound <b>55</b> restores temozolomide efficacy in glioblastoma stem cells. NSs were grown for 48 h (A–E) or 72 h (F) in fresh medium (−) or in medium containing 50 μM temozolomide (T) or 10 nM compound <b>55</b>, alone or in combination. (B–D, F) Pooled data of patients UPN1–3 are presented as the mean ± SD (<i>n</i> = 4 independent experiments for each patient). ACs were included as control cells with undetectable CA XII or Pgp levels. (A) UPN2 NSs were lysed and immunoblotted for Pgp and CA XII. The figure is representative of one out of three experiments. (B) Spectrophotometric measure of Pgp ATPase activity, measured in triplicate in NS. (∗) <i>p</i> < 0.01: T/<b>55</b>/T + <b>55</b>-treated vs untreated (−) cells. (°) <i>p</i> < 0.005: (T + <b>55</b>)-treated vs T-treated cells. (C) Intracellular concentration of temozolomide (TMZ), measured in duplicate after cell radiolabeling. NS clones knocked out for Pgp (KOPgp) and AC were included as control cells where expression of Pgp is undetectable. (∗) <i>p</i> < 0.001: <b>55</b>-treated or KOPgp vs untreated (−) NS. (D) LDH release, measured spectrophotometrically in duplicate. (∗) <i>p</i> < 0.001: treated vs untreated (−) NS or AC. (°) <i>p</i> < 0.001: (T + <b>55</b>)/(T + KOPgp) vs T-treated NS. (E) UPN2 NSs, incubated as reported in (A) and/or knocked out for Pgp, were lysed and immunoblotted for procaspase 3 and cleaved caspase 3. The figure is representative of one out of three experiments. (F) Cell viability measured by a chemiluminescence-based assay in quadruplicates. (∗) <i>p</i> < 0.001: treated vs untreated (−)-NS or AC. (°) <i>p</i> < 0.001: (T + <b>55</b>)/(T + KOPgp) vs T-treated NS.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.9b00282/20190418/images/large/jm-2019-002823_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00282&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.9b00282/20190418/images/medium/jm-2019-002823_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.9b00282/20190418/images/large/jm-2019-002823_0005.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Compound <b>55</b> restores temozolomide efficacy in resistant orthtotopic patient-derived glioblastoma xenografts. (A) Representative in vivo bioluminescence imaging of orthotopically implanted UPN2 NS, in animals treated with vehicle (ctrl), compound <b>55</b>, and temozolomide (T), as follows: (1) control group, treated with 0.2 mL of saline solution intravenously (iv); (2) <b>55</b> group, treated with 3.8 μg/kg compound <b>55</b> iv; (3) T group, treated with 50 mg/kg T per os (po); (4) T + <b>55</b> group, treated with 50 mg/kg T po + 3.8 μg/kg compound <b>55</b> iv (6 animals/group). (B) Tumor volume at the time of sacrifice. Pooled data of patients UPN1–3-derived tumors are presented as the mean ± SD. UPN1, (∗) <i>p</i> < 0.005: T + <b>55</b> vs ctrl. Not significant: T + <b>55</b> vs T. UPN2, (∗) <i>p</i> < 0.001: T + <b>55</b> vs ctrl. (°) <i>p</i> < 0.001: T + <b>55</b> vs TMZ. UPN3, (∗) <i>p</i> < 0.005: T/(T + <b>55</b>) vs ctrl. (°) <i>p</i> < 0.05: T + <b>55</b> vs T. (C) Overall survival probability was calculated using the Kaplan–Meier method. UPN1, <i>p</i> < 0.05: T + <b>55</b> vs ctrl. <i>p</i> < 0.05: T + <b>55</b> vs T. UPN2, <i>p</i> < 0.001: T + <b>55</b> vs ctrl. <i>p</i> < 0.001: T + <b>55</b> vs T. UPN3, <i>p</i> < 0.01: T + <b>55</b> vs ctrl. Not significant: T + <b>55</b> vs T (log rank test; not reported in the figure). (D) Representative intratumor staining with hematoxylin and eosin (HE) or the indicated antibodies, from UPN2-derived tumors. The photographs are representative of sections from 5 tumors/group of treatment. Bar = 10 μm (10× ocular lens, 20× objective). (E) Quantification of immunohistochemical images, performed on sections with 111–94 nuclei/field. The percentage of proliferating cells was determined by the ratio Ki67-positive nuclei/total number (hematoxylin-positive) of nuclei using ImageJ software. The ctrl group percentage was considered 100%. The percentage of caspase 3 positive cells was determined by Photoshop program. Data are presented as the mean ± SD. (∗) <i>p</i> < 0.001: T + <b>55</b> vs ctrl. (°) <i>p</i> < 0.02: T + <b>55</b> vs T.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-8/acs.jmedchem.9b00282/20190418/images/large/jm-2019-002823_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00282&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i83">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72430" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72430" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 31 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neri, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supuran, C. T.</span></span> <span> </span><span class="NLM_article-title">Interfering with pH regulation in tumours as a therapeutic strategy</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">767</span>– <span class="NLM_lpage">777</span>, <span class="refDoi"> DOI: 10.1038/nrd3554</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=10.1038%2Fnrd3554" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=21921921" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFOlsL7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=767-777&author=D.+Neriauthor=C.+T.+Supuran&title=Interfering+with+pH+regulation+in+tumours+as+a+therapeutic+strategy&doi=10.1038%2Fnrd3554"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Interfering with pH regulation in tumours as a therapeutic strategy</span></div><div class="casAuthors">Neri, Dario; Supuran, Claudiu T.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">767-777</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The high metabolic rate of tumors often leads to acidosis and hypoxia in poorly perfused regions.  Tumor cells have thus evolved the ability to function in a more acidic environment than normal cells.  Key pH regulators in tumor cells include: isoforms 2, 9 and 12 of carbonic anhydrase, isoforms of anion exchangers, Na+/HCO3- co-transporters, Na+/H+ exchangers, monocarboxylate transporters and the vacuolar ATPase.  Both small mols. and antibodies targeting these pH regulators are currently at various stages of clin. development.  These antitumor mechanisms are not exploited by the classical cancer drugs and therefore represent a new anticancer drug discovery strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrl7enRfSHzprVg90H21EOLACvtfcHk0ljBm-tFtTEynQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFOlsL7L&md5=7a1e1b7badcf7d2e26bd70da2bfe0925</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrd3554&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3554%26sid%3Dliteratum%253Aachs%26aulast%3DNeri%26aufirst%3DD.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DInterfering%2520with%2520pH%2520regulation%2520in%2520tumours%2520as%2520a%2520therapeutic%2520strategy%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D767%26epage%3D777%26doi%3D10.1038%2Fnrd3554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alterio, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Fiore, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Ambrosio, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supuran, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Simone, G.</span></span> <span> </span><span class="NLM_article-title">Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">4421</span>– <span class="NLM_lpage">4468</span>, <span class="refDoi"> DOI: 10.1021/cr200176r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr200176r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=1%3ACAS%3A528%3ADC%252BC38Xnt1Wrsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2012&pages=4421-4468&author=V.+Alterioauthor=A.+Di+Fioreauthor=K.+D%E2%80%99Ambrosioauthor=C.+T.+Supuranauthor=G.+De+Simone&title=Multiple+binding+modes+of+inhibitors+to+carbonic+anhydrases%3A+how+to+design+specific+drugs+targeting+15+different+isoforms%3F&doi=10.1021%2Fcr200176r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms?</span></div><div class="casAuthors">Alterio, Vincenzo; Di Fiore, Anna; D'Ambrosio, Katia; Supuran, Claudiu T.; De Simone, Giuseppina</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4421-4468</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The aim of this review is to provide an exhaustive description of the structural studies on α-CAs (carbonic anhydrases) so far reported.  In particular, the main structural features of the catalytically active α-CA isoenzymes characterized to date will be described and the current state of the art on complexes of hCA II with the principal classes of inhibitors will be summarized.  A comparison with the corresponding adducts of other isoforms, when available, will be also performed, in order to find for each isoform the key residues responsible for enzyme/inhibitor interaction.  Finally, recent advances in the field of drug design of selective CAIs will be illustrated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA0GdtMHwlZ7Vg90H21EOLACvtfcHk0ljBm-tFtTEynQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xnt1Wrsbg%253D&md5=eb45ffb5efe07980f1388d99bf51406a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Fcr200176r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr200176r%26sid%3Dliteratum%253Aachs%26aulast%3DAlterio%26aufirst%3DV.%26aulast%3DDi%2BFiore%26aufirst%3DA.%26aulast%3DD%25E2%2580%2599Ambrosio%26aufirst%3DK.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26aulast%3DDe%2BSimone%26aufirst%3DG.%26atitle%3DMultiple%2520binding%2520modes%2520of%2520inhibitors%2520to%2520carbonic%2520anhydrases%253A%2520how%2520to%2520design%2520specific%2520drugs%2520targeting%252015%2520different%2520isoforms%253F%26jtitle%3DChem.%2520Rev.%26date%3D2012%26volume%3D112%26spage%3D4421%26epage%3D4468%26doi%3D10.1021%2Fcr200176r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Salaroglio, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mujumdar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Annovazzi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopecka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mellai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiffer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulsen, S.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riganti, C.</span></span> <span> </span><span class="NLM_article-title">Carbonic anhydrase XII inhibitors overcome P-glycoprotein-mediated resistance to temozolomide in glioblastoma</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">2598</span>– <span class="NLM_lpage">2609</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-18-0533</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=10.1158%2F1535-7163.MCT-18-0533" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=30254183" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjs1eltrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2018&pages=2598-2609&author=I.+C.+Salaroglioauthor=P.+Mujumdarauthor=L.+Annovazziauthor=J.+Kopeckaauthor=M.+Mellaiauthor=D.+Schifferauthor=S.-A.+Poulsenauthor=C.+Riganti&title=Carbonic+anhydrase+XII+inhibitors+overcome+P-glycoprotein-mediated+resistance+to+temozolomide+in+glioblastoma&doi=10.1158%2F1535-7163.MCT-18-0533"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Carbonic anhydrase XII inhibitors overcome P-glycoprotein-mediated resistance to temozolomide in glioblastoma</span></div><div class="casAuthors">Salaroglio, Iris C.; Mujumdar, Prashant; Annovazzi, Laura; Kopecka, Joanna; Mellai, Marta; Schiffer, Davide; Poulsen, Sally-Ann; Riganti, Chiara</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2598-2609</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The role of carbonic anhydrase XII (CAXII) in the chemoresistance of glioblastoma is unexplored.  We found CAXII and P-glycoprotein (Pgp) coexpressed in neurospheres derived from 3 of 3 patients with different genetic backgrounds and low response to temozolomide (time to recurrence: 6-9 mo).  CAXII was necessary for the Pgp efflux of temozolomide and second-line chemotherapeutic drugs, detg. chemoresistance in neurospheres.  Psammaplin C, a potent inhibitor of CAXII, resensitized primary neurospheres to temozolomide by reducing temozolomide efflux via Pgp.  This effect was independent of other known temozolomide resistance factors present in the patients.  The overall survival in orthotopic patient-derived xenografts of temozolomide-resistant neurospheres, rodosed with Psammaplin C and lemozolotnide, was significantly increased over temozolomide-treated (P < 0.05) and untreated animals (P < 0.02), without detectable signs of systemic toxicity.  We propose that a CAXII inhibitor in combination with temozolomide may provide a new and effective approach to reverse chemoresistance in glioblastoma stem cells.  This novel mechanism of action, via the interaction of CAXII and Pgp, ultimately blocks the efflux function of Pgp to improve glioblastoma patient outcomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDIcAWXhSfg7Vg90H21EOLACvtfcHk0ljFtGwiPizRYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjs1eltrw%253D&md5=205f8163653f1c7431068eb6301d5f78</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-18-0533&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-18-0533%26sid%3Dliteratum%253Aachs%26aulast%3DSalaroglio%26aufirst%3DI.%2BC.%26aulast%3DMujumdar%26aufirst%3DP.%26aulast%3DAnnovazzi%26aufirst%3DL.%26aulast%3DKopecka%26aufirst%3DJ.%26aulast%3DMellai%26aufirst%3DM.%26aulast%3DSchiffer%26aufirst%3DD.%26aulast%3DPoulsen%26aufirst%3DS.-A.%26aulast%3DRiganti%26aufirst%3DC.%26atitle%3DCarbonic%2520anhydrase%2520XII%2520inhibitors%2520overcome%2520P-glycoprotein-mediated%2520resistance%2520to%2520temozolomide%2520in%2520glioblastoma%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2018%26volume%3D17%26spage%3D2598%26epage%3D2609%26doi%3D10.1158%2F1535-7163.MCT-18-0533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Riganti, C.</span>; <span class="NLM_string-name">Salaroglio, I. C.</span>; <span class="NLM_string-name">Mujumdar, P.</span>; <span class="NLM_string-name">Poulsen, S.-A.</span></span> <span> </span><span class="NLM_article-title">Carbonic Anhydrase Inhibitors</span>. <span class="NLM_patent">WO 2018/204987 A1</span>, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=C.+Riganti&author=I.+C.+Salaroglio&author=P.+Mujumdar&author=S.-A.+Poulsen&title=Carbonic+Anhydrase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRiganti%26aufirst%3DC.%26atitle%3DCarbonic%2520Anhydrase%2520Inhibitors%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mujumdar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulsen, S.-A.</span></span> <span> </span><span class="NLM_article-title">Natural product primary sulfonamides and primary sulfamates</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">1470</span>– <span class="NLM_lpage">1477</span>, <span class="refDoi"> DOI: 10.1021/np501015m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np501015m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpsFartrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2015&pages=1470-1477&author=P.+Mujumdarauthor=S.-A.+Poulsen&title=Natural+product+primary+sulfonamides+and+primary+sulfamates&doi=10.1021%2Fnp501015m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Natural product primary sulfonamides and primary sulfamates</span></div><div class="casAuthors">Mujumdar, Prashant; Poulsen, Sally-Ann</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1470-1477</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">A review.  Primary sulfonamide and primary sulfamate functional groups feature prominently in the structures of U.S. FDA-approved drugs.  However, the natural product chem. space contains few examples of these well-known Zn-binding chemotypes, with just 2 primary sulfonamide and 5 primary sulfamate natural products isolated and characterized to date.  One of these natural products was isolated from a marine sponge, with the remainder isolated from Streptomyces species.  Here, are outlined for the 1st time the discovery, isolation, striking breadth of bioactivity, and total synthesis (where available) for this rare group of natural products.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotEzlMKHzLBbVg90H21EOLACvtfcHk0lgjVUGDe_sH0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpsFartrc%253D&md5=bc2d65ecf920a69108d85c65955b2427</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Fnp501015m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp501015m%26sid%3Dliteratum%253Aachs%26aulast%3DMujumdar%26aufirst%3DP.%26aulast%3DPoulsen%26aufirst%3DS.-A.%26atitle%3DNatural%2520product%2520primary%2520sulfonamides%2520and%2520primary%2520sulfamates%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2015%26volume%3D78%26spage%3D1470%26epage%3D1477%26doi%3D10.1021%2Fnp501015m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mujumdar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teruya, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tonissen, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vullo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supuran, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peat, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulsen, S.-A.</span></span> <span> </span><span class="NLM_article-title">An unusual natural product primary sulfonamide: synthesis, carbonic anhydrase inhibition, and protein X-ray structures of psammaplin C</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">5462</span>– <span class="NLM_lpage">5470</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00443</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00443" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=1%3ACAS%3A528%3ADC%252BC28XnslGjs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=5462-5470&author=P.+Mujumdarauthor=K.+Teruyaauthor=K.+F.+Tonissenauthor=D.+Vulloauthor=C.+T.+Supuranauthor=T.+S.+Peatauthor=S.-A.+Poulsen&title=An+unusual+natural+product+primary+sulfonamide%3A+synthesis%2C+carbonic+anhydrase+inhibition%2C+and+protein+X-ray+structures+of+psammaplin+C&doi=10.1021%2Facs.jmedchem.6b00443"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">An Unusual Natural Product Primary Sulfonamide: Synthesis, Carbonic Anhydrase Inhibition, and Protein X-ray Structures of Psammaplin C</span></div><div class="casAuthors">Mujumdar, Prashant; Teruya, Kanae; Tonissen, Kathryn F.; Vullo, Daniela; Supuran, Claudiu T.; Peat, Thomas S.; Poulsen, Sally-Ann</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5462-5470</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Psammaplin C (I) is one of only two described natural product primary sulfonamides.  Here we report the synthesis of psammaplin C and evaluate the inhibition profile against therapeutically relevant carbonic anhydrase (CA) zinc metalloenzymes.  The compd. exhibited unprecedented inhibition of an important cancer-assocd. isoenzyme, hCA XII, with a Ki of 0.79 nM.  The compd. also displayed good isoform selectivity for hCA XII over other CAs.  We present the first reported protein X-ray crystal structures of psammaplin C in complex with human CAs.  We engineered the easily crystd. hCA II enzyme to mimic both the hCA IX and hCA XII binding sites and then utilized protein X-ray crystallog. to det. the binding pose of psammaplin C within the hCA II, hCA IX, and hCA XII mimic active sites, all to high resoln.  This is the first time a natural product primary sulfonamide inhibitor has been assessed for inhibition and binding to CAs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJ-Lgnq0P26rVg90H21EOLACvtfcHk0lgjVUGDe_sH0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnslGjs7s%253D&md5=46f6934e7d0e393bf97130f688475d05</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00443&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00443%26sid%3Dliteratum%253Aachs%26aulast%3DMujumdar%26aufirst%3DP.%26aulast%3DTeruya%26aufirst%3DK.%26aulast%3DTonissen%26aufirst%3DK.%2BF.%26aulast%3DVullo%26aufirst%3DD.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26aulast%3DPeat%26aufirst%3DT.%2BS.%26aulast%3DPoulsen%26aufirst%3DS.-A.%26atitle%3DAn%2520unusual%2520natural%2520product%2520primary%2520sulfonamide%253A%2520synthesis%252C%2520carbonic%2520anhydrase%2520inhibition%252C%2520and%2520protein%2520X-ray%2520structures%2520of%2520psammaplin%2520C%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D5462%26epage%3D5470%26doi%3D10.1021%2Facs.jmedchem.6b00443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nicolaou, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfefferkorn, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barluenga, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roecker, A. J.</span></span> <span> </span><span class="NLM_article-title">Combinatorial synthesis through disulfide exchange: discovery of potent psammaplin A type antibacterial agents active against methicillin-resistant staphylococcus aureus (MRSA)</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">4280</span>– <span class="NLM_lpage">4295</span>, <span class="refDoi"> DOI: 10.1002/1521-3765(20011001)7:19<4280::AID-CHEM4280>3.0.CO;2-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=10.1002%2F1521-3765%2820011001%297%3A19%3C4280%3A%3AAID-CHEM4280%3E3.0.CO%3B2-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=11686609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnsFOnu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2001&pages=4280-4295&author=K.+C.+Nicolaouauthor=R.+Hughesauthor=J.+A.+Pfefferkornauthor=S.+Barluengaauthor=A.+J.+Roecker&title=Combinatorial+synthesis+through+disulfide+exchange%3A+discovery+of+potent+psammaplin+A+type+antibacterial+agents+active+against+methicillin-resistant+staphylococcus+aureus+%28MRSA%29&doi=10.1002%2F1521-3765%2820011001%297%3A19%3C4280%3A%3AAID-CHEM4280%3E3.0.CO%3B2-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Combinatorial synthesis through disulfide exchange: discovery of potent psammaplin A type antibacterial agents active against methicillin-resistant Staphylococcus aureus (MRSA)</span></div><div class="casAuthors">Nicolaou, K. C.; Hughes, Robert; Pfefferkorn, Jeffrey A.; Barluenga, Sofia; Roecker, A. J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">4280-4295</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH</span>)
        </div><div class="casAbstract">Psammaplin A is a sym. bromotyrosine-derived disulfide natural product isolated from the Psammaplysilla sponge, which exhibits in vitro antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA).  Inspired by the structure of this marine natural product, a combinatorial scrambling strategy for the construction of heterodimeric disulfide analogs was developed and applied to the construction of a 3828-membered library starting from 88 homodimeric disulfides.  These psammaplin A analogs were screened directly against various gram pos. bacterial strains leading to the discovery of a series of potent antibacterial agents active against methicillin-resistant Staphylococcus aureus (MRSA).  The present, catalytically-induced, disulfide exchange strategy may be extendable to other types of building blocks bearing thiol groups facilitating the construction of diverse discovery-oriented combinatorial libraries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6vvVgaxa2ObVg90H21EOLACvtfcHk0lgjVUGDe_sH0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnsFOnu7Y%253D&md5=691cbd6c23343a8eb50ad99cef99e493</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1002%2F1521-3765%2820011001%297%3A19%3C4280%3A%3AAID-CHEM4280%3E3.0.CO%3B2-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1521-3765%252820011001%25297%253A19%253C4280%253A%253AAID-CHEM4280%253E3.0.CO%253B2-3%26sid%3Dliteratum%253Aachs%26aulast%3DNicolaou%26aufirst%3DK.%2BC.%26aulast%3DHughes%26aufirst%3DR.%26aulast%3DPfefferkorn%26aufirst%3DJ.%2BA.%26aulast%3DBarluenga%26aufirst%3DS.%26aulast%3DRoecker%26aufirst%3DA.%2BJ.%26atitle%3DCombinatorial%2520synthesis%2520through%2520disulfide%2520exchange%253A%2520discovery%2520of%2520potent%2520psammaplin%2520A%2520type%2520antibacterial%2520agents%2520active%2520against%2520methicillin-resistant%2520staphylococcus%2520aureus%2520%2528MRSA%2529%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2001%26volume%3D7%26spage%3D4280%26epage%3D4295%26doi%3D10.1002%2F1521-3765%2820011001%297%3A19%3C4280%3A%3AAID-CHEM4280%3E3.0.CO%3B2-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baud, M. G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leiser, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer-Almes, F.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchter, M. J.</span></span> <span> </span><span class="NLM_article-title">New synthetic strategies towards psammaplin A, access to natural product analogues for biological evaluation</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">659</span>– <span class="NLM_lpage">662</span>, <span class="refDoi"> DOI: 10.1039/C0OB00824A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=10.1039%2FC0OB00824A" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2011&pages=659-662&author=M.+G.+J.+Baudauthor=T.+Leiserauthor=F.-J.+Meyer-Almesauthor=M.+J.+Fuchter&title=New+synthetic+strategies+towards+psammaplin+A%2C+access+to+natural+product+analogues+for+biological+evaluation&doi=10.1039%2FC0OB00824A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1039%2FC0OB00824A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC0OB00824A%26sid%3Dliteratum%253Aachs%26aulast%3DBaud%26aufirst%3DM.%2BG.%2BJ.%26aulast%3DLeiser%26aufirst%3DT.%26aulast%3DMeyer-Almes%26aufirst%3DF.-J.%26aulast%3DFuchter%26aufirst%3DM.%2BJ.%26atitle%3DNew%2520synthetic%2520strategies%2520towards%2520psammaplin%2520A%252C%2520access%2520to%2520natural%2520product%2520analogues%2520for%2520biological%2520evaluation%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2011%26volume%3D9%26spage%3D659%26epage%3D662%26doi%3D10.1039%2FC0OB00824A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tanpure, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peat, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornaghi, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vullo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supuran, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulsen, S.-A.</span></span> <span> </span><span class="NLM_article-title">Carbonic anhydrase inhibitors with dual-tail moieties to match the hydrophobic and hydrophilic halves of the carbonic anhydrase active site</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">1494</span>– <span class="NLM_lpage">1501</span>, <span class="refDoi"> DOI: 10.1021/jm501798g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501798g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=1%3ACAS%3A528%3ADC%252BC2MXns12nsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=1494-1501&author=R.+P.+Tanpureauthor=B.+Renauthor=T.+S.+Peatauthor=L.+F.+Bornaghiauthor=D.+Vulloauthor=C.+T.+Supuranauthor=S.-A.+Poulsen&title=Carbonic+anhydrase+inhibitors+with+dual-tail+moieties+to+match+the+hydrophobic+and+hydrophilic+halves+of+the+carbonic+anhydrase+active+site&doi=10.1021%2Fjm501798g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Carbonic Anhydrase Inhibitors with Dual-Tail Moieties To Match the Hydrophobic and Hydrophilic Halves of the Carbonic Anhydrase Active Site</span></div><div class="casAuthors">Tanpure, Rajendra P.; Ren, Bin; Peat, Thomas S.; Bornaghi, Laurent F.; Vullo, Daniela; Supuran, Claudiu T.; Poulsen, Sally-Ann</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1494-1501</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We present a new approach to carbonic anhydrase II (CA II) inhibitor design that enables close interrogation of the regions of the CA active site where there is the greatest variability in amino acid residues among the different CA isoenzymes.  By appending dual tail groups onto the par excellence CA inhibitor acetazolamide, compds. that may interact with the distinct hydrophobic and hydrophilic halves of the CA II active site were prepd.  The dual-tail combinations selected included (i) two hydrophobic moieties, (ii) two hydrophilic moieties, and (iii) one hydrophobic and one hydrophilic moiety.  The CA enzyme inhibition profile as well as the protein X-ray crystal structure of compd. 3, comprising one hydrophobic and one hydrophilic tail moiety, in complex with CA II is described.  This novel dual-tail approach has provided an enhanced opportunity to more fully exploit interactions with the CA active site by enabling these mols. to interact with the distinct halves of the active site.  In addn. to the dual-tail compds., a corresponding set of single-tail derivs. was synthesized, enabling a comparative anal. of the single-tail vs. dual-tail compd. CA inhibition profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQo8V_UTRKTLVg90H21EOLACvtfcHk0lie0ZjcPcfMbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXns12nsg%253D%253D&md5=ffaa9d1f27d04638bece79430e9ba663</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm501798g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501798g%26sid%3Dliteratum%253Aachs%26aulast%3DTanpure%26aufirst%3DR.%2BP.%26aulast%3DRen%26aufirst%3DB.%26aulast%3DPeat%26aufirst%3DT.%2BS.%26aulast%3DBornaghi%26aufirst%3DL.%2BF.%26aulast%3DVullo%26aufirst%3DD.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26aulast%3DPoulsen%26aufirst%3DS.-A.%26atitle%3DCarbonic%2520anhydrase%2520inhibitors%2520with%2520dual-tail%2520moieties%2520to%2520match%2520the%2520hydrophobic%2520and%2520hydrophilic%2520halves%2520of%2520the%2520carbonic%2520anhydrase%2520active%2520site%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D1494%26epage%3D1501%26doi%3D10.1021%2Fjm501798g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanessian, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liak, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanasse, B.</span></span> <span> </span><span class="NLM_article-title">Facile cleavage of benzyl ethers by catalytic transfer hydrogenation</span>. <i>Synthesis</i> <span class="NLM_year" style="font-weight: bold;">1981</span>,  <span class="NLM_volume"><i>1981</i></span>,  <span class="NLM_fpage">396</span>– <span class="NLM_lpage">397</span>, <span class="refDoi"> DOI: 10.1055/s-1981-29467</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=10.1055%2Fs-1981-29467" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1981&publication_year=1981&pages=396-397&author=S.+Hanessianauthor=T.+J.+Liakauthor=B.+Vanasse&title=Facile+cleavage+of+benzyl+ethers+by+catalytic+transfer+hydrogenation&doi=10.1055%2Fs-1981-29467"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1055%2Fs-1981-29467&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1981-29467%26sid%3Dliteratum%253Aachs%26aulast%3DHanessian%26aufirst%3DS.%26aulast%3DLiak%26aufirst%3DT.%2BJ.%26aulast%3DVanasse%26aufirst%3DB.%26atitle%3DFacile%2520cleavage%2520of%2520benzyl%2520ethers%2520by%2520catalytic%2520transfer%2520hydrogenation%26jtitle%3DSynthesis%26date%3D1981%26volume%3D1981%26spage%3D396%26epage%3D397%26doi%3D10.1055%2Fs-1981-29467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prasad, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slade, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clemens, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Repič, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blacklock, T. J.</span></span> <span> </span><span class="NLM_article-title">New trends in palladium-catalyzed transfer hydrogenations using formic acid</span>. <i>Adv. Synth. Catal.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>347</i></span>,  <span class="NLM_fpage">1769</span>– <span class="NLM_lpage">1773</span>, <span class="refDoi"> DOI: 10.1002/adsc.200505132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=10.1002%2Fadsc.200505132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1OgtrvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2005&pages=1769-1773&author=K.+Prasadauthor=X.+Jiangauthor=J.+S.+Sladeauthor=J.+Clemensauthor=O.+Repi%C4%8Dauthor=T.+J.+Blacklock&title=New+trends+in+palladium-catalyzed+transfer+hydrogenations+using+formic+acid&doi=10.1002%2Fadsc.200505132"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">New trends in palladium-catalyzed transfer hydrogenations using formic acid</span></div><div class="casAuthors">Prasad, Kapa; Jiang, Xinglong; Slade, Joel S.; Clemens, Jennifer; Repic, Oljan; Blacklock, Thomas J.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Synthesis & Catalysis</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1769-1773</span>CODEN:
                <span class="NLM_cas:coden">ASCAF7</span>;
        ISSN:<span class="NLM_cas:issn">1615-4150</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">In the presence of a catalytic amt. of org. bases, Pd-catalyzed transfer hydrogenations with formic acid are facile processes.  These new conditions produce innocuous CO2 as the byproduct compared to the use of ammonium formate, which generates NH3 and CO2 as gaseous byproducts which recombine to create unsafe conditions.  Examples include nitro-to-amino conversion of 4-(3-methoxy-4-nitrophenyl)morpholine and 1-(3-methoxy-4-nitrophenyl)-4-methylpiperazine, N-deprotection of (2S)-N-(5-fluoropyridin-2-yl)-1-(benzyloxycarbonyl)pyrrolidine-2-carboxamide, deesterification of benzyl (2R)-(trans-4-propoxycyclohexyl)[[(4-ethoxyphenyl)sulfonyl][(pyridin-4-yl)methyl]amino]acetate and didebenzylation of [cis-3-(dibenzylamino)cyclobutyl]methyl benzoate.  When the substrate is basic enough to form salts with formic acid, no addnl. base is necessary.  In certain cases, the product of the reaction was used to accelerate the transfer hydrogenation process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhFz9e0ubUK7Vg90H21EOLACvtfcHk0lie0ZjcPcfMbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1OgtrvK&md5=4169b7fded09e1af4f9212c4377dffe6</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1002%2Fadsc.200505132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fadsc.200505132%26sid%3Dliteratum%253Aachs%26aulast%3DPrasad%26aufirst%3DK.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DSlade%26aufirst%3DJ.%2BS.%26aulast%3DClemens%26aufirst%3DJ.%26aulast%3DRepi%25C4%258D%26aufirst%3DO.%26aulast%3DBlacklock%26aufirst%3DT.%2BJ.%26atitle%3DNew%2520trends%2520in%2520palladium-catalyzed%2520transfer%2520hydrogenations%2520using%2520formic%2520acid%26jtitle%3DAdv.%2520Synth.%2520Catal.%26date%3D2005%26volume%3D347%26spage%3D1769%26epage%3D1773%26doi%3D10.1002%2Fadsc.200505132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morimoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adachi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kashimura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asaka, T.</span></span> <span> </span><span class="NLM_article-title">Chemical modification of erythromycins IX. selective methylation at the C-6 hydroxyl group of erythromycin A oxime derivatives and preparation of clarithromycin</span>. <i>J. Antibiot.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">647</span>– <span class="NLM_lpage">660</span>, <span class="refDoi"> DOI: 10.7164/antibiotics.46.647</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=10.7164%2Fantibiotics.46.647" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1993&pages=647-660&author=Y.+Watanabeauthor=S.+Morimotoauthor=T.+Adachiauthor=M.+Kashimuraauthor=T.+Asaka&title=Chemical+modification+of+erythromycins+IX.+selective+methylation+at+the+C-6+hydroxyl+group+of+erythromycin+A+oxime+derivatives+and+preparation+of+clarithromycin&doi=10.7164%2Fantibiotics.46.647"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.7164%2Fantibiotics.46.647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7164%252Fantibiotics.46.647%26sid%3Dliteratum%253Aachs%26aulast%3DWatanabe%26aufirst%3DY.%26aulast%3DMorimoto%26aufirst%3DS.%26aulast%3DAdachi%26aufirst%3DT.%26aulast%3DKashimura%26aufirst%3DM.%26aulast%3DAsaka%26aufirst%3DT.%26atitle%3DChemical%2520modification%2520of%2520erythromycins%2520IX.%2520selective%2520methylation%2520at%2520the%2520C-6%2520hydroxyl%2520group%2520of%2520erythromycin%2520A%2520oxime%2520derivatives%2520and%2520preparation%2520of%2520clarithromycin%26jtitle%3DJ.%2520Antibiot.%26date%3D1993%26volume%3D46%26spage%3D647%26epage%3D660%26doi%3D10.7164%2Fantibiotics.46.647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murakata, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoshino, O.</span></span> <span> </span><span class="NLM_article-title">Asymmetric oxidative cyclization of <i>o</i>-phenolic oxime-esters: first synthesis of enantiomerically enriched spiroisoxazoline methyl esters</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">4428</span>– <span class="NLM_lpage">4433</span>, <span class="refDoi"> DOI: 10.1021/jo970082i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo970082i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=1%3ACAS%3A528%3ADyaK2sXjvVSqtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1997&pages=4428-4433&author=M.+Murakataauthor=M.+Tamuraauthor=O.+Hoshino&title=Asymmetric+oxidative+cyclization+of+o-phenolic+oxime-esters%3A+first+synthesis+of+enantiomerically+enriched+spiroisoxazoline+methyl+esters&doi=10.1021%2Fjo970082i"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Asymmetric Oxidative Cyclization of o-Phenolic Oxime-Esters: First Synthesis of Enantiomerically Enriched Spiroisoxazoline Methyl Esters</span></div><div class="casAuthors">Murakata, Masatoshi; Tamura, Masafumi; Hoshino, Osamu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4428-4433</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new method for the synthesis of enantiomerically enriched cyclohexadienonespiroisoxazoline (-)-I [R = OMe] has been described.  Asym. intramol. oxidative cyclization of the o-phenolic oxime-ester II using a novel optically active tertiary alc., R1OH, as a chiral auxiliary proceeded smoothly to afford I [R = OR1] in 83% yield.  R1OH was synthesized from (1S*,8R*,9R*,10R*)-8-phenyl-1-decalol by optical resoln.  Removal of the chiral auxiliary in I [R = OR1] with CF3CO2H followed by methylation gave I [R = OMe] in 74% ee (71% chem. yield).  The abs. configuration of I [R = OMe] was detd. by the synthesis of the marine natural product (+)-aerothionin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzS_EFJSBiBbVg90H21EOLACvtfcHk0lhYZnxYAmRMew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjvVSqtrw%253D&md5=8d94166a6bea81da9f6b895517163042</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjo970082i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo970082i%26sid%3Dliteratum%253Aachs%26aulast%3DMurakata%26aufirst%3DM.%26aulast%3DTamura%26aufirst%3DM.%26aulast%3DHoshino%26aufirst%3DO.%26atitle%3DAsymmetric%2520oxidative%2520cyclization%2520of%2520o-phenolic%2520oxime-esters%253A%2520first%2520synthesis%2520of%2520enantiomerically%2520enriched%2520spiroisoxazoline%2520methyl%2520esters%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1997%26volume%3D62%26spage%3D4428%26epage%3D4433%26doi%3D10.1021%2Fjo970082i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kottakota, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benton, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evangelopoulos, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhakta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McHugh, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groundwater, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marrs, E. C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harburn, J. J.</span></span> <span> </span><span class="NLM_article-title">Versatile routes to marine sponge metabolites through benzylidene rhodanines</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">6310</span>– <span class="NLM_lpage">6313</span>, <span class="refDoi"> DOI: 10.1021/ol303057a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol303057a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=6310-6313&author=S.+K.+Kottakotaauthor=M.+Bentonauthor=D.+Evangelopoulosauthor=J.+D.+Guzmanauthor=S.+Bhaktaauthor=T.+D.+McHughauthor=M.+Grayauthor=P.+W.+Groundwaterauthor=E.+C.+L.+Marrsauthor=J.+D.+Perryauthor=J.+J.+Harburn&title=Versatile+routes+to+marine+sponge+metabolites+through+benzylidene+rhodanines&doi=10.1021%2Fol303057a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fol303057a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol303057a%26sid%3Dliteratum%253Aachs%26aulast%3DKottakota%26aufirst%3DS.%2BK.%26aulast%3DBenton%26aufirst%3DM.%26aulast%3DEvangelopoulos%26aufirst%3DD.%26aulast%3DGuzman%26aufirst%3DJ.%2BD.%26aulast%3DBhakta%26aufirst%3DS.%26aulast%3DMcHugh%26aufirst%3DT.%2BD.%26aulast%3DGray%26aufirst%3DM.%26aulast%3DGroundwater%26aufirst%3DP.%2BW.%26aulast%3DMarrs%26aufirst%3DE.%2BC.%2BL.%26aulast%3DPerry%26aufirst%3DJ.%2BD.%26aulast%3DHarburn%26aufirst%3DJ.%2BJ.%26atitle%3DVersatile%2520routes%2520to%2520marine%2520sponge%2520metabolites%2520through%2520benzylidene%2520rhodanines%26jtitle%3DOrg.%2520Lett.%26date%3D2012%26volume%3D14%26spage%3D6310%26epage%3D6313%26doi%3D10.1021%2Fol303057a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Olah, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narang, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, B. G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malhotra, R.</span></span> <span> </span><span class="NLM_article-title">Synthetic methods and reactions. 62. transformations with chlorotrimethylsilane/sodium iodide, a convenient in situ iodotrimethylsilane reagent</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1979</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">1247</span>– <span class="NLM_lpage">1251</span>, <span class="refDoi"> DOI: 10.1021/jo01322a012</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo01322a012" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=1%3ACAS%3A528%3ADyaE1MXhs1yltLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1979&pages=1247-1251&author=G.+A.+Olahauthor=S.+C.+Narangauthor=B.+G.+B.+Guptaauthor=R.+Malhotra&title=Synthetic+methods+and+reactions.+62.+transformations+with+chlorotrimethylsilane%2Fsodium+iodide%2C+a+convenient+in+situ+iodotrimethylsilane+reagent&doi=10.1021%2Fjo01322a012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic methods and reactions.  62.  Transformations with chlorotrimethylsilane/sodium iodide, a convenient in situ iodotrimethylsilane reagent</span></div><div class="casAuthors">Olah, George A.; Narang, Subhash C.; Gupta, B. G. Balaram; Malhotra, Ripudaman</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1247-51</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">A new, convenient, inexpensive alternative to Me3SiI reagent is explored.  A mixt. of Me3SiCl-NaI in MeCN is a better reagent than Me3SiI for the cleavage of esters, lactones, carbamates and ethers.  Cleavage of esters and lactones (10 examples) occurred somewhat slower with the present system than with Me3SiI.  On the other hand, ethers (7 examples) cleaved much more readily with the present system.  A feasible mechanism is proposed for this disparity.  Carbamates (6 examples) also underwent facile cleavage to give the corresponding amines.  The general applicability of the method was shown using various types of substrates.  The facile conversion of alcs. to iodides using the present method is also reported.  Conversion of alcs. to iodides is much faster with Me3SiCl-NaI than with Me3SiI, and iodides are formed in excellent yield.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeVBGIYr12XLVg90H21EOLACvtfcHk0lhYZnxYAmRMew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1MXhs1yltLo%253D&md5=b392acf5b7cfd15c06b48afea62cfc21</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjo01322a012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01322a012%26sid%3Dliteratum%253Aachs%26aulast%3DOlah%26aufirst%3DG.%2BA.%26aulast%3DNarang%26aufirst%3DS.%2BC.%26aulast%3DGupta%26aufirst%3DB.%2BG.%2BB.%26aulast%3DMalhotra%26aufirst%3DR.%26atitle%3DSynthetic%2520methods%2520and%2520reactions.%252062.%2520transformations%2520with%2520chlorotrimethylsilane%252Fsodium%2520iodide%252C%2520a%2520convenient%2520in%2520situ%2520iodotrimethylsilane%2520reagent%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1979%26volume%3D44%26spage%3D1247%26epage%3D1251%26doi%3D10.1021%2Fjo01322a012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akiyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirofuji, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozaki, S.</span></span> <span> </span><span class="NLM_article-title">AlCl<sub>3</sub>-<i>N</i>,<i>N</i>-dimethylaniline: a new benzyl and allyl ether cleavage reagent</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">1321</span>– <span class="NLM_lpage">1324</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(00)79656-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=10.1016%2FS0040-4039%2800%2979656-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1991&pages=1321-1324&author=T.+Akiyamaauthor=H.+Hirofujiauthor=S.+Ozaki&title=AlCl3-N%2CN-dimethylaniline%3A+a+new+benzyl+and+allyl+ether+cleavage+reagent&doi=10.1016%2FS0040-4039%2800%2979656-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2800%2979656-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252800%252979656-0%26sid%3Dliteratum%253Aachs%26aulast%3DAkiyama%26aufirst%3DT.%26aulast%3DHirofuji%26aufirst%3DH.%26aulast%3DOzaki%26aufirst%3DS.%26atitle%3DAlCl3-N%252CN-dimethylaniline%253A%2520a%2520new%2520benzyl%2520and%2520allyl%2520ether%2520cleavage%2520reagent%26jtitle%3DTetrahedron%2520Lett.%26date%3D1991%26volume%3D32%26spage%3D1321%26epage%3D1324%26doi%3D10.1016%2FS0040-4039%2800%2979656-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fletcher, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunning, P. T.</span></span> <span> </span><span class="NLM_article-title">Mild, efficient and rapid <i>O</i>-debenzylation of <i>ortho</i>-substituted phenols with trifluoroacetic acid</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">4817</span>– <span class="NLM_lpage">4819</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2008.06.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=10.1016%2Fj.tetlet.2008.06.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=1%3ACAS%3A528%3ADC%252BD1cXotFehuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2008&pages=4817-4819&author=S.+Fletcherauthor=P.+T.+Gunning&title=Mild%2C+efficient+and+rapid+O-debenzylation+of+ortho-substituted+phenols+with+trifluoroacetic+acid&doi=10.1016%2Fj.tetlet.2008.06.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Mild, efficient and rapid O-debenzylation of ortho-substituted phenols with trifluoroacetic acid</span></div><div class="casAuthors">Fletcher, Steven; Gunning, Patrick T.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">4817-4819</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The mild and efficient deblocking of aryl benzyl ethers with TFA is reported.  Cleavage was fastest with ortho-electron-withdrawing groups on the phenolic ring, which was attributed to a proton chelation effect, furnishing the deprotected phenols in excellent yields.  The corresponding 4-methoxybenzyl, allyl, and iso-Pr ethers were also cleanly removed under these conditions.  In addn., the selective aryl benzyl ether debenzylation in the presence of benzyl ester, Cbz carbamate, and Boc carbamate functionalities was also obsd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptgd_Cyfonp7Vg90H21EOLACvtfcHk0li_oLPBgt8lDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXotFehuro%253D&md5=11569899fcd5bbf68234091890c06179</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2008.06.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2008.06.022%26sid%3Dliteratum%253Aachs%26aulast%3DFletcher%26aufirst%3DS.%26aulast%3DGunning%26aufirst%3DP.%2BT.%26atitle%3DMild%252C%2520efficient%2520and%2520rapid%2520O-debenzylation%2520of%2520ortho-substituted%2520phenols%2520with%2520trifluoroacetic%2520acid%26jtitle%3DTetrahedron%2520Lett.%26date%3D2008%26volume%3D49%26spage%3D4817%26epage%3D4819%26doi%3D10.1016%2Fj.tetlet.2008.06.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vankar, Y. D.</span></span> <span> </span><span class="NLM_article-title">A one-pot selective deprotective acetylation of benzyl ethers and OTBDMS ethers using the BF<sub>3</sub>·Et<sub>2</sub>O–NaI–Ac<sub>2</sub>O reagent system</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">5207</span>– <span class="NLM_lpage">5210</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2006.05.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=10.1016%2Fj.tetlet.2006.05.016" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2006&pages=5207-5210&author=A.+Brarauthor=Y.+D.+Vankar&title=A+one-pot+selective+deprotective+acetylation+of+benzyl+ethers+and+OTBDMS+ethers+using+the+BF3%C2%B7Et2O%E2%80%93NaI%E2%80%93Ac2O+reagent+system&doi=10.1016%2Fj.tetlet.2006.05.016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2006.05.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2006.05.016%26sid%3Dliteratum%253Aachs%26aulast%3DBrar%26aufirst%3DA.%26aulast%3DVankar%26aufirst%3DY.%2BD.%26atitle%3DA%2520one-pot%2520selective%2520deprotective%2520acetylation%2520of%2520benzyl%2520ethers%2520and%2520OTBDMS%2520ethers%2520using%2520the%2520BF3%25C2%25B7Et2O%25E2%2580%2593NaI%25E2%2580%2593Ac2O%2520reagent%2520system%26jtitle%3DTetrahedron%2520Lett.%26date%3D2006%26volume%3D47%26spage%3D5207%26epage%3D5210%26doi%3D10.1016%2Fj.tetlet.2006.05.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujino, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doi, T.</span></span> <span> </span><span class="NLM_article-title">A concise total synthesis of biologically active frutinones via tributylphosphine-catalyzed tandem acyl transfer-cyclization</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">3452</span>– <span class="NLM_lpage">3458</span>, <span class="refDoi"> DOI: 10.1016/j.tet.2014.03.073</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=10.1016%2Fj.tet.2014.03.073" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmtFWjt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2014&pages=3452-3458&author=M.+Yoshidaauthor=K.+Saitoauthor=Y.+Fujinoauthor=T.+Doi&title=A+concise+total+synthesis+of+biologically+active+frutinones+via+tributylphosphine-catalyzed+tandem+acyl+transfer-cyclization&doi=10.1016%2Fj.tet.2014.03.073"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">A concise total synthesis of biologically active frutinones via tributylphosphine-catalyzed tandem acyl transfer-cyclization</span></div><div class="casAuthors">Yoshida, Masahito; Saito, Koya; Fujino, Yuta; Doi, Takayuki</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">3452-3458</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A concise and step-economical total synthesis of biol. active frutinones has been achieved.  Tributylphosphine (PBu3) efficiently induced the tandem acyl transfer-cyclization of carbonates I (R1 = R2 = H; R1 = H, R2 = OMe; R1 = OTHP, R2 = H) to afford 3-(methoxycarbonyl)flavone derivs. II in excellent yields.  Finally, concomitant deprotection and lactonization under acidic conditions furnished the desired frutinones A, B, and the proposed structure of frutinone C, III, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8gYBYGBhIXbVg90H21EOLACvtfcHk0li_oLPBgt8lDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmtFWjt7g%253D&md5=0df799c5a4d246eddf546f08dd30ae44</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2014.03.073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2014.03.073%26sid%3Dliteratum%253Aachs%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DSaito%26aufirst%3DK.%26aulast%3DFujino%26aufirst%3DY.%26aulast%3DDoi%26aufirst%3DT.%26atitle%3DA%2520concise%2520total%2520synthesis%2520of%2520biologically%2520active%2520frutinones%2520via%2520tributylphosphine-catalyzed%2520tandem%2520acyl%2520transfer-cyclization%26jtitle%3DTetrahedron%26date%3D2014%26volume%3D70%26spage%3D3452%26epage%3D3458%26doi%3D10.1016%2Fj.tet.2014.03.073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Auffinger, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pytel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, A. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesniak, M. S.</span></span> <span> </span><span class="NLM_article-title">The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence AU - Auffinger, Brenda</span>. <i>Expert Rev. Neurother.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">741</span>– <span class="NLM_lpage">752</span>, <span class="refDoi"> DOI: 10.1586/14737175.2015.1051968</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=10.1586%2F14737175.2015.1051968" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=26027432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVKntbfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=741-752&author=B.+Auffingerauthor=D.+Spencerauthor=P.+Pytelauthor=A.+U.+Ahmedauthor=M.+S.+Lesniak&title=The+role+of+glioma+stem+cells+in+chemotherapy+resistance+and+glioblastoma+multiforme+recurrence+AU+-+Auffinger%2C+Brenda&doi=10.1586%2F14737175.2015.1051968"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence</span></div><div class="casAuthors">Auffinger, Brenda; Spencer, Drew; Pytel, Peter; Ahmed, Atique U.; Lesniak, Maciej S.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Neurotherapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">741-752</span>CODEN:
                <span class="NLM_cas:coden">ERNXAR</span>;
        ISSN:<span class="NLM_cas:issn">1473-7175</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Glioma stem cells (GSCs) constitute a slow-dividing, small population within a heterogeneous glioblastoma.  They are able to self-renew, recapitulate a whole tumor, and differentiate into other specific glioblastoma multiforme (GBM) subpopulations.  Therefore, they have been held responsible for malignant relapse after primary std. therapy and the poor prognosis of recurrent GBM.  The failure of current therapies to eliminate specific GSC subpopulations has been considered a major factor contributing to the inevitable recurrence in GBM patients after treatment.  Here, we discuss the mol. mechanisms of chemoresistance of GSCs and the reasons why complete eradication of GSCs is so difficult to achieve.  We will also describe the targeted therapies currently available for GSCs and possible mechanisms to overcome such chemoresistance and avoid therapeutic relapse.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsdXouJjY2qrVg90H21EOLACvtfcHk0li_oLPBgt8lDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVKntbfI&md5=b6bd28f8916f99ef3813999ee111fddc</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1586%2F14737175.2015.1051968&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F14737175.2015.1051968%26sid%3Dliteratum%253Aachs%26aulast%3DAuffinger%26aufirst%3DB.%26aulast%3DSpencer%26aufirst%3DD.%26aulast%3DPytel%26aufirst%3DP.%26aulast%3DAhmed%26aufirst%3DA.%2BU.%26aulast%3DLesniak%26aufirst%3DM.%2BS.%26atitle%3DThe%2520role%2520of%2520glioma%2520stem%2520cells%2520in%2520chemotherapy%2520resistance%2520and%2520glioblastoma%2520multiforme%2520recurrence%2520AU%2520-%2520Auffinger%252C%2520Brenda%26jtitle%3DExpert%2520Rev.%2520Neurother.%26date%3D2015%26volume%3D15%26spage%3D741%26epage%3D752%26doi%3D10.1586%2F14737175.2015.1051968" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bosia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghigo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiffer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salaroglio, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campia, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopecka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Annovazzi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mellai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldera, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riganti, C.</span></span> <span> </span><span class="NLM_article-title">Temozolomide downregulates P-glycoprotein expression in glioblastoma stem cells by interfering with the Wnt3a/glycogen synthase-3 kinase/β-catenin pathway</span>. <i>Neuro-Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1502</span>– <span class="NLM_lpage">1517</span>, <span class="refDoi"> DOI: 10.1093/neuonc/not104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=10.1093%2Fneuonc%2Fnot104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=23897632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslWqsbzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=1502-1517&author=A.+Bosiaauthor=D.+Ghigoauthor=D.+Schifferauthor=I.+C.+Salaroglioauthor=I.+Campiaauthor=J.+Kopeckaauthor=L.+Annovazziauthor=M.+Mellaiauthor=V.+Calderaauthor=C.+Riganti&title=Temozolomide+downregulates+P-glycoprotein+expression+in+glioblastoma+stem+cells+by+interfering+with+the+Wnt3a%2Fglycogen+synthase-3+kinase%2F%CE%B2-catenin+pathway&doi=10.1093%2Fneuonc%2Fnot104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Temozolomide downregulates P-glycoprotein expression in glioblastoma stem cells by interfering with the Wnt3a/glycogen synthase-3 kinase/β-catenin pathway</span></div><div class="casAuthors">Riganti, Chiara; Salaroglio, Iris Chiara; Caldera, Valentina; Campia, Ivana; Kopecka, Joanna; Mellai, Marta; Annovazzi, Laura; Bosia, Amalia; Ghigo, Dario; Schiffer, Davide</div><div class="citationInfo"><span class="NLM_cas:title">Neuro-Oncology (Cary, NC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1502-1517</span>CODEN:
                <span class="NLM_cas:coden">NEURJR</span>;
        ISSN:<span class="NLM_cas:issn">1522-8517</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background: Glioblastoma multiforme stem cells display a highly chemoresistant phenotype, whose mol. basis is poorly known.  We aim to clarify this issue and to investigate the effects of temozolomide on chemoresistant stem cells.  Methods: A panel of human glioblastoma cultures, grown as stem cells (neurospheres) and adherent cells, was used.  Results Neurospheres had a multidrug resistant phenotype compared with adherent cells.  Such chemoresistance was overcome by apparently noncytotoxic doses of temozolomide, which chemosensitized glioblastoma cells to doxorubicin, vinblastine, and etoposide.  This effect was selective for P-glycoprotein (Pgp) substrates and for stem cells, leading to an investigation of whether there was a correlation between the expression of Pgp and the activity of typical stemness pathways.  We found that Wnt3a and ABCB1, which encodes for Pgp, were both highly expressed in glioblastoma stem cells and reduced by temozolomide.  Temozolomide-treated cells had increased methylation of the cytosine-phosphate-guanine islands in the Wnt3a gene promoter, decreased expression of Wnt3a, disrupted glycogen synthase-3 kinase/β-catenin axis, reduced transcriptional activation of ABCB1, and a lower amt. and activity of Pgp.  Wnt3a overexpression was sufficient to transform adherent cells into neurospheres and to simultaneously increase proliferation and ABCB1 expression.  On the contrary, glioblastoma stem cells silenced for Wnt3a lost the ability to form neurospheres and reduced at the same time the proliferation rate and ABCB1 levels.  Conclusions: Our work suggests that Wnt3a is an autocrine mediator of stemness, proliferation, and chemoresistance in human glioblastoma and that temozolomide may chemosensitize the stem cell population by downregulating Wnt3a signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAuefnXFCx4bVg90H21EOLACvtfcHk0lge9yMexto4sA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslWqsbzF&md5=f310d3cb5a5da76b8cbc9f479a41eb51</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1093%2Fneuonc%2Fnot104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fneuonc%252Fnot104%26sid%3Dliteratum%253Aachs%26aulast%3DBosia%26aufirst%3DA.%26aulast%3DGhigo%26aufirst%3DD.%26aulast%3DSchiffer%26aufirst%3DD.%26aulast%3DSalaroglio%26aufirst%3DI.%2BC.%26aulast%3DCampia%26aufirst%3DI.%26aulast%3DKopecka%26aufirst%3DJ.%26aulast%3DAnnovazzi%26aufirst%3DL.%26aulast%3DMellai%26aufirst%3DM.%26aulast%3DCaldera%26aufirst%3DV.%26aulast%3DRiganti%26aufirst%3DC.%26atitle%3DTemozolomide%2520downregulates%2520P-glycoprotein%2520expression%2520in%2520glioblastoma%2520stem%2520cells%2520by%2520interfering%2520with%2520the%2520Wnt3a%252Fglycogen%2520synthase-3%2520kinase%252F%25CE%25B2-catenin%2520pathway%26jtitle%3DNeuro-Oncol.%26date%3D2013%26volume%3D15%26spage%3D1502%26epage%3D1517%26doi%3D10.1093%2Fneuonc%2Fnot104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gottesman, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fojo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bates, S. E.</span></span> <span> </span><span class="NLM_article-title">Multidrug resistance in cancer: role of ATP-dependent transporters</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">48</span>– <span class="NLM_lpage">58</span>, <span class="refDoi"> DOI: 10.1038/nrc706</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=10.1038%2Fnrc706" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=11902585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=1%3ACAS%3A528%3ADC%252BD38XhvF2jtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=48-58&author=M.+M.+Gottesmanauthor=T.+Fojoauthor=S.+E.+Bates&title=Multidrug+resistance+in+cancer%3A+role+of+ATP-dependent+transporters&doi=10.1038%2Fnrc706"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Multidrug resistance in cancer: role of ATP-dependent transporters</span></div><div class="casAuthors">Gottesman, Michael M.; Fojo, Tito; Bates, Susan E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">48-58</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Chemotherapeutics are the most effective treatment for metastatic tumors.  However, the ability of cancer cells to become simultaneously resistant to different drugs, a trait known as multidrug resistance, remains a significant impediment to successful chemotherapy.  Three decades of multidrug-resistance research have identified a myriad of ways in which cancer cells can elude chemotherapy, and it has become apparent that resistance exists against every effective drug, even our newest agents.  Therefore, the ability to predict and circumvent drug resistance is likely to improve chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRJtnCZv-ZtrVg90H21EOLACvtfcHk0lge9yMexto4sA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhvF2jtL8%253D&md5=ec5284e1fe4a878c5ffc30ee83bccc9d</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fnrc706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc706%26sid%3Dliteratum%253Aachs%26aulast%3DGottesman%26aufirst%3DM.%2BM.%26aulast%3DFojo%26aufirst%3DT.%26aulast%3DBates%26aufirst%3DS.%2BE.%26atitle%3DMultidrug%2520resistance%2520in%2520cancer%253A%2520role%2520of%2520ATP-dependent%2520transporters%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2002%26volume%3D2%26spage%3D48%26epage%3D58%26doi%3D10.1038%2Fnrc706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Munoz, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scotto, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rameshwar, P.</span></span> <span> </span><span class="NLM_article-title">Temozolomide competes for P-glycoprotein and contributes to chemoresistance in glioblastoma cells</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>367</i></span>,  <span class="NLM_fpage">69</span>– <span class="NLM_lpage">75</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2015.07.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=10.1016%2Fj.canlet.2015.07.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=26208431" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1amsb%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=367&publication_year=2015&pages=69-75&author=J.+L.+Munozauthor=N.+D.+Walkerauthor=K.+W.+Scottoauthor=P.+Rameshwar&title=Temozolomide+competes+for+P-glycoprotein+and+contributes+to+chemoresistance+in+glioblastoma+cells&doi=10.1016%2Fj.canlet.2015.07.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Temozolomide competes for P-glycoprotein and contributes to chemoresistance in glioblastoma cells</span></div><div class="casAuthors">Munoz, Jessian L.; Walker, Nykia D.; Scotto, Kathleen W.; Rameshwar, Pranela</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">367</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">69-75</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Chemotherapeutic resistance can occur by P-glycoprotein (P-gp), a 12-transmembrane ATP-dependent drug efflux pump.  Glioblastoma (GBM) has poor survival rate and uniformly acquired chemoresistance to its frontline agent, Temozolomide (TMZ).  Despite much effort, overcoming TMZ resistance remains a challenge.  We reported on autonomous induction of TMZ resistance by increased transcription MDR1, the gene for P-gp.  This study investigated how P-gp and TMZ interact to gain resistance.  Using an exptl. model of Adriamycin-resistant DC3F cells (DC3F/Adx), we showed that increased P-gp caused TMZ resistance.  Increasing concns. of TMZ competed with Calcein for P-gp, resulting in reduced efflux in the DC3F/Adx cells.  Three different inhibitors of P-gp reversed the resistance to TMZ in two different GBM cell lines, by increasing active Caspase 3.  Mol. modeling predicted the binding sites to be the intracellular region of P-gp and also identified specific amino acids and kinetics of energy for the efflux of TMZ.  Taken together, we confirmed P-gp targeting of TMZ, a crucial regulator of TMZ resistance in GBM.  This study provides insights on the effectiveness by which TMZ competes with other P-gp substrates, thereby opening the door for combined targeted therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoE7c_rrAe1XrVg90H21EOLACvtfcHk0lge9yMexto4sA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1amsb%252FE&md5=a1f74f27ab415df04ec4acfcf1e3b367</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2015.07.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2015.07.013%26sid%3Dliteratum%253Aachs%26aulast%3DMunoz%26aufirst%3DJ.%2BL.%26aulast%3DWalker%26aufirst%3DN.%2BD.%26aulast%3DScotto%26aufirst%3DK.%2BW.%26aulast%3DRameshwar%26aufirst%3DP.%26atitle%3DTemozolomide%2520competes%2520for%2520P-glycoprotein%2520and%2520contributes%2520to%2520chemoresistance%2520in%2520glioblastoma%2520cells%26jtitle%3DCancer%2520Lett.%26date%3D2015%26volume%3D367%26spage%3D69%26epage%3D75%26doi%3D10.1016%2Fj.canlet.2015.07.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robey, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pluchino, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fojo, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bates, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gottesman, M. M.</span></span> <span> </span><span class="NLM_article-title">Revisiting the role of ABC transporters in multidrug-resistant cancer</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">452</span>– <span class="NLM_lpage">464</span>, <span class="refDoi"> DOI: 10.1038/s41568-018-0005-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=10.1038%2Fs41568-018-0005-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=29643473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=1%3ACAS%3A528%3ADC%252BC1cXosVCgt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2018&pages=452-464&author=R.+W.+Robeyauthor=K.+M.+Pluchinoauthor=M.+D.+Hallauthor=A.+T.+Fojoauthor=S.+E.+Batesauthor=M.+M.+Gottesman&title=Revisiting+the+role+of+ABC+transporters+in+multidrug-resistant+cancer&doi=10.1038%2Fs41568-018-0005-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Revisiting the role of ABC transporters in multidrug-resistant cancer</span></div><div class="casAuthors">Robey, Robert W.; Pluchino, Kristen M.; Hall, Matthew D.; Fojo, Antonio T.; Bates, Susan E.; Gottesman, Michael M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">452-464</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">A review.  Most patients who die of cancer have disseminated disease that has become resistant to multiple therapeutic modalities.  Ample evidence suggests that the expression of ATP-binding cassette (ABC) transporters, esp. the multidrug resistance protein 1 (MDR1, also known as P-glycoprotein or P-gp), which is encoded by ABC subfamily B member 1 (ABCB1), can confer resistance to cytotoxic and targeted chemotherapy.  However, the development of MDR1 as a therapeutic target has been unsuccessful.  At the time of its discovery, appropriate tools for the characterization and clin. development of MDR1 as a therapeutic target were lacking.  Thirty years after the initial cloning and characterization of MDR1 and the implication of two addnl. ABC transporters, the multidrug resistance-assocd. protein 1 (MRP1; encoded by ABCC1)), and ABCG2, in multidrug resistance, interest in investigating these transporters as therapeutic targets has waned.  However, with the emergence of new data and advanced techniques, we propose to re-evaluate whether these transporters play a clin. role in multidrug resistance.  With this Opinion article, we present recent evidence indicating that it is time to revisit the investigation into the role of ABC transporters in efficient drug delivery in various cancer types and at the blood-brain barrier.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTrmO71Nb38rVg90H21EOLACvtfcHk0lgMTBttRZz20g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXosVCgt7Y%253D&md5=9c4b00f17a7ae98158862504bf1a8292</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fs41568-018-0005-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41568-018-0005-8%26sid%3Dliteratum%253Aachs%26aulast%3DRobey%26aufirst%3DR.%2BW.%26aulast%3DPluchino%26aufirst%3DK.%2BM.%26aulast%3DHall%26aufirst%3DM.%2BD.%26aulast%3DFojo%26aufirst%3DA.%2BT.%26aulast%3DBates%26aufirst%3DS.%2BE.%26aulast%3DGottesman%26aufirst%3DM.%2BM.%26atitle%3DRevisiting%2520the%2520role%2520of%2520ABC%2520transporters%2520in%2520multidrug-resistant%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2018%26volume%3D18%26spage%3D452%26epage%3D464%26doi%3D10.1038%2Fs41568-018-0005-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kopecka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campia, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frei, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghigo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wollscheid, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riganti, C.</span></span> <span> </span><span class="NLM_article-title">Carbonic anhydrase XII is a new therapeutic target to overcome chemoresistance in cancer cells</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">6776</span>– <span class="NLM_lpage">6793</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.2882</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=10.18632%2Foncotarget.2882" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=6776-6793&author=J.+Kopeckaauthor=I.+Campiaauthor=A.+Jacobsauthor=A.+P.+Freiauthor=D.+Ghigoauthor=B.+Wollscheidauthor=C.+Riganti&title=Carbonic+anhydrase+XII+is+a+new+therapeutic+target+to+overcome+chemoresistance+in+cancer+cells&doi=10.18632%2Foncotarget.2882"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.2882&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.2882%26sid%3Dliteratum%253Aachs%26aulast%3DKopecka%26aufirst%3DJ.%26aulast%3DCampia%26aufirst%3DI.%26aulast%3DJacobs%26aufirst%3DA.%26aulast%3DFrei%26aufirst%3DA.%2BP.%26aulast%3DGhigo%26aufirst%3DD.%26aulast%3DWollscheid%26aufirst%3DB.%26aulast%3DRiganti%26aufirst%3DC.%26atitle%3DCarbonic%2520anhydrase%2520XII%2520is%2520a%2520new%2520therapeutic%2520target%2520to%2520overcome%2520chemoresistance%2520in%2520cancer%2520cells%26jtitle%3DOncotarget%26date%3D2015%26volume%3D6%26spage%3D6776%26epage%3D6793%26doi%3D10.18632%2Foncotarget.2882" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibahara, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugiyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanamori, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonoda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tominaga, T.</span></span> <span> </span><span class="NLM_article-title">Temozolomide reverses doxorubicin resistance by inhibiting P-glycoprotein in malignant glioma cells</span>. <i>J. Neuro-Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">235</span>– <span class="NLM_lpage">242</span>, <span class="refDoi"> DOI: 10.1007/s11060-015-1968-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=10.1007%2Fs11060-015-1968-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=26530267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVaqsr7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2016&pages=235-242&author=R.+Zhangauthor=R.+Saitoauthor=I.+Shibaharaauthor=S.+Sugiyamaauthor=M.+Kanamoriauthor=Y.+Sonodaauthor=T.+Tominaga&title=Temozolomide+reverses+doxorubicin+resistance+by+inhibiting+P-glycoprotein+in+malignant+glioma+cells&doi=10.1007%2Fs11060-015-1968-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Temozolomide reverses doxorubicin resistance by inhibiting P-glycoprotein in malignant glioma cells</span></div><div class="casAuthors">Zhang, Rong; Saito, Ryuta; Shibahara, Ichiyo; Sugiyama, Shinichiro; Kanamori, Masayuki; Sonoda, Yukihiko; Tominaga, Teiji</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuro-Oncology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">235-242</span>CODEN:
                <span class="NLM_cas:coden">JNODD2</span>;
        ISSN:<span class="NLM_cas:issn">0167-594X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Temozolomide is a std. chemotherapy agent for malignant gliomas, but the efficacy is still not satisfactory.  Therefore, combination chemotherapy using temozolomide with other anti-tumor compds. is now under investigation.  Here we studied the mechanism of the synergistic anti-tumor effect achieved by temozolomide and doxorubicin, and elucidated the inhibitory effect of temozolomide on P-glycoprotein (P-gp).  Temozolomide significantly enhanced sensitivity to P-gp substrate in glioma cells, particularly in P-gp-overexpressed cells.  Synergetic effects, as detd. by isobologram anal., were obsd. by combining temozolomide and doxorubicin.  Subsequently, flow cytometry was utilized to assess the intracellular retention of doxorubicin in cells treated with doxorubicin with or without temozolomide.  Temozolomide significantly increased the accumulation of doxorubicin in these cells.  The P-gp ATPase (ATPase) assay showed that temozolomide inhibited the ATPase activity of P-gp.  In addn., temozolomide combined with doxorubicin significantly prolonged the survival of 9L intracranial allografted glioma-bearing rats compared to single agent treatment.  Collectively, our findings suggest that temozolomide can reverse doxorubicin resistance by directly affecting P-gp transport activity.  Combination chemotherapy using temozolomide with other agents may be effective against gliomas in clin. applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrReNjnit1DUrVg90H21EOLACvtfcHk0lgMTBttRZz20g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVaqsr7P&md5=53920a514ad0859a2c02eedc7b64710b</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1007%2Fs11060-015-1968-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11060-015-1968-x%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DSaito%26aufirst%3DR.%26aulast%3DShibahara%26aufirst%3DI.%26aulast%3DSugiyama%26aufirst%3DS.%26aulast%3DKanamori%26aufirst%3DM.%26aulast%3DSonoda%26aufirst%3DY.%26aulast%3DTominaga%26aufirst%3DT.%26atitle%3DTemozolomide%2520reverses%2520doxorubicin%2520resistance%2520by%2520inhibiting%2520P-glycoprotein%2520in%2520malignant%2520glioma%2520cells%26jtitle%3DJ.%2520Neuro-Oncol.%26date%3D2016%26volume%3D126%26spage%3D235%26epage%3D242%26doi%3D10.1007%2Fs11060-015-1968-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khalifah, R. G.</span></span> <span> </span><span class="NLM_article-title">The carbon dioxide hydration activity of carbonic anhydrase</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1971</span>,  <span class="NLM_volume"><i>246</i></span>,  <span class="NLM_fpage">2561</span>– <span class="NLM_lpage">2573</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=10.1016%2FS0021-9258%2818%2962326-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=4994926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=1%3ACAS%3A528%3ADyaE3MXhtlGmu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=246&publication_year=1971&pages=2561-2573&author=R.+G.+Khalifah&title=The+carbon+dioxide+hydration+activity+of+carbonic+anhydrase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Carbon dioxide hydration activity of carbonic anhydrase.  I.  Stop-flow kinetic studies on the native human isoenzymes B and C</span></div><div class="casAuthors">Khalifah, Raja G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1971</span>),
    <span class="NLM_cas:volume">246</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2561-73</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">The kinetics of catalysis of carbon dioxide hydration by human carbonic anhydrases B and C (EC 4.2.1.1) has been reinvestigated with the use of an improved pH indicator stop-flow approach that was checked by studying the uncatalyzed rate of hydration, with Michaelis-Menten parameters being detd. between pH 5.8 and 8.8 in noninhibitory buffers.  For both isoenzymes, Km was independent of pH, whereas Vmax increased with increasing pH with results being similar to the finding of others on bovine carbonic anhydrase, but differing from earlier reports of Gibbons and Edsall (1964) in the finding that Km was pH-independent.  Despite the differences between the low and high activity forms of the enzyme, there were close kinetic similarities between them that indicated underlying similarities in active site structure.  Imidazole (I) (0.22-1.32M) inhibited the B enzyme, apparently competitively, and had no effect on the C enzyme.  N-Methyl substitution of I abolished its inhibitory effect.  Nitrous oxide (11-45mM) did not inhibit catalysis of carbon dioxide hydration by either of the 2 human isoenzymes, or by bovine carbonic anhydrase.  The enzyme-catalyzed hydration of carbon dioxide probably requires not only water activation by a basic group, but also charge neutralization in the transition state by an electron acceptor function.  The zinc-bound water in carbonic anhydrase could be involved in both donor and acceptor roles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGri57EkpgPMx7Vg90H21EOLACvtfcHk0lgMTBttRZz20g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3MXhtlGmu7k%253D&md5=2764970fcd4f08250b28b9e8e9474681</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2FS0021-9258%2818%2962326-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9258%252818%252962326-9%26sid%3Dliteratum%253Aachs%26aulast%3DKhalifah%26aufirst%3DR.%2BG.%26atitle%3DThe%2520carbon%2520dioxide%2520hydration%2520activity%2520of%2520carbonic%2520anhydrase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1971%26volume%3D246%26spage%3D2561%26epage%3D2573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drillaud, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornaghi, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulsen, S.-A.</span></span> <span> </span><span class="NLM_article-title">Synthesis of S-glycosyl primary sulfonamides</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">2811</span>– <span class="NLM_lpage">2816</span>, <span class="refDoi"> DOI: 10.1021/jo9000367</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo9000367" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2009&pages=2811-2816&author=M.+Lopezauthor=N.+Drillaudauthor=L.+F.+Bornaghiauthor=S.-A.+Poulsen&title=Synthesis+of+S-glycosyl+primary+sulfonamides&doi=10.1021%2Fjo9000367"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjo9000367&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo9000367%26sid%3Dliteratum%253Aachs%26aulast%3DLopez%26aufirst%3DM.%26aulast%3DDrillaud%26aufirst%3DN.%26aulast%3DBornaghi%26aufirst%3DL.%2BF.%26aulast%3DPoulsen%26aufirst%3DS.-A.%26atitle%3DSynthesis%2520of%2520S-glycosyl%2520primary%2520sulfonamides%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2009%26volume%3D74%26spage%3D2811%26epage%3D2816%26doi%3D10.1021%2Fjo9000367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Winum, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vullo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montero, J.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scozzafava, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supuran, C. T.</span></span> <span> </span><span class="NLM_article-title">Carbonic anhydrase inhibitors. Inhibition of cytosolic isozymes I and II and transmembrane, tumor-associated isozyme IX with sulfamates including EMATE also acting as steroid sulfatase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">2197</span>– <span class="NLM_lpage">2204</span>, <span class="refDoi"> DOI: 10.1021/jm021124k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm021124k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtFagtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=2197-2204&author=J.-Y.+Winumauthor=D.+Vulloauthor=A.+Casiniauthor=J.-L.+Monteroauthor=A.+Scozzafavaauthor=C.+T.+Supuran&title=Carbonic+anhydrase+inhibitors.+Inhibition+of+cytosolic+isozymes+I+and+II+and+transmembrane%2C+tumor-associated+isozyme+IX+with+sulfamates+including+EMATE+also+acting+as+steroid+sulfatase+inhibitors&doi=10.1021%2Fjm021124k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Carbonic Anhydrase Inhibitors. Inhibition of Cytosolic Isozymes I and II and Transmembrane, Tumor-Associated Isozyme IX with Sulfamates Including EMATE Also Acting as Steroid Sulfatase Inhibitors</span></div><div class="casAuthors">Winum, Jean-Yves; Vullo, Daniela; Casini, Angela; Montero, Jean-Louis; Scozzafava, Andrea; Supuran, Claudiu T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2197-2204</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of sulfamates or bis-sulfamates incorporating aliph., arom., polycyclic (steroidal), and sugar moieties in their mols. has been synthesized and assayed as inhibitors of the zinc enzyme carbonic anhydrase (CA), and more precisely of the cytosolic isoenzymes CA I andII, and the transmembrane, tumor-assocd. isoenzymes CA IX.  Some of these compds. were previously reported to act as inhibitors of steroid sulfatases, among which estrone sulfatase (ES) and dehydroepiandrosterone sulfatase (DHEAS) are the key therapeutic targets for estrogen-dependent tumors.  Very potent (nanomolar) inhibitors were detected against the three investigated CA isoenzymes.  Best CA I inhibitors were phenylsulfamate and some of its 4-halogeno derivs., as well as the aliph. compd. n-octyl sulfamate.  Against CA II, low nanomolar inhibitors (1.1 - 5 nM) were phenylsulfamate and some of its 4-halogeno/nitro derivs., n-octyl sulfamate, and estradiol 3,17β-disulfamate among others.  All the investigated sulfamates showed efficient CA IX inhibitory properties, with inhibition consts. in the range of 18 - 63 nM.  The best CA IX inhibitor detected so far was 4-chlorophenylsulfamate.  These data are crit. for the design of novel antitumor properties, mainly for hypoxic tumors that overexpress CA IX, which are nonresponsive to radiation or chemotherapy.  The antitumor properties of the ES/DHEAS inhibitors in clin. trials may on the other hand also be due to their potent inhibitory properties of CA isoenzymes involved in tumorigenicity, such as CA II and CA IX.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5jPZo4GLHsbVg90H21EOLACvtfcHk0ljwiGtwaaIu_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtFagtrk%253D&md5=409f29b6cc34daa89727aeb0b258ee9d</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm021124k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm021124k%26sid%3Dliteratum%253Aachs%26aulast%3DWinum%26aufirst%3DJ.-Y.%26aulast%3DVullo%26aufirst%3DD.%26aulast%3DCasini%26aufirst%3DA.%26aulast%3DMontero%26aufirst%3DJ.-L.%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DCarbonic%2520anhydrase%2520inhibitors.%2520Inhibition%2520of%2520cytosolic%2520isozymes%2520I%2520and%2520II%2520and%2520transmembrane%252C%2520tumor-associated%2520isozyme%2520IX%2520with%2520sulfamates%2520including%2520EMATE%2520also%2520acting%2520as%2520steroid%2520sulfatase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D2197%26epage%3D2204%26doi%3D10.1021%2Fjm021124k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vullo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Innocenti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishimori, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pastorek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scozzafava, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pastoreková, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supuran, C. T.</span></span> <span> </span><span class="NLM_article-title">Carbonic anhydrase inhibitors. Inhibition of the transmembrane isozyme XII with sulfonamides—a new target for the design of antitumor and antiglaucoma drugs?</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">963</span>– <span class="NLM_lpage">969</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2004.12.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=10.1016%2Fj.bmcl.2004.12.053" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=963-969&author=D.+Vulloauthor=A.+Innocentiauthor=I.+Nishimoriauthor=J.+Pastorekauthor=A.+Scozzafavaauthor=S.+Pastorekov%C3%A1author=C.+T.+Supuran&title=Carbonic+anhydrase+inhibitors.+Inhibition+of+the+transmembrane+isozyme+XII+with+sulfonamides%E2%80%94a+new+target+for+the+design+of+antitumor+and+antiglaucoma+drugs%3F&doi=10.1016%2Fj.bmcl.2004.12.053"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2004.12.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2004.12.053%26sid%3Dliteratum%253Aachs%26aulast%3DVullo%26aufirst%3DD.%26aulast%3DInnocenti%26aufirst%3DA.%26aulast%3DNishimori%26aufirst%3DI.%26aulast%3DPastorek%26aufirst%3DJ.%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DPastorekov%25C3%25A1%26aufirst%3DS.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DCarbonic%2520anhydrase%2520inhibitors.%2520Inhibition%2520of%2520the%2520transmembrane%2520isozyme%2520XII%2520with%2520sulfonamides%25E2%2580%2594a%2520new%2520target%2520for%2520the%2520design%2520of%2520antitumor%2520and%2520antiglaucoma%2520drugs%253F%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D963%26epage%3D969%26doi%3D10.1016%2Fj.bmcl.2004.12.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kopecka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salzano, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campia, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lusa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghigo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Rosa, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riganti, C.</span></span> <span> </span><span class="NLM_article-title">Insights in the chemical components of liposomes responsible for P-glycoprotein inhibition</span>. <i>Nanomedicine</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">77</span>– <span class="NLM_lpage">87</span>, <span class="refDoi"> DOI: 10.1016/j.nano.2013.06.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=10.1016%2Fj.nano.2013.06.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=23850894" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1altLnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=77-87&author=J.+Kopeckaauthor=G.+Salzanoauthor=I.+Campiaauthor=S.+Lusaauthor=D.+Ghigoauthor=G.+De+Rosaauthor=C.+Riganti&title=Insights+in+the+chemical+components+of+liposomes+responsible+for+P-glycoprotein+inhibition&doi=10.1016%2Fj.nano.2013.06.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Insights in the chemical components of liposomes responsible for P-glycoprotein inhibition</span></div><div class="casAuthors">Kopecka, Joanna; Salzano, Giuseppina; Campia, Ivana; Lusa, Sara; Ghigo, Dario; De Rosa, Giuseppe; Riganti, Chiara</div><div class="citationInfo"><span class="NLM_cas:title">Nanomedicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">77-87</span>CODEN:
                <span class="NLM_cas:coden">NANOBF</span>;
        ISSN:<span class="NLM_cas:issn">1549-9634</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">In this work we investigated how the surface charge and the presence of polyethylene glycol (PEG) on liposome carriers affect the delivery of the encapsulated doxorubicin in P-glycoprotein (Pgp)-overexpressing cells.  We found that neutral net charge was crit. to favor the liposome uptake and decrease the Vmax of doxorubicin efflux.  PEG-coating was necessary to increase the Km of doxorubicin for Pgp.  In particular the PEGylated phospholipid present in neutral liposomes, i.e.  PEGylated distearoyl-phosphatidylethanolamine (DSPE-PEG), was a Pgp allosteric inhibitor, increased doxorubicin Km and inhibited Pgp ATPase activity.  Site-directed mutagenesis expts. suggested that the domain centered around glycine 185 of Pgp was necessary for these inhibitory properties of DSPE-PEG and PEGylated neutral liposomes.  We conclude that both surface charge and PEGylation must be considered to optimize the doxorubicin delivery within chemoresistant cells.  DSPE-PEG-enriched particles may represent promising tools for therapeutic and diagnostic applications in tissues with high levels of Pgp.  From the Clin. Editor: These authors investigated how surface charge and PEGylation of liposome carriers affect the delivery of encapsulated doxorubicin to Pgp-overexpressing cells, concluding that both factors need to be considered to optimize doxorubicin delivery to chemoresistant cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPloIAvjdG3bVg90H21EOLACvtfcHk0ljwiGtwaaIu_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1altLnO&md5=8ac17aeda34790cf65afb79d53003b8b</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.nano.2013.06.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nano.2013.06.013%26sid%3Dliteratum%253Aachs%26aulast%3DKopecka%26aufirst%3DJ.%26aulast%3DSalzano%26aufirst%3DG.%26aulast%3DCampia%26aufirst%3DI.%26aulast%3DLusa%26aufirst%3DS.%26aulast%3DGhigo%26aufirst%3DD.%26aulast%3DDe%2BRosa%26aufirst%3DG.%26aulast%3DRiganti%26aufirst%3DC.%26atitle%3DInsights%2520in%2520the%2520chemical%2520components%2520of%2520liposomes%2520responsible%2520for%2520P-glycoprotein%2520inhibition%26jtitle%3DNanomedicine%26date%3D2014%26volume%3D10%26spage%3D77%26epage%3D87%26doi%3D10.1016%2Fj.nano.2013.06.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i80"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00282">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_77545"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.9b00282">10.1021/acs.jmedchem.9b00282</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline"><sup>1</sup>H and <sup>13</sup>C NMR spectral data images of all compounds, Supporting Information Figure 1 showing biological activity of <b>1</b> and <b>55</b> in doxorubicin-treated cells, Supporting Information Table 1 listing in vitro mouse plasma stability and mouse microsome stability data for compound <b>55</b>, and supporting Information Table 2 listing expression profile of Pgp and CA XII in AC and NS glioblastoma cells (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00282/suppl_file/jm9b00282_si_001.pdf">PDF</a>)</p></li><li><p class="inline">SMILES format representations of compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00282/suppl_file/jm9b00282_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00282/suppl_file/jm9b00282_si_001.pdf">jm9b00282_si_001.pdf (5.15 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00282/suppl_file/jm9b00282_si_002.csv">jm9b00282_si_002.csv (4.3 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b00282&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b00282%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-8" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b00282" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677b6ceda85a3d1e","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
